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The work in this thesis is a study of the endocrin¬
ology of pregnancy in the marmoset monkey, Callithrix
jacchuso The hormonal profiles in the peripheral plasma
were studied during pregnancy and lactation, Samples
were taken from timed pregnancies throughout gestation to
investigate ovarian and placental function, the fetal
hormonal environment and the fetal development0 The
hormonal changes and the relative ovarian and placental
function during pregnancy in primate species is reviewed.
The marmoset may ovulate and conceive soon
after giving birth. Suckling was not associated with any
lengthening of the interval between birth and post-partum
ovulation despite elevated prolactin levels. Concentra¬
tions of LH/CG, androstenedione and testosterone rose in
early pregnancy to maximum values at 6-10 weeks. Proges¬
terone, oestradiol-17p and oestrone increased after ovulat¬
ion and remained high throughout pregnancy, Oestrone was
the major oestrogen for the first 12 weeks of pregnancy.
Progesterone declined at 3-5 weeks of pregnancy and then
remained relatively stable until 12 weeks. At 13 weekSj
progesterone and oestradiol rose rapidly above the luteal
phase range. Whereas maximum oestradiol and oestrone
levels were found during the last week of pregnancy, pro¬
gesterone levels significantly declined. There was a
decline in prolactin levels between 10-19 weeks followed
by an increase during the last week of pregnancy,
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The corpus luteum was the major source of proges¬
terone and oestrone for the first 50-60 days of pregnancy,
although its function declined between 20-60 days0 In
contrast, utero-ovarian oestradiol levels were not related
to the presence or absence of the corpus luteum,, The
placental contribution to hormonal levels became increas¬
ingly evident between 50-80 days^and by 90 days/was the
major hormonal source and was responsible for the steep
increase in progesterone and oestradiol which occurred at
this time.
The profile of the placental content of LIl/CG,
progesterone and oestrogens was. similar to the profiles
in the peripheral plasma, whereas the profile of the
placental content of androgens was. different.
In addition, the placenta secretion of progesterone and
LH/CG in vitro reflected the proposed in vivo function.
Progesterone, oestrogen and androgen concentrations
increased in the fetus between 90-100 days of pregnancy.
This was coincident with the increased placental content
of all these hormones and the increased progesterone and
oestradiol peripheral plasma levels. There was no overall
sex difference for any of the fetal hormones. Although
there was a sex difference for testosterone and progester¬
one in male-female co-twins, it appeared that testicular
androgen secretion was not a major component in male
androgen levels.
The hormonal data indicated that comparable hormonal
changes in the peripheral plasma occurred later in gesta¬
tion than in other spebies. Also, the ovary remained
V
important for longer and a major placental influence on
hormonal levels occurred later. Prenatal growth mea¬
surements showed that marmoset development also occurred
more slowly for the first half of pregnancy. However,
during the latter half, there were similar patterns and
rates of growth as for other primate species, and at
birth, a comparable ratio to the adult size was achieved.
The data on prenatal growth could be utilised as stand¬
ards of growth by other investigators as it was related to
an accurate gestational age.
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CHAPTER 1 : GENERAL INTRODUCTION
This thesis is concerned with the hormonal profiles
in the peripheral plasma, and with ovarian and placental
function during pregnancy in the marmoset monkey,
Callithrix jacchus0 The fetal hormonal profiles and devel¬
opment were also assessed in timed pregnancies and related
to the hormonal profiles in the peripheral plasma and to
ovarian-placental function. The hormones measured in this
thesis included progesterone (4-pregnene-3, 20-dione),
oestradiol 17-"^ ( 1, 3 , 5 £l0) -oestratriene-3 ,17 ^ -diol ) ,
oestrone (3-hydroxy-l, 3 ,'5 Ciol -oestratrien~17~4-one),
androstenedione (4-androstene-3,17-dione) testosterone (17p-
hydroxy-4-androsten-3-one), prolactin and luteinising-
hormone/chorionic gonadotrophin (LH/CG).
In this chapter, the quantitative and qualitative
hormonal changes in the peripheral plasma and ovarian and
feto-placental function during pregnancy are reviewed
(section 1,1 to 1.4) for the human and the primate species
which have been developed as laboratory models for studies
on pregnancy. The review is confined to the aforementioned
hormones. In section 1.5, the studies on the marmoset that
are relevant to its use as a sub-human primate model in
reproductive research are reviewed. The aims and scope of
this thesis are given in section 1.6. Relevant references to
fetal endocrinology and development are reviewed in Chapters
6 an d 7.
I
1.1 Quantitative changes - Interspecies comparison
One of the first steps in evaluating a species as a
possible model for studies on human reproduction is com¬
parison of its hormonal levels and profiles0 A quantita¬
tive comparison of the values found at the end of pregnancy
shows that there is enormous interspecies variation in
levels. The highest plasma progesterone and oestradiol
values during pregnancy are found in women (Tulchinsky,
Hobel, Yeager and Marshall, 1972; Dellertogh, Thomas,
Bietlot, Vanderheyden and Ferin, 1975) and marmosets
(Hearn and Lunn, 1975; Chambers and Hearn, 1979); intermed¬
iate values in the chimpanzee (Reyes, Winter, Faiman and
Hobson, 1975) and the lowest values among the Old World
primates so far studied: the baboon (Papio bamadryas)
(Dawood and Fuchs, 1980; Albrecht and Townsley, 1976),
sooty mangabey (Cercocebus atys) (Stabenfeldt and Hendrickx
1973a), African green monkey (Cercopithecus aethiops)
(Hess, Hendrickx and Stabenfeldt, 1979), and the macaque
species; which include the rhesus (Macaca mulatta). (Neill,
Johansson and Knobil, 1969; Bosu, Johansson and Gonzell,
1973a and b; Challis, Davies, Benirschke, Hendrickx and
Ryan, 1974; Weiss, Butler, Hotchkiss, Dierschke and Knobil,
1976), bonnet (Macaca radiata) (Stabenfeldt and Hendrickx,
1972), crab-eating (Macaca fascicularis) (Stabenfeldt and
Hendrickx, 1973b; Hodgen, Stouffer, Barber and Nixon, 1977)
and pig-tailed monkeys (Macaca nemestrina) (Chandrashekar
et al. 1980),
Why are there interspecies variations in the hormonal
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levels during pregnancy? Factors that could be inves¬
tigated are production rates, metabolic clearance rates,
levels of binding proteins, etc. . For example, the sub¬
stantial difference between the human and rhesus in
hormonal levels is due, at least in part, to diminished
endocrine activity of the monkey placenta. Associated
with the lower progesterone levels in the rhesus are
lower placental progesterone concentrations (human:
Zander and von Munstermann, 1956: Runnebaum, Runnebaum,
Stober and Zander, 1975; Runnebaum, Stober and Zander,
1975; rhesus: Short and Eckstein, 1961; Hagemenas and
Kittinger, 1974), a lower progesterone production rate
(human: Lin et al, 1972; rhesus; Thau, Lanman and Brinson,
1977) and in addition, lower plasma levels of progesterone
binding proteins (human: Slaunwhite and Sandberg, 1959;
Doe, Fernandez and Seal, 1964; rhesus: Beamer, Hagemenas
and Kittinger, 1972).
Comparison of peripheral concentrations give little
indication of the dynamics of the production and metabolism,
and does not show whether the availability to target tiss¬
ues is affected by binding to high-affinity plasma proteins
or by the availability of receptors in the target tissue.
This point is partly illustrated by a comparison between
the human.and guinea pig. Both species show a substan¬
tial increase in progesterone values to high levels during
pregnancy. However, unlike the human, the increase in
the guinea pig was primarily caused by a decrease in the
metabolic clearance rate whereas in the human the increase
was primarily caused by an increase in the production rate
(Challis, Heap, Illingworth, 1971; Illingworth, Heap and
Perry, 1970)„ This alteration in metabolism in the
guinea pig was related to the production in pregnancy of
a progesterone binding protein, which binds a high percen¬
tage of progesterone (Heap and Illingworth, 1974), thus
a much smaller amount of progesterone is actually avail¬
able to the target tissues0
To what extent do the levels achieved by a species
during pregnancy reflect the requirement for these levels?
It may be of clinical interest to establish the minimum
hormonal level compatible with continuing pregnancy so
thati if necessary, appropriate therapy could be instituted.
Studies of this nature have been mostly confined to the
human, but sub-human species may have a significant role
to play in assessing the effect of treatments used to
prevent abort ion;as the treatment may have unexpected
effects on aspects of the pregnancy (e.g. fetal development)
that were not initially considered (e.g. progestin adminis¬
tration - see Whalen, Peck and Lo Piccolo, 1966 )„
1.2 The peripheral plasma hormonal profiles during
pregnancy
(a) Human
The hormonal profiles are reviewed for specific
hormones in the human and are compared with the results for
the marmoset obtained in this thesis in Chap 4. The rela¬
tionship of progesterone, oestradiol and LH/CG to ovarian
M
and/or placental function are reviewed later in separate
sections (1„4 and 1,5).
(i ) Progesterone
The conception cycle resembles the non-
fertile cycle until 8 to 11 days after the pre-ovulatory
LH peak, when hCG is first elevated and progesterone
values remain high0 Progesterone continues to rise for
the first 3 weeks of pregnancy coincident with the rapidly
increasing hCG concentrations (Mishell, Thorneycroft,
Nagata, Murata and Nakamura, 1973; Corker, Michie, Hobson
and Parboosingh, 1976).
It might be expected that the progester¬
one profiles during pregnancy are well defined for the
human, in view of the possible clinical importance in estab¬
lishing normal levels and trends in the diagnosis and
treatment of abortion associated with hormone deficiency.
However, there is often disagreement among authors.
Between the third and eighth week of pregnancy, some report
a further insignificant rise (Tulchinsky and Hobel, 1973),
a plateau (Harrison, Youssefnejadian, Brodovcky, Johnson
and Dewhurst, 1978 ) or a fall (Johannson, 1969; Yoshimi,
Strott, Marshall and Lipsett, 1969; Mishell et al, 1973;
Corker et al, 1976) in progesterone levels. The criteria
used for the selection of patients, the sampling regimes
and the methods for dating samples must be examined to
evaluate the conclusions. For instance, only for 3 of
the studies were results calculated using serial samples
from several individuals (Tulchinsky and Hobel, 1973;
Harrison et al, 1978; Corker et a1. 1976). Another
included results from both serial sampling regimes from
a small number of patients, and individual samples (Mishell
et al, 1973)„ These studies usually fairly accurately
estimated the gestational age by a combination of menstrual
history, basal body temperature charts, vaginal smears,
ultrasound measurements and/or hormonal measurements
around ovulation„ In contrast, the stage of gestation in
Johannson's study was often estimated on the menstrual
history alone and, since several of the patients were
scheduled for therapeutic abortion, only limited numbers
of serial samples from different times ranges "were obtained.
The study of Yoshimi et al included data from gonadotrophin-
induced pregnancies, in which there may have been over¬
stimulation of the ovaries (Fogel, Rubin and Ossowski, 1972)
and levels in this study were higher than those generally
reported by others. The last factor to be considered is
the normal individual variation in trends and levels.
All of the studies in which serial samples were taken over
the whole time range from normal pregnancies showed that
there was a wide range in individual values and trends.
The diagnostic value^ thertfore, of following progesterone levels
remains debatable, and is possibly only useful if the
levels and trends fall well outwith the normal pattern, or
at least, are analysed in combination with other data
(reviewed: Batzer, 1980).
It is generally agreed that by about the
*
8-9th week of pregnancy, a steeper increase in progesterone
is initiated. Thereafter, there is a-sustained rise
until 1-3 weeks before term (Johansson, 1969; Lindberg,
t
Nilsson and Johansson, 1974; Tulchinsky et al, 1972;
Batra, Bengtsson, Grundsell. and Sjoberc^, 1976) or until
term (Yannone, McGardy and Goldfein, 1968; Johansson and
Jonasson, 1971)„ A significant fall in progesterone in
the weeks preceding birth has also been reported (Csapo,
Knobil, vanderMolen and Wiest, 1971; Turnbull et al, 1974)
but other more recent studies have failed to confirm this
(loc cit). The decline in progesterone was not observed
in all the patients in Turnbull's et' al study (1974), and
was only reflected in mean values if strict criteria were
used in the selection of patients0 The fall in progesterone
in Csapo's et al study (1971) was small compared with the
wide range of individual levels observed at the onset of
labour„
The interest in progesterone during the
last weeks of pregnancy is partly related to its physiolo¬
gical effects, which have been largely encompassed in
the theory of 'progesterone withdrawal' formulated primar¬
ily by Csapo and co-workers (1956, 1959, 1977 and others). How¬
ever, this theory was based primarily on studies in the
rabbit, and although a significant decline in plasma.pro¬
gesterone is also observed in other species (e.g. sheep,
cow, pig, goat), it does not appear to be a prerequisite
for the onset of labour (reviews include: Bedford, Challis,
Harrison and Heap, 1972; Thorburn, Ch'allis and Currie,
1977; Challis 1980). The human studies show that there
is not a consistent change in the peripheral plasma prog¬
esterone level during late pregnancy in women. This has
1
led to the questioning of the relevance of measuring the
peripheral plasma level,, It may not necessarily reflect
local changes in intrauterine tissues (review: Batra,
1979)^the uterine circulation (Thau, Lanman and Brinson,
1976)^ or the myometrial "action of progesterone" (Csapo,
Eskola and Ruttner, 1980). Changes in the binding prot¬
eins in the fetal membranes may cause local progesterone
withdrawal (Schwarz, Milewich, Johnston, Porter and
MacDonald, 1976)^ which may trigger the initial steps that
lead to the preparturient increase in prostaglandin
production (Challis, 1980) „
(ii) Oestradiol and oestrone
Oestrone and oestradiol rise continu¬
ously after the postovulatory nadir (Tulchinsky and Hobel,
1973; Mishell et al, 1972; Thomas, DeHertogh, Pizarro,
van Exeter and Ferin, 1973), in part,as a result of the
pregnancy-induced increase in sex steroid-binding globulins
(Westphal, 1971). Oestradiol has been noted by some
authors to be useful for evaluation of early pregnancy.
Abnormal oestradiol levels appear to be as predictive as
progesterone (see above) or possibly more so (Brown, Evans,
Beischer, Campbell and Fortune, 1970; Kunz and Keller,
1976; Jovanovic, Dawood, Landesman and Saxena, 1978;
Batzer, 1980).
Unlike progesterone, both oestrogens
increase during the first 8-9 weeks of pregnancy but.; like
progesterone, there is a more rapid increase after the
8-9th week, which continues until term (Tulchinsky et al
1972; Sybulski and Maughan, 1972; Lindberg, Johansson,
8
Nilsson, 1974; Dehertogh et al, 1975; and others )„
Turnbull etal (1974) found a sharp increase in the oes-
tradiol levels over the last 6 weeks in the same group of
patients for which he reported a significant decline in
progesterone (section 1.3a-ii)0 However, other studies
(loc cit), have found no consistent marked change in
levels at term,,
(iii) Androgens
During pregnancy, there is a significant
increase in the testosterone level (Mizuno, Lobotsky,
Lloyd, Iioboyaski and Murasawa, 1968; Rivarola, Forest and
Migeon, 1968; Gandy, 1971; 1977; Dawood and Saxena, 1977;
Klinga, Bek and Runnebaum, 1978; Nagami, McDonough, Ellegood
and Mahesh, 1979; Bamman, Coulam and Jiang, 1980) and an
increase in androstenedione which may (Mizuono et al, 1968;
Gandy, 1971, 1977) or may not (Rivarola et al, 1968) be
significant„ In those studies in which there was a signif
icant increase in levels, the increase occurred during the
first trimester and again at about 37 weeks.
Although there is a sex difference in
fetal plasma and amniotic fluid testosterone levels, at
least from approximately week 7 to 20 (Chapter 7.1 for
references), it was not reported by Gandy (1971, 1977) or
by Dawood and Saxena (1977), as being reflected in the
maternal plasma„ This was felt to be compatible with the
view that the effective aromatase system of the placenta
would protect the maternal compartment from receiving large
amounts of androgens (Beling, 1977) „ A more recent study
by Klinga et a] (1978) did find' a significant difference
in maternal plasma testosterone levels between 7 and 14
weeks dependent on the sex of the fetus. Has study in¬
cluded data from more individuals, and although the diff¬
erence was significant, the overlap between the 2 groups
was large. Therefore determination of maternal testos¬
terone levels would still give no reliable indication of
the fetal sex. The other studies either did not cover
this period of pregnancy, or had only a limited number of
samples to compare„
The significance of raised androgen
levels during pregnancy is not known, The increases may
simply be related to sex-hormone-binding globulin (SHBG)
levels, which increase during pregnancy (Pearlman, Crepy
and Murphy, 1967; Rivarola et al, 1967; Anderson, 1974)
and following oestrogen administration (Migeon, Rivarola
and Forest, 1968). A few investigators have noted, that
pregnancies with testosterone levels within the normal
non-pregnancy range often terminated in abortion.
The abnormal conceptus may not have produced enough oes¬
trogen to induce sufficient quantities to SHBG to increase
plasma testosterone levels significantly (Vermeulen,
Verdonck, Vander Straeten and Orie, 1969; Barman et al,
1980). The lack of virilisation during pregnancy is
often attributed to the lack of increase in the unbound
fraction of testosterone (Rivarola et al, 1968; Forest,
Ances, Tapper and Migeon, 1971) although Ba'nmann1 s et a 1
(1980) data indicated an increase in free testosterone
level after week 28.
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(iv) Human chorionic gonadotrophIn (hCG)
It is generally reported, using various
assay systems, that hCG is first detected in serum about
9-13 days after ovulation (Vaitukaitis, Braunstein and
Ross, 1972; Kosasa, Levesque, Goldstein and Taymor, 1973;
Mishell, Nakamura, Barberia and Thorneycroft, 1974; Catt,
Dufau and Vaitukaitis, 1975). The detection of hCG-like
activity on day 5 by Saxena, Hasan, Haour and Schmidt-
Gollwitzer (1974), using a. radioreceptor assay, has not
been confirmed0
Following its initial detection, hCG
rises to maximum values at 6 to 10 weeks of pregnancy
(Marshall et al, 1968; Tulchinsky and .Hobel, 1973;
Braunstein, Rasor, Adler, Danzer and Wade, 1976)^ and then
decreases to approximately 10% of peak values for the
remainder of gestation. Some investigators report a small
secondary rise in the last trimester, the height of
which may be related to the sex of the fetus (Boroditsky,
Reyes, Winter and Faiman, 1975; Penny, Olambiwonnu and
Frasier, 1976). The actual level measured depends on the
assay employed. Biological in vivo and in vitro assay
systems generally show peak values 2 to 3 times higher than
specific hCG radioimmunassays (Vaitukaitus, 1977) „
A correlation between the pattern of hCG
and events occurring during pregnancy has led to much res¬
earch as to its possible functions. For .each proposed func¬
tion, an effect of hCG has been shown, but'it has hot been
verified that the effect is caused exclusively by hCGyand
i!
the role of other factors, including other hormones, has
not been excluded.
What are some of the proposed functions?
first, the initial detection in plasma corresponds to the
implantation period and an immunosuppressive role has been
suggested (Adcock et al, 1973; Borland, Loke and Wilson,
1975)o Second, rising levels of hCG occur when the life
of the corpus luteum is extended into early pregnancy
(reviewed: Goebelsmann, 1979; Talwar, 1979). A luteo-
trophic function exists for only a limited time as corpus
iuteum function declines despite the continued increase in
hCG (see section 103). Third, a role in sexual differen¬
tiation lias been investigated, as maximal peripheral levels
correspondyto maximal fetal hCG levels.(Clements, Reyes,
Winter and Faiman, 1976), to( elevated testosterone concen¬
trations in testicular tissue (Reyes, Winter and Faiman,
1:973) and in fetal serum (Reyes, Boroditsky., Winfer and
Faiman, 1974), and to the proliferation of Beydig cells in
the fetal testis (Pfelliniemi and ."Niemi, 1969; Gondos and Hobel,
1971}.. Also., FCG -will stimulate testosterone secretion
from tbe fetal testis (.Abramovich,, Baker and Heal,, 1974:;
Ahluwalia, Williams and ¥erma, 1974:; Huhtan.i-.emi., Forenbrot
and Jaffe , 1977 ) .„ Other possible roles of hCG in regula¬
ting fetal steroid production (e.g. BHAS secretion by the
fetal adrenal) and in its interrelationships -with placental
steroidogenesis are reviewed in section 1.40
In contrast to the above suggestions,
Gordon and Chard (1977) suggested that "none of the specific
12-■
placental proteins has any biological function in the
sense of being essential for the mother or the fetus.
They are by-products of a more fundamental process con¬
cerned with the basic functioning and maintenance of the
placenta as an individual and independent organism. In
other words, production of placental proteins may indicate
nothing other than that the placenta is there". The
idea was further put forward that future approaches should
perhaps be directed to the study of a combination of hor¬
mones and not just further utilisation- of purified proteins,
(v) Prolactin
Prolactin in pregnancy is not signifi¬
cantly elevated until 31-33 days following the midcycle LII
peak. Its concentration continues to increase approximat¬
ely linearly until a plateau is reached at the end of preg¬
nancy (Tyson, Hwang, Guyda and Friesen, 1972; Rigg and Yen,
1977; Kletzky, Marrs, Howard, McCormick and Mishell, 1980).
There is much evidence supporting the
importance of oestrogens in the physiological regulation
of prolactin secretion in man. The initial prolactin
increase occurs 1-3 days after the increase in serum oes-
tradiol after implantation (Barberia, Abu-Fadil, Kletzky,
Nakamura and Mishell, 1975). Increased levels of oestro¬
gen, either during pregnancy or when induced by exogenous
oestrogen administration, is accompanied by a parallel
increase in prolactin secretion (Wiedeman, Schwartz and
Frantz, 1976; Kletzky et al, 1980). A parallel exists in
the increase of oestrogen and prolactin secretion in girls
at puberty (Ehara, Yen an'd Siler, 1975) and their decrease
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in ageing women (Vekemans and Robyn, 1975).
The relationship between prolactin and
oestrogen is probably not so simple as implied above, at
least during pregnancy. The suppression of oestrogen
levels during pregnancy, by dexamethasone administration,
did not suppress prolactin levels (Kauppila, Puukka and
Tuimala, 1979),even though the dosages of dexamethasone
used were markedly higher than those which inhibit prolac¬
tin secretion in non-pregnant subjects (Cospinschi et al,
1975 ) 0 During pregnancy other factors, possibly other
hormones than oestrogen, prevent the inhibitory action of
dexamethasone on prolactin secretion. For example,
progesterone also shows a high correlation with baseline
prolactin levels and is able to produce small increments
in prolactin secretion in vivo (Meites and Clemens, 1972),
and progesterone levels are unaffected by dexamethasone
administration (Kauppila, Jouppila, Karvonen, Tuimala. and
Ylikorkala, 1976). In the rat, both oestrogen (Jacobi,
Lloyd and Meafes, 1977) and progesterone (Caligaris, Astrada
and Taleisnik, 1974) induce a significant elevation in
prolactin.
(b) Sub-human primates
Non-human primates are widely used as models
in research on human reproduction, but detailed hormonal
data on the relationships between the sex steroids and
chorionic gonadotrophin during pregnancy are available
only for the rhesus monkey and,to a more limited extent,
the chimpanzee. * This section will review the plasma
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hormonal patterns found in these two species and in
the other primate species in which there have been
preliminary studies,, Their patterns during pregnancy
will be compared to the human„ The limitation in the
data for some of these species is probably partly due to
the difficulty in handling these primates and to the
small numbers of pregnant animals availableb
(i) ' Chimpanzee
Among the sub-human primates so far
studied, the chimpanzee (Reyes et al, 1975) probably most res¬
embles the human in its peripheral plasma hormonal profiles.
Yet the study of Reyes and colleagues is the only report
on peripheral plasma hormonal levelsJand data was obtained
from only 4 pregnant animals, in 2 of which sampling was
discontinued well before the end of pregnancy. Of the 2
remaining animals, one produced a twin and one a singleton,
therefore the profile and/or level may not be entirely
representative of that found in the more usual singleton
pregnancies„
Despite these limitations, the data,
showed that the extension of the life of the corpus luteum
into pregnancy was reflected by prolongation of the luteal
phase progesterone peak, and subsequently, by a transient decline
There was a sustained increase in progesterone initiated
sometime after day 80, which is well after the maximum
LH/CG values found at day 30-50.
Oestrone and oestradiol rose in early
pregnancy, but unlike the human, declined during the first
I5
trimester. Levels subsequently increased steadily and
maximum levels were found at term. Prolactin levels
also increased during pregnancy with irregular fluctua¬
tions but there was no analysis of its relationship to
progesterone or oestradiol,
Reyes et al (1975) study showed that
although there were some differences in the hormonal and
temporal relationships from the human during pregnancy,
the overall pattern of a sustained increase in levels,
over a large proportion of gestation^resembled the human.
In addition, the excretion of oestriol during pregnancy
(Jirku and Layne, 1965), the metabolism of exogenous
oestrone in vivo (Jirku and Lyne, 1965) and the biosyn¬
thesis and metabolism of■progesterone and oestrogen by
placental tissue in vitro (Shinada and Ryan, 1973) sugg¬
ested comparable feto-placental steroidogenic systems
(Ryan and Hopper, 1974),
(ii) Rhesus
The rhesus monkey is the most widely used
of the sub-human primate species and several studies have
defined in detail the hormonal changes during pregnancy for
several hormones.
Comparison of the rhesus monkey with the
human shows that the time-course of events surrounding
implantation, the initiation of chorionic gonadotrophin
secretion, and the subsequent stimulation of progesterone
secretion by the corpus luteum in this species -(Tullner
and-IIertz, 1966a; Neill et al, 1969; Meyer, 1972; Reinius,
Fritz, and Knobil, 1973; Hodgen, Tullner, Vaitukaitis,
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Ward and Ross, 1974; Ilodgert, Dufau, Catt and Tullner, 1974;
Atkinson et al, 1975) is very similar to that shown in
women. However, - » -x the post-implantation
renaissance of luteal progesterone secretion is clearly
distinguishable in the rhesus, whereas it is not in the
*
human, even when daily blood samples are examined (Mishell
et al, 1973; Thomas et al, 1973 )„
Maximum CG values are found earlier in
pregnancy in the rhesus than in the human (Atkinson et al,
1975), but in a similar temporal relationship to the pro¬
gesterone profile and the dispensability of the corpus
luteum. Progesterone levels decline from the luteal phase
levels during the period of maximum CG levels, followed by
a transient increase due to a placental source during the
declining phase of CG (Atkinson et al, 1975; see also sec¬
tions l„2a and 1.3b)e.The corpus luteum is dispensable in
both human and rhesus (human: Csapo, Pulkkinen, Ruttner,
Sauvage, and Wiest, 1972; rhesus: Hodgen and Tullner, 1974;
Bosu, Johannson and Gemzell, 1974; (see sect. l„3a) around
the time of maximum CG values0 Despite this similarity
in these temporal relationships, no causal relationships
have been shown. In fact, since CG is widely implicated
in stimulating progesterone production from the corpus
luteun^much research has gone into confirming and explain¬
ing why this function exists for only a limited period of
time in both the human and rhesus (human: Hanson, Powell
and Stevens, 1971; Runnebaum, Holzmann, Bierwirth and
Zander, 1972; Garner and Armstrong, 1977; Rao, Griffin and
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Carman, 1977;' Halrae, Ikonen Rutanen and Seppala, 1978;
rhesus: reviewed'. Neill and Knobil, 1972; Knobil, 1973).
Probably one of the most striking differ¬
ences between the rhesus and human in their hormonal pro¬
files is that, in the former, the takeover of hormonal
production by the placental tissue does not result in a
sustained substantial increase in either progesterone or
©estradiol^ and progesterone levels usually remain in the
luteal phase range (Bosu et al, 1973a,b; Neill et al,
1969} see also section 1.1)„ The lack of increase in
prolactin, except for during the last week of pregnancy
(Weiss et al., 1976)Jmay suggest a similar relationship to
progesterone and oestradiol as seen in the human (section 1.
2a-v)but an acute stimulatory effect of oestradiol on
prolactin secretion has not been demonstrated in the rhesus
monkey (Butler, Krey, Lu, Peckham and Knobil, 1975; Weiss
et al, 1976). The lack of oestriol in rhesus plasma may
be due to failure of the rhesus adrenal and liver to pro¬
duce sufficient amounts of 18-hydroxylated intermediates
for oestriol formation by the placenta (Heinrichs and
Colas, 1970).
In addition, there are probably signif¬
icant differences in the metabolism of progesterone and
oestradiol during pregnancy between the human and rhesus.
Whereas pregnanediol is the major urinary metabolite of
progesterone in the human (Bell and Lorraine, 1971) it
appears to be androsterone in the rhesus (Plant, James and
Michael, 1971; Liskowski and Wolf, 1972). The major
oestrogen metabolite is oestriol in the human (Bell and
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Lorraine, 1971)(but. oestrone in the rhesus (Liskowski,
Wolf, Chandler and Meyer, 1970; Hodgen et al, 1972).
(iii) Other sub-human primate species
With a view to assessing alternatives
to the widely used rhesus monkey, the peripheral plasma
levels of several other sub-human primate species have
been studied to a limited extent. This has included
i
investigations into several other of the macaque species,
such as the bonnet (Stabenfeldt and Hendrickx, 1973; Hodgen,
'et al, 1977), crab-eating (Hodgen et al, 1972; Stabenfeldt
and Hendrickx, 1973), and pig-tailed monkeys (Chandrashekar
et' al, 1980). The results obtained for peripheral hormonal
levels indicate that the rhesus is fairly typical of the
macaque species and that in this respect, there is no
great advantage to these other macaque speciesc Another
Old World primate, the African green monkey, also showed
more
. qualitative similarities in its progesterone and
oestrogen profiles during pregnancy to the macaque species
rather than to the human (Hess' et al, 1979). Unlike the
species mentioned above, the term levels in the baboon are
significantly elevated over the luteal phase; however,
unlike the human, there does not appear to be any signifi¬
cant change in progesterone levels during the latter half
of pregnancy (Albrecht and Townsley, 1976; Dawood and
Fuchs, 1980). The sooty mangabey probably most resembles
the human with a general upward trend in progesterone,dur¬
ing the latter two thirds of pregnancy (Stabenfeldt and
Hendrickx, 1973). -How suitable this species will turn out
to be in other respects as a model for the human has yet to
be determined.
1.3 Ovarian function during pregnancy
The major source of progesterone and oestradiol in
primates is-initially the ovary and then the placenta or
feto-placental unit (Heap, Perry and Challis, 1973). This
section will review ovarian function during pregnancy and
its relationship to the peripheral plasma profiles for proge¬
sterone and oestradiol (Sect 1,2) for the human and rhesus.
These are the only 2 primate species for which there is
much data. The next section will review feto-placental funct¬
ion with'respect to progesterone, oestrogen and LH/CG secret¬
ion. This review will provide a background for comparisons
with the present study in the marmoset (Chapter 5).
(a) Human
The continuance of luteal phase oestradiol and
progesterone values during the first 3-4 weeks of pregnancy
(section l„2a) indicates continued or increased corpus
luteum function into early pregnancy since at this stage
of pregnancy, ovariectomy will result in a decline in
progesterone and oestra-diol, and then in abortion (Froewis,
1962; Csapo et al. 1972),
A decline in corpus luteum function after the
4th week of pregnancy, is indicated in the maternal plasma
by the decline in 17c{ -hydroxyprogesterone levels (Yoshimi
et al. 1969; Saunders and Elton, 1971; Solomon and Fuchs,
1971; Tulchinsky and Hobel, 1973; Mishell et al. 1973) and
the decline or plateau in progesterone levels (section 1.2a).
Placental tissue does not possess the 17c< -hydroxylase enzyme
system at this stage of -gestation (Palmar, Blair,
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Eriksson and Diczfalusy, 1966) so this hormone is commonly
used to reflect corpus luteum function.
During this period of declining corpus luteum
function, there is an increasing placental contribution
to levels. This was concluded both from lutectomy and
removal of the feto-placental unit (leaving the corpus
luteum) (Holmdahl, Johansson and Wide, 1971; Csapo and Pulkkinen,
1978, Karim, Rao and Salmon, in press). There appears, there¬
fore, to be a transitional period, during which there is
both ovarian and placental contribution to levels. This period
corresponds to the period during which peripheral progester¬
one levels remain stable and oestradiol levels increase
gradually. It is not known how much individual variation
there is in the proportions of hormone secreted by the
ovary or placenta at a specific time during this transit¬
ional period#or how critical is the timing of the comple¬
tion of the luteo-placental shift.
Bilateral ovariectomy experiments have estab¬
lished that the corpus luteum is dispensable after the 7th
week of pregnancy. Csapo and Pulkinnan (1978)j in a re¬
examination of the original case reports between 1896 and
1963, found 7 cases (out of 36) of pregnancy maintenance
following unilateral ovariectomy prior to the 5th week of
pregnancy. The discrepancy in timing can possibly be
explained by the 10% incidence of an accessory corpus
luteurn which is only identified after thorough examination
(Csapo et al, 1972). Ovariectomy and replacement therapy
experiments have shown that the secretion of progesterone,
but not of oestradiol^by the corpus luteum is necessary
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for pregnancy maintenance (Csapo, Pulkkinen and Wiest, 1973
Csapo, Pulkkinen and Kaihola, 1973). It should be noted
that such experiments do not take into account that the
early conceptus may also be capable of steroid hormone
secretion which is immeasurable in the peripheral plasma
but may be significant physiologically in the uterine
environment.
Comparison of utero-ovarian, uterine and
peripheral vein hormone levels indicate that the corpus
luteum remains active throughout pregnancy' (Mikhail and
Allen, 1967; LeMaire, Conley, Moffet and Cleveland, 1970;
Guraya, 1972; Crisp, Dessouky and Denys, 1973). In add¬
ition, morphological studies reveal that the corpus
luteum appears functional at term (Green, Garcil ilazo and
Maqueo, 1967; Adams and Hertig, 1969), contains proges¬
terone throughout pregnancy (Zander, Forbes, vonMunstermann
and Nehar, 1958), and is capable of synthesizing progester¬
one in vitro throughout pregnancy (Hammerstein, Rice and
Savard, 1964; LeMaire, Rice and Savard, 1968). Compared
to the amount of progesterone produced by the placenta at
term, the ovarian contribution is small. Its physiolog¬
ical role is obscure but it cannot be vital, for the
ovaries can be removed after the first 7 weeks of pregnancy
without untoward effect or obvious hormonal changes in the
peripheral plasma (loc cit).
(b) Rhesus
The dispensability of the corpus luteum was de¬
termined in a similar manner in the rhesus as in the
human and it was shown not to be necessary after day 21,
(Tullner and Hertz, 1966b; Bosu and Johansson, 1974;
•Hodgen and Tullner, 1975; Bosu, Johansson and
Gemzell, 1974$ and that abortion following ovariectomy
ceo.uld also be prevented by progesterone replacement
:alone (Meyer, Wolf and Arslan, 1969) „ The transitory
decrease in peripheral oestrogen levels following ovari¬
ectomy or lutectomy suggested an ovarian source up to
The 5-6th week of pregnancy, but the lack of a decline in
peripheral progesterone levels and the persistence of the
transitory increase that is observed in normal pregnancies
around week 6—7 indicated a predominantly placental source
(loc cit)o
Although removal of the corpus luteum at known
stages of pregnancy can time its dispensability, it does
not necessarily establish the functioning of the corpus
luteum ±n normal pregnancies„ Comparison of peripheral
plasma levels of intact pregnancies with ovariectomised
©t luteciomised pregnancies may give a limited idea of
corpus luteum function in the early stages but it is not
mseful for later stages. Also, results in the sheep
showed -thai although peripheral progesterone levels in
©©phoreelomised animals were about \ those in intact ani-
mxal£. ((Falling., 137Of.,), the ovary probably did not contribute
5VS% to progesterone levels in normal pregnancy as measur¬
ement of uterine vein secretion rates showed that the
progesterone secretion rate of the placenta was at least
5—fold that of the ovary (Linzell and Heap, 1968).
A better indication of ovarian function during
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normal pregnancy is obtained by comparison of hormonal
values in the utero-ovarian vein, uterine vein, and
maternal peripheral vein. Studies of this nature in
the rhesus indicated that the corpus luteum is actively
secreting progesterone at day 22 and 157 (gestation
length: 165 days), but at day 42, it is either inactive
or its secretory activity is very low. It was therefore
suggested that a period of low activity or dormancy was
followed by a period of renewed function near the end of
pregnancy (Treloer, Wolf, and Meyer, 1972; McDonald,
Yoshinga, and Greep, 1973; Walsh, Wolf and Meyer, 1974;
Walsh, Wolf, Meyer and Robinson, 1979). Walsh et al
(1979) further suggested that the renewal of function was
limited to a reactivation of progesterone (or progestins)
production and that it was relatively inactive with respect
to oestrogen production during mid and late pregnancy.
This was corroborated by the fact that extensive luteal
ai'oraatase activity is found during early pregnancy, but not
during late. Likewise, the rise in progesterone output
was associated with an increase in the 3^~HSD isomerase
activities in the corpus luteum (Sholl, Wolf,and Colas,
1974, 1977). In addition, morphological studies show that
the rhesus corpus luteum appears functional at term (Koering,
Wolf,and Meyer, 1973; Gulyas, 1974) and that isolated
luteal cells from late pregnancy corpus .luteum will secrete
progesterone in vitro (Stouffer, Nixon and Hodgen, 1979).
Sholl, Anderson, Colas and Wolf (1976) also
measured hormonal levels in the utero-ovarian, uterine and
peripheral vein and concluded that/at least in some cases,
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the corpora lutea remained active throughout gestation
and were not quiescent during mid-gestation, and that
both progestins and oestrogens were secreted,. In addi¬
tion, in some animals, the corpora lutea did not appear
to remain active,, Part of the discrepancy between the
studies may well lie in the normal interanimal variation
in corpora lutea function during pregnancy„ This was
indicated, but to a more limited extent, in all of the
studies if the data from individual animals is examined.
The interpretation that oestrogen is secreted throughout
gestation by Sholl et al (1976) was based on a greater
utero-ovarian vein value than uterine vein value for only
1 of 4 animals at day 160 and the difference was only
lOOpg/ml. Similarily at day 49, a positive difference
for the utero-ovarian vein (400pg/ml) was found for only
1 of 6 animals.
The stimulus for a recrudescence of corpus
luteum function has not been ascertained. Factors simi¬
lar to those operative during the luteal phase of the
cycle may be important as luteal cells from late pregnancy
exhibit gonadotrophin-sensitive steroidogenesis in vitro
similar to late luteal cells from the cycle (Stouffer,
Nixon and Hodgen, 1979). However, mCG is either very low
or undetectable in both the peripheral and uterine vein
blood during late pregnancy in the rhesus (Hodgen et al,
1972; Atkinson et al, 1975; Walsh, Wolf, Meyer, Aubert and
Friesen, 1977). Both prolactin and mCG were elevated in
late pregnancy in the rhesus (Weiss et al, 1976; Walsh et
al, 1977) but undetectable levels following hypophysectomy
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and/or fetal death did not result in a lack of progester¬
one secretion from either the corpus luteum or placenta
(Walsh, Meyer, Wolf and Friesen, 1977)„ This data also
indicated that neither the maternal pituitary nor a live
fetus were necessary for placental or corpus luteum pro¬
gesterone production,,
It may be that the corpus luteum of late preg¬
nancy responds to different stimuli than that of the cycle.
One factor that „ is consonant with high utero-ovarian vein
progesterone levels is the presence of the placenta and
fetus as a unit, regardless of whether the fetus was
alive or dead,, The feto-placental unit may be the source
of the luteotrophic stimulus or there may be a feedback
relationship between placental progesterone production
and corpus luteum function (Lanman, Thau, Sundaram, Brinson
and Bonk, 1975),
Identification of a specific obligatory role
for the revival of the corpus luteum during late pregnancy
remains unresolved. Hormonal patterns associated with
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the initiation of parturition were similar in ovariectom-
ised and intact animals (Bosu et al, 1974a; and others, see
above) and support the concept that the function of the
feto-placental unit during late pregnancy is similar, whether
or not the corpus luteum is available for revival,
Nevertheless, a functional, though dispensable,
corpus luteum during pregnancy may be useful to supplement
progesterone production, particularly if placental hormone
production becomes marginal or inadequate. This may be
of greater significance in a species such as the rhesus in
"Zb
which placental progesterone production is already low.
Such a role for the corpus luteum could be postulated from
fetectomy experiments. After fetectomy, maternal periph¬
eral plasma progesterone levels are maintained but the
source of progesterone changes from the placenta to the
ovary. Peripheral oestrogen levels decline and like
normal pregnancy, (Walsh et al, 1979; and others, see
above) there is no compensating ovarian production of
oestrogen (Tullner and Hodgen, 1974; Lanman e'f al, 1975).
However, in contrast to normal pregnancy, after fetectomy,
maternal progesterone levels ultimately decline prior to
expulsion of the placenta (Lanman et al, 1975 )„ This pre¬
sumably reflects declining ovarian progesterone produc¬
tion which may be caused by deterioration of the corpus
luteum or of that placental function by which ovarian
progesterone production is maintained.
Based on these experiments, Lanman et al (1975)
proposed the existence of a feedback control system where¬
by the placenta stimulates the corpus luteum if progester-
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one production by the placenta becomes inadequate. The
mechanism by which such a feedback control operates is
unknown and it may be similar to that which may operate
in normal pregnancy (see above). The apparent interanimal
variation in corpus luteum function reported for normal
pregnancy could possibly be related to interanimal varia¬
tion in placental function. An obvious feedback control
mechanism would be the progesterone level; but it did not
appear to be a factor as altering the progesterone levels
in both intact and fetectomised monkeys did not affect the
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production rate in the pregnant rhesus (Thau, Lanman
and Brinson, 1979 )„ However, an effect on the proges¬
terone production rate of a change in progesterone levels
at sites less subject to influence by infused progester¬
one (e.go fetus, placenta or utero-ovarian circulation)
could not be excluded.,
Unlike other species so far studied, the life
of the corpus luteum of pregnancy in the rhesus is exten¬
ded into the post part urn period as long as suckling con¬
tinues (Weiss et al, 1973; Stouffer, Bennett, Nixon and
Hodgen, 1977). Ilistochemical techniques and hormonal
measurements suggested that human corpora "lutea were also
functional for a few days after birth but that their
activity decreased rapidly (Deane, Lobel and Romney, 1962;
Yannone et al, 1968; LeMaire et al, 1971), The biological
importance of luteal function during the post partum
period may not relate to lactation as ovariectomy during
pregnancy does not affect the survival ana growth of nurs¬
ing infants (Tullner and Hertz, 1966 Hodgen and Tullner,
1975 ). Although the significance of the extension of
the corpus luteum life post partum is not known, the
presence of a functional corpus luteum may serve to delay
the re-initiation of ovulatory menstrual cycles (Goodman,
Nixon, Johnson and Hodgen, 1976).
1 ° 4 Fcto-placenta 1 function
(a) Progesterone and oestrogen
Although the human placenta is capable of main¬
taining pregnancy after the 7th week (Csapo et al, 1972;
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section 1.3a), and there is . in vitro synthesis of proges¬
terone and oestradiol from endogenous precursors in the
placenta from at least 6 weeks (Rao, 1979), the completion
of the placental takeover in hormone production in normal
pregnancies does not probably occur until closer to 9 weeks
Csapo and Pulkkinen, 1978; Hoimdahl etal, 1971; Karim etal, in
press), This is evident hormonally by the initiation of
a steeper increase in progesterone and oestradiol
(Tulchinsky et al, 1972; Dehertogh, 1975; section l02a).
Also, the steroid aromatisation capacity of the placenta
becomes evident and thereafter increases with advancing
gestation (Siiteri and MacDonald, 1966).
Over the last 15 years, the concept has evolved
that the placenta is an incomplete steroid-producing organ,
unlike the adult adrenal, testis and ovary, and must rely
on precursors reaching it from the maternal and fetal com¬
partments. Prom the unique interdependence of the fetus,
placenta and mother, arose the concept of an integrated
feto-placental-maternal unit (Diczfalusy, 1969). Several
authors have extensively reviewed the biosynthetic path¬
ways of placental progesterone and oestrogen production
(Davies and Ryan, 1972; Allen, 1975; Beling, 1977; Klopper
and Fuchs, 1977) and Figure 1-1 outlines the major pathways
to progesterone and oestrogen formation in the feto-plac-
ental unit in the human.
The importance of the fetus for providing andro¬
gen precursors for all 3 oestrogens is evident, even though
the pathways used for the formation of oestrone and
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Fig. 1-1: Progesterone and oestrogen metabolism in the
feto placental unit. DHA =■ deydroepiandrosterone; s =
sulfate conjugation, (from Beling, 1977).
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oestradiol differ from that for oestriol, Siiteri and
MacDonald (1963, 1966) estimated that 90% of the oestriol
precursors and 50% of the oestradiol precursors originate
in the fetal compartment„ The placentae of several
primate species also aromatise androgen to oestrogen and
none could convert C21 steroids to androgens or oestro-
gens (human: Bolte et al, 1964a,b,c and d; baboon:
Ainsworth, Daenen and Ryan, 1969; Milevich and Axelrod,
1971; chimpanzee: Shinada and Ryan, 1973; orangutan:
Ainsworth and Ryan, 1969; rhesus, cynomol gous, squirrel
monkeys: Ainsworth et al, 1969; marmoset: Ryan, Benirschke
and Smith, 1961), Pregnenolone could be converted to
oestrogen in vitro only if the fetal adrenal and placenta
were incuba.ted together and not by either tissue alone
w
(iris monkey (Macaca fasciculata): Davies, Ryan and Petro,
1970),
The involvement of the fetus in placental
oestrogen production is well documented in vivo in both the
human and rhesus, and this fact is used to monitor the
well-being of pregnancies with varying degrees of success
(reviewed: Klopper, 1977), Fetal death or anencephaly
is associated with a decline in the oestrogen content in
the urine and/or plasma (human: Frandsen and Stakemann,
1961; Mikakawa, Ikeda, Nakayama and Maeyama, 1976; rhesus:
Bosu et al, 1S741?; Walsh, Kittinger and Novy, 1979),
Oestrogens also decline following fetectomy (human: Kim,
Borth, McCleary, Woolever and Young, 1971; rhesus: Tullner
and Hodgen, 1974) and dexamethasone administration (human:
Ohrlander, Gennser, Batra-and Lebech, 1977; rhesus: Bosu
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et al, 1974b; Challis, Davies, Benirschke, Hendrickx and
Ryan, 1974). '
Although a live fetus appears essential for
normal maternal oestrogen levels, the picture is compli¬
cated by the finding in the rhesus, that fetal anencephaly
affects maternal oestradiol but not oestrone. The mech¬
anism by which anencephaly selectively affects maternal
oestradiol but not oestrone is not known. One explanation
is that there is a major non-placental source of oestrone
during late pregnancy. This, however, does not seem
likely in view of the fact that oestrone, not oestradiol,
is the major oestrogen in the uterine vein both in intact
and ovariectomised monkeys in late pregnane;' (Dierschke,
Wehrenberg, Clark and Robinson, 1978) and that rhesus
placental tissue in vitro aromatises G19 steroids with a
predominance of oestrone over oestradiol (Ainsworth et al,
1969; Ryan and Hopper, 1974).
In contrast to oestradiol, it is often stated
that it is unlikely that any control factor on placental
progesterone synthesis originates in the fetus. This is
deduced largely from observations that the same
experiments of fetal death, fetectomy, suppression of
fetal adrenal function or fetal anencephaly have no effect
on maternal progesterone levels (loc cit and Allen, 1953;
Lurie, Reid and Villee, 1966). It should be noted that
most studies measure only peripheral plasma hormone levels
and these do not necessarily define the ovarian and plac¬
ental source of hormones.
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There is some evidence which, although not
demonstrating a direct fetal role^may suggest that the
placenta is not autonomous with respect to progesterone
production.. Surgically induced intrauterine fetal death
in the rhesus eventually produces a marked reduction in
maternal plasma concentrations of progesterone (Bosu et al,
1974b) and these authors were probably the first to suggest
that the decline in progesterone reflected some undeter¬
mined effect caused by the absence of the feto-placental
circulation, Lanman et al (1976) later formulated a simi¬
lar conclusion, based on their observations of a shift to
ovarian progesterone production following fetectomy and
the abrupt decline in maternal progesterone if ovariectomy
was superimposed on fetectomy.
These observations did not show why the plac¬
ental production of progesterone should decline following
fetectomy. It may be due to degenerative changes and
modifications in placental perfusion thattMpft associated with
fetal removal, Albrecht, Haskins and Pepe (1980) and
Albrecht (1980) suggested, based on fetectomy_and anti oes¬
trogen (ethamoxytriphetolr MER-25) experiments in the baboon,
that the decline in placental progesterone production
might be related to the concomitant loss of oestrogen
associated with fetectomy. No mechanism of action of
oestrogen on sustaining the placental progesterone produc¬
tion was suggested other than that its role appeared ess¬
ential. rather than stimulatory, in a dose-related fashion./ /
Since MER-25 is a non-steroidal oestrogen antagonist, which
interferes with oestrogen binding to its receptor site
(Katzenellenbogen and Ferguson, 1975), it would be
desirable to characterise an oestrogen receptor in the
placenta. Oestrogen levels are higher in MER-25 treated
baboons, than in controls, and it would be necess¬
ary to determine exactly what is occurring in these treated
baboons„
It should be noted that unlike the rhesus, fet-
ectomy in the baboon, resulted in an immediate decline in
peripheral progesterone levels,, The interspecies
difference between the baboon and rhesus may perhaps be
due to differences in the placental progesterone-oestradiol
relationship (Albrecht et al, 1980), or it may only be that
there is no compensating ovarian progesterone production
,in the baboon as there is in the rhesus. This latter
factor was not considered by Albrecht et al (1980), which
is somewhat surprising in view of the rhesus results.
A role for the fetus in controlling placental
progesterone production was also suggested by the finding
in the rhesus that progesterone umbilical vein levels were
higher with female fetuses than males (Ilagemenas and.
Kittinger, 1972)/and that placental tissue from pregnancies
with female fetuses secreted signfic .antly more progester¬
one in vitro than that from pregnancies with male fetuses
(Hagemenas and Kittinger, 1974). The influence of the
fetal hypothalamic-pituitary axis on placental progester¬
one biosynthesis was implied by the finding that fetal
hypophysectomy significantly lowered the' in Vitro placental
secretion of progesterone (Hagemenas and Kittinger, 1975).
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Since addition of pregnenolone abolished the sex differ¬
ence, it appeared that the step(s) in progesterone
synthesis which may be affect.ed by the fetal genotype
lie between cholesterol and pregnenolone. The results
of these experiments were complicated by the fact that
the placental content in these same pregnancies did not
always confirm the presence or absence of the sex differ-
ences;and it would be desirable to have further valida¬
tion of the placental culture system to establish whether the
endogenous secretion represents primarily preformed or newly
syntnesised hormone.
Hagemenas and Kittinger (1973) implied that
human placental tissue from a pregnancy with a female
^fetus might also produce more progesterone than from a
male fetus. This was not a direct findingsbut was deduced
from the finding of a s ex difference in the fetal metabol¬
ism of progesterone. This was based on a total of 7
female and 9 male pregnancies but there was considerable
* *
overlap between the 2 groups.
A sex difference in fetal metabolism of prog¬
esterone was not confirmed by other authors and there was
no indication of a sex difference in the amount of prog¬
esterone in the umbilical vein (Effef, Gupta and Younglai,
1973; Tulchinsky and Okada, 1975; Dawood and Helmkamp,
1977). There have not been 'in vitro studies from the
human or any other species -comparable to those in the




The concentration of hCG in placental tissue
correlates with the peripheral plasma profile (Diczfalusy,
1953; Hobson, 1971; see section 1,2a). The factors
involved in the regulation of hCG production and secre¬
tion remain largely unknown although several lines of in¬
vestigation have been pursued to interrelate its placental
produc'l'ton with other physiological factors.
An interrelationship with oestrogen was first
shown in vitro by cyclic adenoise monophosphate (cAMP),
which stimulated the release of hCG with enhanced oestro¬
gen secretion (Hussa, Story and Patillo, 1974; Russa,
Patillo, Ruckert and Scheuermann, 1978). Perfusion
experiments with human term placenta showed that hCG
increased aromatisation of androgen to oestrogen; presum¬
ably by stimulation of cAMP (Cedard, Alsat, Urtasun and
Varangot, 1970). hCG may also affect oestrogen production
by regulating fetal DHAS production as a precursor for
placental conversion to oestrogen (Seron-Ferre, Lawrence
and Jaffe, 1978), Not all authors confirm that
there is a stimulation of DHAS by hCG in vitro (Voutilainen,
Kahri and Salmenpara, 1979).
A negative correlation in the peripheral plasma
between hCG and oestradiol levels led to the speculation of
the existence of a. feedback relationship between placental
oestrogen production and secretion of hCG (Penny, Parlow
and Frasier, 1979). Yuen, Cannon, Lewis, Sy and Woofley
(1980) then suggested a role for prolactin in the control
of hCG and oestrogen secretion by the feto-placental uiiit,
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This was based on their observations of a significant
negative correlation between hCG and prolactin, a posi¬
tive correlation between prolactin and oestradiol, and that
long term suppression of prolactin was associated with
augmentation of the hCG peak in the first trimester and
in late pregnancy. Their data wa.ce.quite limited, e.g.
augmentation of the hCG peak with long term suppression
of prolactin was observed in only 1 patient, and therefore
more definitive studies would be necessary to elucidate
the relationship.
Recently, some interest has focused on the rel¬
ationship between placental luteinising hormone-releasing
hormone (LHRH), progesterone and hCG, The placenta
contains large quantities of biologically active LHRH
which is biochemically and immunologically indistinguish¬
able from hypothalamic LHRH (Gibbons, Mitnick and Chieffo,
1975; Siler-Khodr and Khodr, 1978),
*
LHRH added to placental organ cultures enhanced
hCG secretion in a dose-dependent manner. The responsive¬
ness of the 2 placentae cultured was not the same but this
may be because of the differing gestations,! ages of the
placentae (Khodr and Siler-Khodr, 1978), If one examines
the data, it is difficult to interpret what is actually
happening in vitro. The stimulation of hCG by LHRH was
greatest on the 1st day, still significant on the 2nd day,
but there was no effect by-the 3rd and 4th days. Other stu¬
dies using organ cultures of human placental tissue have
suggested that the factors involved in the secretion of
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hCG in the media change with successive days of culture/
and that it is possibly not until the third day that the
secretion is not primarily the release of preformed hormone.
(Golander, Barrett, Tyrey, Fletcher and Handwerger, 1978;
Huot, Foidart and Strcmberg, 1979). At this time (day
3-4), the secretion of hCG begins to increase. It was
postulated that there is an inhibitory factor in
the placenta present in the explants at the beginning of
culture which disappears with time. In Khodr and Siler-
Khodr (1978) study, hCG secretion did not increase at the
3rd -4th day of culture but continued to decline with
each successive day. However, they did show that there
was some in vitro synthesis by comparison of the amount
secreted in vitro with the placental content.
« ' " 1 ■
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In contrast to the in vitro results, in vivo
administration of LHRII failed to increase maternal hCG
levels (Tamado, Akabori, Konuma and Araki, 1976; Seppala
Wahlstrom, Lehtovirta, Lee and Leppalouto, 1980). The
authors of these papers acknowledge that this may not be
surprising since circulating LHRH may not influence
placental metabolism# and that a high enough dose of LHRH
may not have been used because there are very high con-
concentrations of LHRH in the placental tissue,and high
dosages are required for an effect in vitro.
In addition to enhancing hCG production in vitro
the addition of LHRII to placental cultures inhibited pro¬
gesterone secretion in a dose-response manner (Wilson and
Jawad, 1980). Placenta obtained earlier in gestation (12
and 22 weeks) demonstrated greater spontaneous progesterone
production and increased sensitivity to LHRH than term placen¬
ta. The dosages of LHRH used were far in excess of those in
the hCG stimulation experiements and were possibly pharma¬
cological o Since the weight of the placental tissue cultured
is not given, it is not possible to compare the dosage with
the reported placental content of LIIRH.
The in vitro results cited above are difficult to
reconcile with the in vivo situation because the period
of greater sensitivity to LHRH in suppressing progesterone
coincides with the period of the establishment of plac¬
ental production and of increasing placental concentrations
of LHRH. Likewise, although LHRH stimulated hCG in vitro,
the placental concentration of LHRH is still increasing when
hCG production is in decline. These observations do not
exclude such a relationship but it seems additional factors
are involved,
A more direct interrelationship between hCG and
progesterone was indicated by the suppression of hCG
secretion in vitro by progesterone, pregnenolone and 20^ -
dihydroprogesterone and by the significant suppression of the
•augmented hCG response to dibutyl cAMP. However, the addition
of aminoglut.ethimide, which blocks the synthesis of proge¬
sterone, did not enhance hCG secretion (Wilson, Jawad and
Dickson, 1980). This study suggested that the increasing
placental synthesis of progestins may be responsible for the
decline in•hCG secretion, but the mechanism by which proges¬
tational steroids, or their metabolites, decrease hCG
secretion is not known. ,
3°(
The study of the factors involved in the control and
synthesis of placental hormones must be considered to be
still in its initial stages,, Most of the theories are
based primarily on peripheral plasma hormonal interrelat¬
ionships with generally little experimental evidence for
support, and/or on what must be regarded as preliminary
in vitro studies. The use of greater numbers at more
stages of gestation would benefit most of the studies
citedo In addition, far more rigorous investigations are
necessary. Organ placental culture may prove to be a
suitable method, but it is difficult to delineate the
factors controlling the endogenous secretion of hCG iii
vitro; factors which may well change with successive days
in culture and thereby confound experimental results.
Although organ culture may be desirable because the tissue
is kept basically intact, it also is a highly complex
system.
lo5 The marmoset monkey
The macaque monkeys, especially the rhesus macaque,
have been most frequently used species in biomedical
research. The increasing costs of obtaining and main¬
taining rhesus monkeys, the* increasing demands for lab¬
oratory primates, and the differences between the rhesus
and the human in their reproductive endocrinology has
prompted a search for other suitable species of subhuman
primates. As a result, considerable attention has focussed
on marmosets. Marmosets have been maintained in captiv¬
ity for studies in behavio.ur (reviewed: Rothe, Wo Iters .
MsO
and Hearn, 1978), conservation and biology (reviewed:
Bridgwater, 1972; Kleiman, 1977) and various aspects
of biomedical research, such as immunology, virology,
genetics, teratology and endocrinology (reviewed:
Gengozian and Dienhart, 1978) „
In physical terms, the marmoset has several
advantages as a laboratory primate. Their small size
makes them relatively easy to handle for routine
procedures such as blood sampling, and they are,inex¬
pensive to house and feed. The marmoset breeds rapidly
in captivity, shows no lactational anoestrus, often
produces 2 sets of twins each year and reaches maturity
within 2 years(Hearn, Lunn, Burden and Pilcher, 1975;
Hearn, Abbott, Chambers, Hodges and Lunn, 1978; Ogden,
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Wolfe and Dienhardt, 1978; Hampton, Gross and Hampton,
1978). The high fecundity of the marmoset is one of the
major attributes that make . this species highly suitable
for studies in reproductive biology and means that it is
one of the few primates that can be maintained in large
self-supporting colonies at a reasonable cost.
The disadvantages to using the marmoset are that
their small size causes problems if complicated surgery
or the withdrawal of large quantities of blood is
required. Also, since marmosets do not menstruate, show
any externally obvious oestrus, or clearcut cyclical
vaginal cytology (Hampton and Hampton, 1975; Hearn and
Renfree, 1975), there is no simple procedure by which
the stage of the ovarian cycle can be determined. The
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simplest method at present of overcoming this problem is
by following peripheral plasma progesterone as there is
a clear hormonal cycle (Preslock, Hampton, and Hampton,
1973; Hearn and Lunn, 1975).
The studies in this thesis were concerned with the
hormonal profiles in the peripheral plasma during lactation
and pregnancy, the ovarian and placental function, and the
fetal hormonal environment and development. (See Sect.
1.6) To date, the reproductive endocrinology and fetal
development of the marmoset has received little detailed
attention. Preliminary studies on the endocrinology of
the cycle (Preslock et al, 1973; Hearn and Lunn, 1975)
and pregnancy (Hearn and Lunn, 1975) indicated that the
.marmoset may show some quantitative and qualitative
4
similarities to the human in its hormonal profiles in
the peripheral plasma.• These studies did not cover a
wide range of hormones or define the hormonal changes in
detail^ and the assays used either werd not specific
(Preslock et al. 1975) or were not fully validated for
marmoset samples (Hearn & Lunn, 1975). Identification of
the urinary metabolites of progesterone and oestrogen
in the pregnant marmoset (Shackleton, 1974; Lunn, 1978)
suggested that, also similar to the human, there was a
high excretion of the metabolites of these hormones during
pregnancy. Whether the reasons for the high hormonal
levels during marmoset pregnancy dee.similar to those in
the human is not. known, as there have been no studies in
the marmoset on the steroid metabolic clearance rates,
the levels of steroid binding proteins in plasma or on
ovarian-placental function.
Little is known about ovarian and placental function
during pregnancy in this species, Hearn (1978) suggested
that the corpus luteum may be removed after approximate¬
ly the 6th week of gestation without disrupting the
course of pregnancy, but this was not considered
definitive as the stage of gestation was estimated and
interstitial tissue in the ovary of the marmoset under¬
goes considerable luteinisation, which may be a source
of progesterone (Hampton and Taylor, 1971). Immunisation
of the marmoset against~hCG suggested that this hormone
may have a role in maintaining the corpus luteum of
early pregnancy and/or in implantation, because immunised
animals cycle normally, but remain infertile, when anti¬
body titres are high,, (Hearn, Short and Lunn, 1975).
These experiments also indicated that immunisation against
-hCG may affect ovarian and/or "placental function later
in pregnancy because when these actively immunised animals
returned to breeding, they experience a series of
recurrent abortions prior to the 10th-12th week of
pregnancy, (Hearn, 1976),
Nothing has ye*" been reported on the fetal hormonal
environment of marmosets and there is little data on
prenatal or placental development. Studies have, however,
shown that the marmoset is unusual among primates in
that it regularly produces dizygotic twins (Hampton et al,
1978; Odgen et al, 1978). There is an'early development
of a shared chorionic cavity and shared placental
circulation (Hill and Hill, 1932; Wislocki, 1939), and
co-twins are XX/XY haemaopoietic chimeras. However,
the freemartin condition or masculinisation of the female
fetus is not observed in females born co-twin to a male.
(Benirschke and Brownbill, 1962; Benirschke, Anderson
and Brownhill, 1962; Gengozian, Batson and Eide, 1964;
Benirschke and Layton, 1969)„
Phillips (1976) studied embryonic development during
approximately the first half of pregnancy, and suggested
that embryos could be assessed according to the Streeter
classification of developmental horizons,and that there
may be a lengthening of the ea.rly stages of embryonic
developmento The reason for the lengthening of the early
stages of development are not known but may be related
to the unusual embryology of the marmoset. Some
information is also available on placental (Hampton, 1975),
fetal gonadal (Hampton and Taylor; 1971) and adrenal
(Benirschke and Richart, 1964) development. However,
the data in all of the studies on fetal and placental
development was not related to accurately dated pregnan¬
cies.
1.6 Aims and scope of this thesis
The endocrinology of pregnancy has been most
extensively studied in the human and rhesus, and to a
lesser extent in other Old World primate species (See
section 1.1-4). In contrast, there has been no compre-
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hensive study on the endocrinology of pregnancy in New
World primateso The common marmoset, a New World primate,
has proved to be a suitable laboratory primate model
for studies in reproductive biology and there have been
a number of applied studies on aspects of its reproductive
biology (Sect„ 1„5) which indicated that the marmoset
may have considerable inherent scientific interest„ First,
the marmoset is unusual among primates in that it does
not show lactational anoestrus. It may be that suckling
is not associated with elevated levels of prolactin or
that the marmoset is not susceptible to the inhibitory
influences of suckling and/or prolactin on reproductive
functiono Second, although further removed taxonomically
from the human than the much used rhesus monkey, the
high hormonal levels during pregnancy in the marmoset
appear to resemble the human more than the rhesus, but
the relationship between these high hormonal levels and
the ovarian-placental secretion of these hormones is not
knowno Third, there is some indication that, compared to
the human, there may be a lengthened period of embryonic
developmento However, the data obtained was not related
to accurately timed pregnancies. Furthermore, the delay
may apply only to embryonic development or, in addition,
to the hormonal profiles in the maternal and fetal plasma,
and to the changeover from ovarian to placental function.
Fourth, the embryology of the marmoset is unusual but the
effect of this on the fetal hormonal environment in which
normal fetal development and sexual differentiation occurs
is not known'.
The studies in this thesis were designed to
investigate the aforementioned aspects and to provide
detailed information throughout pregnancy on the inter¬
relationships between the peripheral plasma hormonal
profiles, ovarian-placental function and fetal endocrin¬
ology and development. These aspects were studied in
acctirately dated pregnancies. This is the first such
study for a New World primate and the data obtained
allowed comparison of this species with the Old World
sub-human primates and the human. The studies in this
thesis are described below:
1, The hormonal profiles during lactation and
pregnancy were studied. The detailed analysis of the
trends and interrelationships of a wide range of hormones
throughout gestation and for specified periods are an
essential base for the remainder of the studies in
this thesis,
2, The changes in ovarian-placenta! function
thoughout pregnancy were assessed and related to the changes
in the hormonal levels in the peripheral and fetal plasma.
This is the first primate species in which ovarian-
placental function has been defined throughout pregnancy
at frequent intervals in timed pregnancies,
3, The changes in the fetal hormonal environ¬
ment throughout pregnancy were investigated and related
to the sex of the fetus, to the placental function and to
the stage of fetal development.
4. The fetal development was studied in
timed pregnancies throughout gestation. It was necessary
to confirm, and to more accurately define, the nature of
the delay in the prenatal development; and to relate the
timing of the hormonal events outlined above (nos, 1-3)
to the prenatal development. It was also desirfoj>le to
produce a set of easily utilised fetal growth standards
so that future investigations in this species could be
related to an accurate gestational age.
The general procedures applicable to all the
studies reported in this thesis are given in Chapter 2,
and the development and validations"of the radio-
immunassays for marmoset samples in Chapter 3„ The
hormonal profiles in the peripheral plasma during
pregnancy and lactation are reported in Chapter 4,
Chapter 5 reports on the ovarian and jjlacental function
b°th in vivo and in vitro, Studies on fetal hormones
and fetal development are given in Chapters 8 and 7
respectively. In Chapter 8, a brief general discussion
of the findings in this thesis in relation to the aspects
outlined in this chapter is presented.
CHAPTER 2 : MATERIALS AND METHODS
2.1 Animals'
The animals used in this study were common marmoset
monkeys, Callithrix jacchus. They were maintained at the
MRC Unit of Reproductive Biology Primate Laboratory at the
Bush Estate, Midlothian. Animals used were adults (over
2 years old and 280gm body weight) either obtained from
the wild, more than 18 months before their use in experi¬
ments and fully adapted to captive conditions, or born in
captivity. All females involved in the studies on preg¬
nancy had at least one previous successful pregnancy.
2.2 Management
Marmosets were kept in family groups of a male-
female pair with their young of less than 300 days of
age. Hearn, Lunn, Burden and Pilcher (1975) have published
full details of the management of this colony.
2•2 Collection of blood
Blood samples were taken between 09.00 and 12.00
hours without anaesthesia from the femoral vein using an
0.46mm diameter (27 gauge) needle and a heparinised 1ml
syringe, and placed immediately on ice. ■ The syringe was
sealed with a steriseal cap, centrifuged at 2500 rpm for
20 minutes at 4°C, and the plasma was stored at -20°C
until assayed. Animals were either restrained manually
by a handler or in a restraining device that allowed a
single person to manipulate the monkey and collect the
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blood sample (Hearn, 1977).
When either system was in use, the marmosets remained
relaxed and appeared to be under little stress. After
collecting the blood sample, the animals were given
0.1-0.2ml of iron syrup ("Fersamal", Glaxo Laboratories
Ltd.) as a reward, and for replacement of iron. An
0.1-0.3ml intramuscular injection of Imferom (Fisons Ltd.)
was also given once weekly to animals undergoing serial
bleeds.
2.4 Diagnosis of pregnancy
After parturition or abortion, 35 females were bled
every 2-3 days and progesterone concentrations were measured
to detect ovulation. Pregnancy was confirmed 3-4 weeks
after ovulation by continued luteal phase levels of proges¬
terone and by an increase in the uterine diameter.
A rise in progesterone of more than lOng/ml which
was followed by luteal phase levels ( 30ng/ml) was consid¬
ered -to be the first day (Day 1) of pregnancy. All preg¬
nancies dated by the progesterone rise will be referred to
as timed (T) pregnancies. The interval between the rise
in progesterone concentration and the day of birth was used
to calculate the gestation length.
Samples were also taken from animals in which the
stage of gestation was estimated by abdominal palpation
only, in order to supplement the number of samples at
particular stages of gestation. Pregnancies which were
carried to term were dated retrospectively from the day of
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birth. The stage of gestation in these animals will be
referred to as estimated (E).
2.5 Surgery
Surgery was performed under aseptic conditions.
All animals for surgery were anaesthetised with an intra¬
muscular injection of 0.5-0.8ml "Saffan" (18mg/kg)
(Alphaxalone 0.9% w/v, Alphadolone acetate 0.3% w/v; Glaxo
Laboratories Ltd.), and received an intramuscular injection
of 0.2ml Penidural (Fortified Injection Veterinary - John
Wyeth and Brother) and 0.3ml of Imferom. The dose of
anaesthetic was sufficient to maintain animals under con¬
trolled, deep anaesthesia for a period of about 1 hour.
When the anaesthetic had taken effect the animals were
shaved in the appropriate region, the skin disinfected
with Hibiscrub (I.C.I. Parmaceuticals Ltd.), and the
surrounding area covered with surgical dressing.
Prior to surgery, all females were weighed and a 1.0ml
blood sample was taken from the femoral vein. Immediately
following surgery, females were reweighed and a 0.3ml
blood sample was taken.
2.6 Surgical procedures




Both these operations were performed by Dr. J.P. Hearn with
assistance by the author,
SO
1) Laparotomy
A 10-15mm vertical incision was made through
the skin in the ventral region of the abdomen, immediately
to the right of the midline. A similar incision was made
through the muscle layer, taking care to leave the periton¬
eum intact. The abdominal cavity was then exposed by
cutting through the peritoneum using scissors. The size
of the ovaries and corpus luteum (length x width) and the
width of the uterine fundus were measured using calipers.
Notes were made on the presence and distribution of the
corpora lutea (CL) and general ovarian appearance.
Approximately 0.3ml of blood was taken from
both utero-ovarian veins using a 27 gauge needle. Follow¬
ing sampling, a cotton swab v/as pressed over the site to
minimize haematoma formation.
The incisions in the peritoneum and muscle
layer were closed with a continuous stitch (4/0 chromic
suture; Ethicon Ltd.) and the tissue carefully aligned.
After the application of Trinamide power (May and Baker)
the incision in the skin was closed with a continuous sub¬
cuticular purse stitch and then with two or three loose
surface stitches.
Laparotomy was repeatable within 1 week on an
individual animal. In some cases, utero-ovarian vein
blood was difficult to obtain in subsequent laparotomies.
2) Hysterotomy
The procedure was as described for laparotomy
later pregnancy, The gravid uterus and the ovaries were
delivered through the ventral midline incision. Ovarian
and uterine measurements and notes were taken. Utero-
ovarian vein blood was taken from both sides,
The conceptusi sac was removed, intact if
possible, through a horizontal incision in the uterine
wall between the two main branches of the myometrial
vascular tree. The uterine incision was closed and con¬
traction of the uterus in animals more than 50 days preg¬
nant was aided by 0.1-0.3ml of Ergometrine (Burroughs,
Wellcome & Co. Ltd.) injected into the myometrium and by
a 0.1-0.25ml intramuscular injection of Syntocinon (Sandoz
Products Ltd,).
Following removal of the feto-placental unit and
the stitching of the uterus, approximately 0.3ml of blood
was taken from each utero-ovarian vein using the same pro¬
cedure as described in section 2.6"1 . The samples were
taken within 15 minutes of removal of the feto-placenfal
unit's. It was not possible to always obtain blood from
both veins after removal,
2.7 Sampling regime for laparotomies and hysterotomies
Data obtained from laparotomies and hysterotomies are
given in Chapters 4-7 and therefore a summary of the samp¬
ling regime applicable to all these chapters is given in
this section (Table 2-1).
• It was not considered practical to remove the concep¬
tual sac prior to day 30 without hysterectomy. Laparotomies
S2-
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were performed on 2 animals 3-4 days following birth,Dar¬
ing pregnancy, a total of 11 laparotomies between days 1
and 60 were done on 6 animals.. Serial laparotomies were
done at days 1 and 10 and days 5 and 10 in 1 animal, and
at days 20, 40 and 60 in 2 animals. A total of 27 hyster¬
otomies were done, 18 of which were timed pregnancies. At
least 1 timed pregnancy was taken at every 10 day interval
between days 30 and 140. Of these 27 pregnancies, 19 con¬
sisted of twins, 7 of triplets and 1 of a singleton.
2.8 Collection and processing of samples
The conceptus . was measured (prior to day 90) and
then opened by carefully cutting through the chorionic sac.
Amniotic fluid was collected and the amniotic sacs opened
leaving vascular connections intact. Notes on the fetal and
placental attachments were taken. Fetal samples were then
taken.
Vascular connections were cut and the placental tissue
was dissected free of membranes. The 2 placental dis"cs were
weigh'ed and measured and then divided into pieces approximately
3mm in size. A random selection of pieces from each disc
were preserved in Bouins solution for histological examination
by other investigators, or were frozen immediately using dry
ice and stored at -20°C for hormonal content studies (Chapter
5), or weighed pieces were taken for culture studies (Chapter 5).
Fetal body and organ weights and measurements were Chen
taken (Chapter 7.2). Embryos prior to day 90 were fixed in
10% buffered formalin. Sections of some of these
embryos were prepared by the Department of Obstetrics and
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Gynaecology, University of Edinburgh. Fetal organs were
preserved in Bouins solution for histological studies by
other investigators. A section of the fetal gonads and
adrenals was also taken for culture. A sample from
the amniotic membrane, fetal gonads and plasma was given to
Drs. Speed and Chandley, MRC Clinical and Population
Cytogenetics Unit, Edinburgh for studies on blood and tissue
chimaerism that are still in progress.
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CHAPTER 3 : RADIOIMMUNOASSAYS
3.1 Introduction
The small size of the marmoset precludes the with¬
drawal of large amounts of blood. In the present study,
it was necessary to simultaneously measure several hormones
in small smaple volumes and in several types of samples,
Antisera to the hormones of interest were already avail¬
able but these assays were not validated for marmoset
samples. This chapter describes the application and
validation of several radioimmunoassays for a variety of
sample types for the marmoset.
The general radioimmunoassay procedure and valida¬
tion will be given for the steroid (Sect, 3-2), LH/CG
(Sect. 3-3) and prolactin (Sect, 3-5) assays. Generally,
the adaptation and validation of these assays for placental
tissue (Sect, 3-3, K) and cultures (Sect, 3-4) is given
in separate sections.
3.2 Steroid radioimmunoassays
The steroids measured in this thesis were progester¬
one, oestradiol-17p, oestrone, androstenedione and
testosterone. The samples included peripheral, utero-
ovarian, umbilical vein and fetal plasma, amniotic fluid,
placental tissue and culture media,
(a) Reagents, solvents and steroids
Unless stated otherwise, all reagents used were
analar grade from BDH.
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Assay buffer: 0.05M phosphate gelatin buffer.
45gm of sodium chloride, 43gm of disodium hydrogen ortho-
phosphate, 34gm of sodium dihydrogen orthophosphate and
5gm of gelatin were dissolved in 5 litres of distilled
water. Sodium thiomersalate (0.001%w/v) was added as a
preservative.
Solvents: Analar grade petroleum ether (B.P.
40-60°C), methanol, ethyl acetate, Aristar grade ethanol,
analytical grade diethyl ether (BDH), hexane (BDH), iso-
octane (BDH), and benzene (BDH).
Stripping agents: Activated charcoal Norit A
was obtained from Sigma, and dextran T 70 was supplied by
Pharmacia Fine Chemicals.
Scintillation fluid: This was prepared by
adding lOgm of 2,5-diphenyl-oxazole (PPO; Koch-Light) and
750mg of p-tris-(2-(2phenyl-oxazolyl))-benzene (POPOP;
Koch-Light) to 2.5 litres of toluene (analytical grade;
Koch-Light) and 1.25 litres of Triton X-100 (analytical
grade; Koch-Light).
Steroids: Nonradioactive progesterone,
oestradiol, oestrone, androstanedione and testosterone
were obtained from Sigma. Accurately weighed amounts
were dissolved in ethanol and stored at 4°C.
Chromatography compounds: Celite (Johns-
Manville Celite 545, U.S.A.), Alumina (Savory & Moore,
London), Sephadex LH-ZO (Pharmacia, Fine Chemicals).
Radioactive steroids: The radioactive hor-
3
mones used were: 1,2,6,7- H-progesterone; specific
si
activity (s.a.) 180jjCi/mg (Radiochemical Centre,
3
Amersham); 6,7- H-oestradiol-17 ; s.a. = 45-50uCi/mM
(New England Nuclear: N.E.N.);" 2,4,6,7-^H-oestrone;
s.a. = 98pCi/mM (N.E.N. ); 1, 2-^H-testost erone ; s.a.
= 40-45pCi/mM (N.E.N.); and 1,2-^H-androstenedione;
s.a. = 60pCi/mM (N.E.N. ). All radioactive steroids
were diluted to a concentration of- approximately lOuCi/'ml
in ethanol and stored at 4°C.
Antiserum: The details for the steroid anti¬
serum are given in Table 3-1. The conjugate, the species
the antiserum was raised in, the major cross reactions, the
reference for a complete description of the antiserum and
the person who kindly supplied the antiserum is given.
(b) Extraction of steroids from plasma and amniotic
fluid.
A range of sample volumes (0.01 to 0.10ml) was
used for extraction depending on the expected concentration
of steroid. All samples were made up to 0.10ml with
phosphate gelatin buffer. Progesterone, oestrogens and
androgens were extracted separately. The 2 oestrogens
were extracted separately for the peripheral plasma
samples.
Progesterone was extracted with 1.0ml petrol¬
eum ether,oestradiol and oestrone with 1ml diethyl ether,
and androstenedione and testosterone with 1,0ml of hexane
ether (4 volumes to 1 volume). Petroleum ether and
hexane were distilled not more than 24 hours before use.
(©0
Table3-1.Detailsofthentis rumf progesterone(P4),e t adiol-17p(0E2) oestrone(0E1),androstenedioneAntesto t roTs ays.3=estriol; bovineserumalbumin=BSA. ConjugateSpeciesCross-reactions
Reference
Source
P4 0E2 0E1 A
11*-hydroxyprogesterone- BSA oestradiol6- (O-carboxymethyl)oxime- BSA oestrone-6- O-carboxymethyl)oxime- 11*-hydroxy-4- androstene-3,17-dione hemisuccinate-BSA testosterone-3-(0- carboxymethyl)oxime- BSA
Rabbit11«-hydroxy-Dighe& progesterone36%,Hunter, 17-hydroxy- progesteronev 1.4%,pregnenolone 0.05%,A3 Rabbit0E13.0%,34B irdet T0.003%,P4 0.002%,A RabbitOE20.08%,3 0,011%,P4,A, T0.001% Rabbit11A-hydroxy- androstenedione 36%,androsten- one43%,T0.3 Goat5«-dihydro- testosterone25% 0E2.20%,A. 0.08%
al,1976 Rowe,C ok &Dean, 1973 Bairdet al,1974 Corker& Davidson, 1978
Dr.Kighe, Edinburgh Dr.Baird, Edinburgh Dr.PRowe, Liverpool Dr.WSchopman, Rotterdam Dr.STillson, AlzaCorporation U.S.A.
Diethyl ether was washed with 50% (W/v) ferrous sulphate
(BDH) in 5% (W/y) sulphuric acid (BDH) and distilled
water (11. of diethyl ether to-50ml acidified ferrous
sulphate solution and 200ml of water) and distilled not
more than 24 hours before use.
The hormones were extracted by mixing the
tubes (75 x 15mm, Gallenkamp) vigorously in a multi-
vortex mechanical shaker (Baird and Tatlock) for three
minutes. When the aqueous and solvent phases had
separated, the aqueous phase was frozen quickly by plac¬
ing the tubes into methanol containing dry ice.
■ The solvent phase was then decanted into
75 x 12mm glass tubes (Kimble) for the progesterone,
oestradiol and oestrone assays. These tubes were placed
in a heated block (Driblock DB3, Tecam) and the solvent
evaporated to dryness under a regulated flow of nitrogen.
The extract for the testosterone and androstenedione
vua.s
assay levelsvplaced directly on alumina columns (see
section 3.2f).
(c) Estimation of procedural losses
The recovery of hormone from plasma and
amniotic fluid was estimated for each hormone by the
addition of tracer amounts of radioactive progesterone
(5pg, >V 2000cpra), oestradiol (7pg,-%/1000cpm) , oestrone
(5pg, ^lOCfcpm), androstenedione (5pg, ^lOCCbpm) . Samples
were equilibrated with the tracer hormones for a minimum
of 30 minutes at room temperature. At the same time as
al'iquots were taken for radioimmunoassay, an aliquot was
IcO-
taken for recovery estimation. 3 20jil aliquots of the
tracer hormone (total counts) were also taken.
A mean (+s.d.) reeoveryof labelled hormones
of 68±2% (n=100), 85±1% (n=100) and 83+2% (n=100) was
found for progesterone, oestradiol and oestrone respec¬
tively. This mean recovery figure was used to correct
for procedural losses for progesterone and oestradiol in
peripheral plasma samples taken between the 1st and 12th
week of pregnancy. There was no significant difference
(P<0.05, paired t-test) using the mean recovery figure or
the actual recovery figure for progesterone (n=100) or
■oestradiol (n=100).
Procedural losses were estimated individually
in all other samples for progesterone and oestradiol and
in all samples for oestrone, androste.nedione and testos¬
terone. The mean (±s.d.) recovery figure for oestradiol
and oestrone in 50 plasma samples in which a celite chrom¬
atography step was included was 75^5% and 70+7% respect¬
ively... The mean (+s.d.) recovery figures for 50 plasma
sampels of androstenedione and testosterone assay were
77±4% and 72i3% respectively.
Differing amounts of plasma for extraction or
differing amounts of buffer for redissolving the dried
extract did not affect the recovery figure. (Table 3-2)
(d) Radioimmunoassay of progesterone
The dried residue from the extraction proce¬
dure was re-dissolved in 0.3ml of buffer. The contents
of the tubes were mixed thoroughly on a vortex mixer and
Table 3-2a. The percentage (Is.e.m. n=3) of the radio¬
active tracer recovered from differing volumes of
marmoset plasma.
Progesterone Oestradiol
lOOpl 80 + 2 92 + 2
50pl 77 + 1 94
+ 2
20pl 81 + 2 90
+ 1
iopi 82 1 90
+ 1
5pl 79
+ 1 93 + 2
Table 3-2b. The percentage (±s.e.m. n=3) of radio¬
activity recovered from the extraction of 20pl plasma
which had been redissolved in differing amounts of




+ 2 ' 83 + 1
300j.il 72
a.
3 85 + 1
SOOul 69 + 3 83 + 2
1ml 70 + 2 86 "f- 2
2ml 68 + 3 85 + 2
lo4
were incubated for at least 1 hour. After mixing,
duplicate lOOpl aliquots were transferred to glass assay
tubes (75 x 10mm; Kimble: Corning).. 50jil aliquots were
transferred simultaneously to counting vials for recovery
determination (see 3-2c).
For each assay a standard curve was constru¬
cted. Standards were diluted in buffer and dispensed
in triplicate so that tubes contained 15-1000pg of prog¬
esterone in a volume of lOOjal. lOOpl of antiserum in
buffer (initial dilution 1:10,000) and lOOpl of 1,2,6,7-
3
H-progesterone in buffer (10,000cpm, 25pg) were added
to all tubes containing standard and unknowns, to give a
final incubation volume of 300ul. In addition, tripli¬
cate sets of total counts (TC), non-specific binding '(NSB)
and total bound (TB) tubes were set up as follows:
TC : ^H-progesterone - (lOOul)
NSB : ^H-progesterone (lOOpl)
buffer (200pl)




Tubes were either incubated overnight at 4 C
or at room temperature for at least 1 hour, and then
placed on ice. The free and bound fractions were separ¬
ated with a suspension of dextran-coated charcoal in buffer
(25mg. dextran and 250mg. charcoal per 100ml. of buffer).
1.0ml of this suspension was added to all tubes, except the
TC tubes which received 1.0ml buffer. The tubes were
ioS
mixed and left on ice for 15 min. All tubes were
centrifuged at 2500rpm for lOmin. at 4°C, and the super-
natants immediately decanted into counting vials. Foll¬
owing the addition of 10ml. of scintillation fluid, the
vials were allowed to equilibrate in a cooled (4°C)
scintillation counter (^-particle radiation detector;
Packard, Model 3375) for 30-60min. before counting.
(e) Radioimmunoassay of oestradiol-17fi and oestrone
No celite chromatography step was used (Baird
et al, 1974) for peripheral plasma samples. A comparison
of results from samples taken throughout pregnancy (paired
t test) for oestradiol (P>0.05; n=12) and oestrone P>0.05;
n=10)' with and without celite chromatography showed that
chromatography was not necessary for these samples,
(Table 3-3)
The high values of oestrone relative to
oestradiol in the utero-ovarian vein, umbilical vein and
fetal plasma, amniotic fluid and placental extracts necess¬
itated the use of a celite chromatography step. The
method used was described by Baird et al (1974). Essen¬
tially, the dried residue was redissolved in 0.5ml
iso-octane, which had been distilled no more than 24 hours
prior to use. The samples were then transferred to
celite columns prepared as described by Abraham, Tuichinsky
and Korenman (1970). A further 5.5ml iso-octane was
applied to the column. Oestrone was then eluted with 4mi
of 15% (15:85v/'v) ethyl acetate in iso-octane and then
oestradiol was eluted with 35% (35:65v/v) ethyl acetate in


















iso-octane. The eluates containing oestradiol and
oestrone were evaporated.
The dried residue .from .the peripheral plasma
extracts and celite columns was redissolved in 0.1 to
0.5ml of buffer. Duplicate 0.1ml samples were taken for
radioimmunoassay and 0.05ml for recovery estimation.
Samples in which no radioactive traces had been added for
recovery estimation were assayed singly as they had been
extracted in duplicate.
The remainder of the radioimmunoassay proced¬
ure was carried out as described for progesterone apart
from the following differences: Oestradiol and oestrone
standards were diluted to concentrations of 8-500pg/lOOpl
buffer. Approximately 5000cpm/100>il of radioactive
oestradiol-17^ (35pg) and oestrone (25) were added to the
appropriate assay. The oestradiol antiserum was diluted
1: 8000/lOOjil and the oestrone antiserum 1: 6000/lOOpl.
30-50% of the labelled steroid hormones were bound using
t'nis^ antiserum dilution.
(f) Radioimmunoassay of androste nedione and
testosterone
The hexane-ether extracts of androstenedione
and testosterone were transferred to prepared alumina
columns (Furuyama, Mayes and Nugent, 1970). The column
separation was essentially as described by McNatty et al
(1976) with minor modifications to the column elution.
After placing the extract on a previously washed alumina
column, the column was rinsed with 4.8ml 0.2% ethanol in
hexane (Et-Hex). Androstenedione was then eluted with
2.4ml 0.2% Et-Hex. A further ,5.4ml 0.2% Et-Hex was run
through the column before elut'ing testosterone with 3.2ml
1% Et-Hex. A clear separation of the 2 hormones was
obtained with this elution. (Figure 3-1)
The elutes were evaporated and the dried
residue was redissolved in 0.25 to 0.50ml of buffer.
Duplicate 0.1ml aliquots were taken for radioimmunoassay
and 0.02 to 0.10ml aliquots for recovery estimations.
The radioimmunoassay procedure for adroste.ne-
dione and testosterone was similar to that for progester¬
one except in the following ways: Testosterone standards
were diluted to concentrations of 12.5-400pg/lOOul buffer
and adrostenedione standards to 8-lOOOpg/lOOpl buffer.
About 5000cpm of radioactive testosterone (30pg) and
androstenedione (30pg) was added to the appropriate assay.
The testosterone antiserum was diluted 1:8000/ 100j.il and the
androstenedione antiserum 1:1500Q/100ul. 40-50% of the
labelled steroid hormones were bound using these dilutions.
(g) Calculations
A program for a desk computer (9821A Calculator
Hewlett Packard) was written to construct a straight
line from the typically sigmoid standard curve by
Mr. R, Sharpe. A standard curve was calculated using a. Y
axis of the logit transformation of B/Bo, and an X axis of
the pg values"of the standards on a log scale at a dose
interval of 2. Values for logit B/Bo.versus dose of
standard were plotted by the computer. The calculation of
Fig. 3-1: The elution pattern for radioactive andros-
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a standard curve omitted the points>90% of Bo and<10% of
Bo, and a straight line of best fit for the data points
was drawn. Steroid concentrations were calculated by
the computer as pg/tube. The results were then correc¬
ted to give ng/ml plasma.
The program gave values for the 90%, 50%
and 10% binding and the slope-of the line. This allowed
inter-assay comparison of the standard curves, which was
important when new standards were prepared. The coeff¬
icient of variation for 10 assays for the 90% and 10%
binding and the slope of the line was less than 5% for
all hormones. The assays were chosen over the whole
range of time during the study.
(h) Assay sensitivity
The sensitivity of the assays (the precision
of the measurement of zero (Bo)) was for practical reasons
defined as the mass of hormone required to suppress the
binding of the labelled hormone to 90% of the binding
achieved with no hormone added (B/Bo). The assay sensi¬
tivity (pg/tube and pg/ml) is given in Table 3-4. The
sensitivity of the assay per sample (pg/ml) varied, depend¬
ing on the dilution used. The minimum detection limit
was not always obtained due to insufficient sample.
Buffer blanks were extracted in duplicate with
every assay and were >90% B/Bo for all hormones. Plasma
from ovariectornized marmosets and from male marmosets
were also extracted. The values for progesterone,
oestradiol-17p> and oestrone were>90% B/Bo. Male
1.1
Table 3-4 . The assay sensitivity (mean ± s.d.,
for the steroids measured in marmoset plasma.
Assay sensitivity
pg/tube pg/ml
Progesterone ' 15 ± 2 1470
Oestradiol-17^ 9 ± 2 211
Oestrone 14+4 1010
Androste nedione 16 ± 3 1000
Testosterone 15 ± 3 300
TU
marmoset testosterone values were a mean of 27l5ng/ml
(s.d. n=10).
(i) Inter-assay and intra-assay precisions
The inter-assay and intra-assay precisions
were expressed as the coefficient of variation for
replicate determinations of 2 pools of marmoset plasma
and are given for the 5 steroid hormones in Table 3-5.
These precisions apply to assays containing plasma and
amniotic fluid samples.
(j ) Assay validations
The steroid assays were validated as follows:
(1) There was no significant departure from
parallelism between standards and serial dilutions of
marmoset plasma (peripheral, utero-ovarian vein, umbilical
vein, and fetal plasma), amniotic fluid, culture media or
placental extracts for progesterone, oestradiol, oestrone
androstenedione or testosterone (P>0.05 to P>0.2) using
2-factor analysis of variance with replication. (ANOVAR)
(2) The recovery of non-radioactive iigand
ad.ded to pooled samples of plasma, amniotic fluid, culture
media and placental tissue gave regression lines and
correlation coefficients as shown in Table 3-6. No sys¬
tematic errors in the methods were indicated.
(3) The concentrations of oestradiol-17£>
and oestrone in marmoset plasma and placental tissue were
confirmed by gas-chromatography-mass-spectrometry (GCMS)
(Kelly, 1971; Kelly and Taylor, 1976). GCMS was done by
15
Table 3-5. The inter-assay and intra-assay coefficients
of variations (n = 10) for 2 pools (1 and 2) of marmoset
plasma for the steroid hormones measured in this study.
Coefficient of variation
Hormone ng/ml Inter-assay Intra-assay
1 2 1 2 1 2
Progesterone 30 160 9 -10 5 3
Oestradiol-17j3 0.5 70 13 10 7 5
Oestrone 8 20 11 12 6 7
Androst«nedione 12 8 15 13 9 9
Testosterone 2 1 14 12 10 8
14
Table3-£.heregressionlineandthcorr lationco fficientfrecov ryof non-radioactiveligandaddetsampl sP4.0.0Vi lc ses. Theamountofhor neaddedwas1.2-25ng/mlf rpr gesterone,0'.3-125ng/ lfor oestradiol,1.6-24.7ng/mlfoestrone,0.48-12ng/ml.foandrostenedi neand 0.3-9,6ng/mlfortestosterone.ĥCoi-e^^ s'iooaAcoVccfcxcm. PlasmaAmnioticfluidCultureMedia
PlacentalTissue
-J IP
Progesterone Cestradiol-173 Oestrone Androstenedione Testosterone
y=0.985x+0.451 r=0.999 y=0.978x+0.526 r-0.999 y=l.008x+0.006 r=0.998 y=l.024x+0.007 r=0.997 y=l.155x+0.274 r=0.950
y=0.954x+0.351 r-0.980 y=l,078+0.489 r=0.997 y=l.201+0.008 r=0.950 y=0.985+0.010 r=0.999 y=l.100+0.200 r=0.980
y=0.979x+0.500 r=0.998 y=0.995+0.460 r=0.997 y=l.031x+0.059 r=0.980 V=0.96x+0.100 r=0.970
y=0.910x+0.300 r=0.995 y=l.102x+0.390 r=0.950 y=0.950x+0.105 r=0.999 y=l.046x+0.080 r=0.997 y=l.079+0.301 r=0.998
Dr. R. Kelly. Radioimmunoassay values for plasma
oestradiol-17(l were 116 and llOng/ml and GCMS values
were 106 and 106ng/ml. The values for plasma oestrone
were 10.3ng/ml (radioimmunoassay) and 9.7ng/ml (GCMS).
The values for placental oestradiol-17£ were 47ng/gm
(radioimmunoassay) and 50ng/gm (GCMS), and for placental
oestrone, 62ng/gm (radioimmunoassay) and 57ng/gm (GCMS).
Progesterone was not compared because of
the instability of the derivative required for GCMS.
Testosterone and androstenedione were not compared
because the low plasma levels would have required a large
amount of plasma to be used for GCMS.
(4) Other investigators did not find a chrom¬
atography purification step necessary for the progesterone
antiserum in other species (K.Dighe, I.Clarke, K.Henderson,
pers comm. ) It was desirable to confirm this for •
marmoset samples. Table 3-7 shows the values obtained
with and without the addition of a Sep'nadex LH-20 step.
There was no significant difference in the values obtained
by the 2 procedures (paired t-test, P>0.05, n=13)
indicating that a purification step was not necessary.
The method used for LH-20 chromatography
was as described by Carr, Mikhail and Hicklinger (1971)
and by the Bulletin on Sephadex LH-20 (1970). A solvent
mixture of heptane: benzene: methanol (85:10:5) (S-3) was
used and the elution pattern of Carr et al (1971) was
confirmed by the application and recovery of cholesterol,
progesterone, pregnenolone, andrqstenedione and testosterone.
nL
Table 3-7. A comparison of values (ng/ml or ng/gm)
obtained for progesterone in marmoset samples with and
without Sephadex LH-2-0 chromatography.
No chromatography Sephadex LH-^O
Peripheral 1 55 62
2 180 165
Utero-ovarian 1 1250 1340
2 2380 2204
Umbilictil vein 1 928 901
2 315 ' 392
Fetal 1 502 475
2 274 268
Amniotic fluid 1 151 160
2 300 320
Placental 1 80 75
tissue 2 2650 2789
3 1890 1900
ni
The progesterone (ll-14ml) fraction was thereafter coll¬
ected. An extract of buffer gave >90% B/Bo indicating
no solvent blank from the Sephadex columns.
(k) Steroid concentrations in placental tissue
Several investigators have described methods
for the extraction of steroids from placental tissue.
(Diczfalusy and Troen, 1961; Leung and Solomon, 1972;
Diczfalusy and LindkVist, 1956; Telegdy, Weeks, Wiquist
and Diczfalusy, 1970; and others). These methods were
established before the advent of the more specific radio¬
immunoassay procedures and numerous separation and purifi¬
cation steps were necessary. In addition tissue quanti¬
ties well in excess of 10 grams were used and probably
presented problems that have been avoided for the marmoset
by the use of less than 0.08 grams of- tissue.
The following procedures, which were validated
for marmoset placental tissue only, demonstrate a fairly
simple method for placental steroid extraction and purifi¬
cation prior to measurement by radioimmunoassay.
Placental tissue was stored at -20°C in small
pieces following hysterotomy (see Chapter 2 -*8).
All procedures prior to steroid extraction were done in
an ice bath. A minimum of 3 homogenates per placental
disc, were done on tissue obtained after day 60 of preg¬
nancy. 2 to 4 homogenates were obtained from placental
tissue at 40-50 days of pregnancy. Weighed amounts of
tissue (0.03 to 0,08 grams) were hand homogenized with
76
0.8ml of phosphate gelatin buffer. Microscopic examina¬
tion of the homogenate showed that the cells were broken
up. The homogenate was transferred to accurately
calibrated (for 2.0ml) centrifuge tubes. The homogenis-
ers were rinsed 3 times with a total of 0.6ml of buffer
and the rinses were added to the appropriate centrifuge
tube. The tubes were then centrifuged at lOOOrpm at
4°C for 5 minutes to get rid of the foam caused by the
nomogenisation procedure.
The volume in all the homogenates was made
up to 2.0ml. The homogenate was mixed well and 0.2ml
(10%) was removed for the progesterone assay, 0.5ml
(25%) for the oestradiol and oestrone assays and 1.0ml
(50%) for the androstenedione and testosterone assays.
The recovery of each hormone was estimated
after this stage for each placental homogenate by the
addition of tracer amounts of the appropriate radioactive
steroid (see section 3.2a,c).
Procedural losses were not estimated prior to
this stage as it was desirable to use the same homogenate
stock for all steroids. Any steroid loss prior to this
stage was shown to be minimal. No measurable amount of
progesterone was being left in the homogenisers. Also,
the recovery figure for progesterone was not significantly
different when tracer was added at the beginning or at the
normal point in the proceedings.
Following equilibration with the tracer, the
progesterone homogenates were extracted with 2.0ml
petroleum ether, the oestrogen homogenates with 5ml
diethyl ether and the androgen homogenates with 10.0ml of
hexane ether (4:1, v/v). No emulsions formed as long as
the volume of organic solvent was at least 10 times the
volume of the buffer homogenate. The extraction of
equivalent quantities of buffer with equivalent amounts
of solvent showed that these larger volumes of organic
solvents did not introduce a high 'blank' value. In all
cases, the buffer extracts were >90% B/Bo.
Three homogenates for each hormone were extr¬
acted a 2nd and 3rd time to check the completeness of the
1st extraction. In all cases, less than 3% of the total
radioactivity added was recovered with additional
extractions. In addition, radioimmunoassay of progester¬
one values in the 2nd and 3rd extract showed values less
than 2% of those obtained in the 1st extraction. There¬
fore it seemed that the extraction of radioactivity
paralleled the endogenous hormone in the tissue, and J;hat
only. 1 extraction of the placental homonogenate was
necessary.
A similar percentage of radioactive tracer
was recovered irrespective of the amount of tissue used.
The percentage of progesterone radioactive tracer recovered
was 75-80% 'from tissue concentrations of 0,01 to 0.08 grams
(n=8). The percentage of oestradiol, oestrone, androsten-
edione and testosterone radioactive tracer recovered from
5 homogenates prior to the chromatography step was 80 to
90% for all 4 hormones. . This indicated that a substantial
80
amount of the hormone was being extracted from the
tissue despite differences in the amount of tissue used.
Most authors utilised a centrifugation step
of the placenta.1 homogenate prior to hormone extraction.
The value of this was assessed. 2 placental homogenates
for each hormone were equilibrated with radioactive
tracer and then centrifuged at 3000rpm for 30 minutes at
30°C. The supernatant and precipitant were extracted
for each hormone. The amount of radioactivity recovered
in each fraction is shown in Table 3-0.
Radioimmunoassay of the amount of hormone
in the supernatant and precipitant extracts showed a simi¬
lar ratio for the endogenous hormone in the supernatant and
precipitant as the percentage ratio for the recovery of
radioactive hormone (Table 3-6).
This data indicated that the 2 most fat
soluble hormones, progesterone and oestrone (Kelly $.pers.1
comm.,' ) were being trapped in the precipitant. However,
the •■hormones could be extracted from both the precipi¬
tant and supernatant.with the appropriate organic solvent.
The extraction of radioactivity from the precipitant and
supernatant reflected the extraction of the endogenous
placental hormone.
Either a finer homogenate or extraction of the
whole homogenate (with no centrifugation) were 2 alterna¬
tives to overcoming the problems with progesterone and
oestrone. Since the latter was the easier solution, this
was tested first and assay validations were done without a
Table 3~$. The percentage recovery of radioactivity
from an extract of the placental supernatant and prec¬
ipitant following centrifugation and of buffer.
Supernatant Precipitant Buffer
Progesterone 56 26 92
Oest radio 1-17(2 91 < 3 85
Oestrone 66 20 88
Androstemedione 90 3 83
Testosterone 86 3 80
$2-
centrifugation.step.
After obtaining an extract of the placental
homogenates, the procedures for radioimmunoassay were
essentially as described in sections 2.2d,e & f. The
procedures are summarised at the end of this section
(3 . 2kl).
The coefficient of variation (CoV) for 10
placental homogenates prepared from 1 placental disc
was 5%, a similar figure to the intra-assay CoV for plasma
samples (Ta.ble 3-5). This showed that the small piece of
placental tissue used for homongenisation was fairly
representative of the overall placental hormonal concentr¬
ation .
The inter-assay CoV was determined by
replicate determinations of a placental homogenate and was
similar to values in Table 3-5 for all hormones.
The mean value for each placental homogenate
was calculated (using 2-4 replicates). 3 mean placental
homogenate values were used to calculate the mean value
per ..placental disc (except for the 40-50 day values).
(1) Summary of method
1) Weigh and homogenise tissue with 0.Sml buffer.
Centrifuge lOOOrpm for 5 minutes. Make volume to
2.0ml. Mix.
2) Take "0.1ml for progesterone assay
a) Add progesterone tracer and equilibrate
b) Extract with 1ml petroleum ether
c) Dry extract and redissolve in 0.3-1.0ml buffer.
d) Take 0.05-0.2ml for recovery determinations.
e) Take duplicate 0.01 and 0.10ml for radioimm¬
unoassay
f) Assay as in section 3.2d.
3) Take 0.5ml for oestrogen assays
a) Add oestradiol and oestrone tracers.
Equilibrate
b) Extract with 5ml diethyl ether and dry extract
e) Redissolve residue in iso-octane and apply to
celite columns. Collect oestradiol and
oestrone fractions. Dry
f) Redissolve in 0.25-0.05ml buffer
g) Take 0.02-0.lml for recovery determinations
h) Take duplicate 0.02-0.10ml for radioimmuno¬
assay ,
i) Assay as in section 3.2e.
4) Take 1.0ml for androgen assays
a) Add androstenedione and testosterone tracers.
Equili.bra.te
b) Extract v/ith 10ml hexane: ether (4:l,v/v)
c) Reduce extract to about 1.0ml
d) Apply extract to alumina columns and collect
androstenedione and testosterone fractions.
Dry .
e) Redissolve in 0.25-0.30ml buffer
f) Take 0.02-0.05ml .for recovery determinations
g) Take duplicate 0.10ml for radioimmunoassays
h) Assay as in section 3.2f,
(2) Summary of validations for placental
tissue
There was no significant departure from parallelism
between standards and serial dilutions of placental
extracts. (See section 3.2k).
The recovery of known amounts of added hormone
showed no systematic error in the method. (Table
3-7)
There were good recoveries of radioactive tracers
for all hormones from placental homogenates with a
range of tissue amounts. The recovery of the
radioactive tracers reflected the recovery of endo¬
genous hormone.
Progesterone values were similar in placental
extracts with and without Sephadex LH-20 chromato¬
graphy (Table 3-8). Oestradiol and oestrone level
were confirmed by GCMS (see section 3.1j).
Intra-assay precision (utilising individual homogen
ates) was within the normal range. This also -
indicated that the small piece of tissue used was
probably fairly representative of the overall plac¬
ental hormone concentration.
Larger volumes of solvents used did not interfere
with the assay.
3.3 Radioimmunoassay of lutein!sing hormone/chorionic
gonadotrophin (LH/CG)
The majority of the samples measured for LH/CG
were from pregnancy. In the present study, marmoset
LII/CG was measured by adaptation of the heterologous
double-antibody radioimmunoassay for marmoset LH.
(Hodges, 1977, 1978). The assay used NIAMDD-rat LHI-1
for iodination, NIAMDD-rat LHRP-1- for standards and anti-
ovine LH610V for antiserum. (Dr. J.Uillenbrock, Amsterdam)
There were problems over parallelism between marmoset
pregnancy samples and the NIAMDD-rat LHRP-1 standards.
As there is not yet available a,standard preparation for
marmoset CG, serial dilutions of an extract from a 60
day marmoset placental tissue were used as a standard.
(See section 3.3h)
The assay cross-reacted with NIAMDD-rat LHRP-1
by 3%, with bovine FSH (6FSH CH-1-76) and NIAMDD-rat FSH
1-1 by 0.17% and<0.3% respectively, and with all human
preparations by less than 0.05%. (Hodges, 1977, 197-8.)
(a) Reagents
Buffers
Phosphate buffered saline (PBS; 0.01M, pH 7.8):
This buffer was made from stock solutions of 0.4M disodium
hydrogen orthophosphate (A) and 0.4M sodium dihydrogen
orthophosphate (B). 36gm. of sodium chloride, 91.6ml. of
A and 8.4ml. of B were made up to 41 with distilled water.
0,04gm. of sodium thiomersalate was added as a preservative.
Phosphate buffered saline (PBS; 0.05M, pH 7.8):
This buffer was prepared in an identical way to the one
above except that the solution was made up to 800ml.
Phosphate buffered saline plus bovine serum
albumin (PBS + BSA): BSA was added to 0.01M PBS to give
a concentration of lgm. per 100ml. (1% BSA).
"Special buffer": 3.72 gm. ethylenediamin-
etetra-acetic acid (EDTA; Sigma) was dissolved in 11. of
0.01M PBS. The pH of this solution was adjusted to 7.5
using 3N. sodium hydroxide. Normal rabbit serum (6.7ml.
NRS; Wellcome Reagents Ltd.) and 2gm. BSA were added.
Barbitone buffer (0.12M; pH 8.5): Diethyl
barbituric acid (llOgm.) was dissolved in 4.51 of distil¬
led water, and 19gm. of sodium hydroxide in 11. of
de-ionised water was added and stirred for 2 hours. The
solution was then made up to 51. with distilled water and
stirred for 24 hours.
Barbitone buffer plus BSA: 5gm. BSA were
dissolved in lOOmg. Barbitone buffer (i.e. 5% BSA).
All buffers were stored at 4°C.
(b) Iodlnation of rat LH
Rat LH preparation NIAMDD-rat LHI-1 was
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labelled with Na I (Radiochemical. Centre, Amersham) by
a modification of the chloramine-T method of Greenwood,
Hunter and Glover (1963). All iodinations were done by
Dr. J. K. Hodges and the method used has been fully des¬
cribed. (Hodges, 1977, 1978). For each assay, the label
was diluted to lOOOOcpm in lOOyil PBS + 1% BSA.
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(c) Antiserum . ,
raised in raVjbrb
Anti-ovine LH610V, was stored at -20°C. For
each assay, the antiserum was diluted 1:70,000 with
special buffer.
(d) Standards
Standard LH solutions were prepared from 50pl
aliquots (lOmg. hormone) stored at -20°C by diluting with
PBS + 1% BSA buffer to concentrations of 0.6-160ng/lOOpl.
Standard placental solutions for pregnancy
samples were prepared from dilutions of the supernatant
of a 60 day marmoset placental homogenate. This stage
was chosen for the combination of high hormonal values and
sufficient quantities of tissue.
LH/CG was extracted from placental tissue by
homogenisation of tissue (0.02-0.15 grams) in 3ml. of
0.01 molar PBS. The homogenate was shaken for 3 hours in
a mechanical shaker (Gallenkamp) and then centrifuged
at 3000rpm for 30 minutes at 4°C. The supernatant was
decanted and aliquots were removed for serial dilution with
PBS + 1% BSA for the standard solutions. The top dose
was assigned the value of 100 units and each dose was
calculated from this value.
The same method was used for extracting LH/CG
from all placental tissue samples.
(e ) Assay
__ procedure
All samples were assayed in duplicate using
plastic 63 x 11mm. tubes. (Sarstedt).
£2
The protocol of each assay included:
1) Total count tubes (TC):
125I-LH (lOOjil).*
2) Non-specific binding tubes (NSB) :
special buffer (lOOpl);
PBS + 1% BSA (200/11);
log
I-LH (lOO/il) .
3) Total bound tubes (TB) :









5) Unknowns and quality controls :
Samples (plasma, placental extracts or culture





Standards or unknowns and antiserum was added on the
first day. The tubes were mixed and incubated at 4°C for
1253 days. I-labelled LH was added to all tubes which
were mixed and incubated at 4°C for a. further 2 days.
Separation of antibody bound and free hormone
was achieved by adding 200/al of donkey anti-rabbit gamma
globulin (1:30 V/v, in 0.01M PBS) (Burroughs Wellcome, RD17)
si
and incubation was continued at 4°C for 12 hours. The
unbound radio-activity was diluted with 1ml 0.01M PBS
and the tubes centrifuged at 4°C for 30 minutes at 2500
rpm. The supernatants were discarded, the tubes dried
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with tissue paper, and the antibody-bound I-labelled
LH in the precipitate was measured in an automatic gamma
spectrometer (Wallac Decern - GT2).
(f) Precisions and sensitivity
The inter-assay CoV was 4% for repeated assays
(n = 5) of a pool of marmoset pregnancy plasma. The
detection limit of the assay for placental standards
v/as 1 unit/tube; 20 units/ml for pregnancy plasma samples
and 185 units/gram for placental tissue. The detection
limit for LH standards was Ing/tube and 20ng/ml for plasma.
These limits were not always obtained due to insufficient
sample.
(g) Calculations
A typically sigmoid standard curve was obtained
using Y-axis of B/Bo and an X-axis of values of the stan¬
dards on a log scale at a dose interval of two. The curve
was drawn to pass through the mean value of each dose of
standard. LH standards were used for samples taken
around ovulation and placental standards for all pregnancy
samples.
(h ) Assay validation
There was no significant departure from para¬
llelism (py0 * 2, ANOVAR) between NIAMDD LHRP-1 standards,
SO
non-pregnancy plasma and marmoset pituitary extracts
between 25 and 87% B/Bo. There was also no significant
departure from parallelism between serial dilutions of
marmoset peripheral and utero-ovarian vein pregnancy
plasma and placental extracts or between 3 placental
extracts (days 40, 60, 75) (p>0.2, ANOVAR). Placental
tissue and pregnancy plasma were not parallel to the
NIAMDD LHRP-1 standards, non-pregnancy plasma or pituit¬
ary extract.
A comparison of some of the inhibition curves
obtained for these samples is given in Figure 3-2.
Estimation of pregnancy samples.using LH standards would
have resulted in a large underestimation of gonadotrophin
values. In view of these findings and the lack of an
alternative standard for marmoset pregnancy samples, it
was decided to use serial dilutions of a marmoset placental
extract for all pregnancy samples.
The placental extract could be assayed in a
biological system (e.g. radio-receptor assay, Parlow "
ovarian ascorbic acid depletion assay, OAAD) to assign a.
potency to these standards which would allow quantitative
comparison to other species.
The parallelism between pregnancy plasma and
placental extracts and the non-parallelism with non-
pregnancy plasma and pituitary extracts indicated a dist¬
inct 'pregnancy' gonadotrophin with a placental source.
Sephadex chromatography should confirm a clear separation
of the immunological fractions between the non-pregnant
31 '
Fig. 3-2: Inhibition curves for NIAMDD-rat LKRP-1 (0~),
pooled peripheral (&,) and ute'ro-ovarian (O—)plasma from
pregnant marmosets, a marmoset placental extract (&) and
pituitary extract ).
Plasma or extract added (pi)
« r « ——t 1 1— i r 1
0*33 0*75 1«5 3»1 6«2 12'5 25 50
0«37 V5 6-2 25 100
Amount of hormone (ng ^+ube)
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and pregnant state. In addition, a biologically and
immunologically active gonadotrophin (CG) from the
placenta of the marmoset was demonstrated. (Hobson,
1972) which cross-reacted biologically (Hobson and
Wide, 1972) and to a lesser extent immunologically
(Hodgen et al, 1976) with hCG.
Although absolute confirmation of the assay
must await purification of a marmoset CG preparation,
the utilisation of the present assay system gave compara¬
tive CG levels during pregnancy for the marmoset.
3.4 Radioimmunoassay of culture media
(a) Progesterone, oestradiol, androstenedione and
testosterone
Culture media, wftpft not extracted prior to radio¬
immunoassay for progesterone (McNatty, Henderson and
Sawers, 1975). The direct assay of culture media was not
assessed for the other hormones as relatively few samples
were measured.
Duplicate 0.01-0.lml aliquots of culture media
or of diluted culture media were taken directly for assay
(progesterone, section 3.2d) or for extraction, chromato¬
graphy and assay (sections 3.2e & f).
Validations were as follows:
1) 2 standard curves, with an extra 0s. lml of buffer or
0.1ml culture media, were superimposable for all
hormones.
2) There was no significant difference in progesterone
values (paired t-test, p>0.05, n-6) for extracted
and non-extracted samples.
3) There was no significant departure from parallelism
between standards and placental cultures (ANOVAR,
p>0.05).
4) Recovery of added hormone indicated no systematic
error in the method. (See Table 3-7.)
(b) LH/CG
The measurement, of LH/CG secreted into culture
media by placental tissue followed the protocol described
in section 3.3. There was no significant departure from
parallelism between placental standards and serial dilu¬
tions of placental culture media (ANOVAR, P>0.05). The
addition of culture media (0.1ml) to the standard curve
had no effect.
3.5 Radioimmunoassay for prolactin
Marmoset prolactin was measured using a heterologous
double-antibody radioimmunoassay described in detail prev¬
iously (McNeiliy and Friesen, 1978; McNeilly, Abbott, Lunn,
Chambers and Hearn, 1981). The assay uses a guinea-pig
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anti-human prolactin antiserum (33-9) with ~ I-labellea
ovine prolactin as tracer and ovine progactin (NI1I-P.S6,
26iu/mg) as standard. The assay cross-reacted with
\j
prolactin preparations from the sheep, cow and pig by 80%
and more, with dog (Schering) by 79%, with rabbit (McNeilly
76-1-MC) by 17% and with rat NIAMDD P-I-l bye 0.1%.
Growth hormone, placental lactogen, LH and FSH preparations
from many species all cross-reacted by less than 0.1%
(McNeilly and Friesen, 1978). All prolactin assays were
done by Dr. A.S.McNeilly.
(a) Reagents
O'.OIM PBS, 0.05M PBS and PBS + 1% BSA :
identical to the recipes in the LH assay (section 2.16a( i)).
0.1% and 1%-Tris-HCl buffer (0.025M; pH 7.5) :
3.025gm/l of 2-amino-2-(hydroxymethyl)propane-l,3-diol,
(tris) (Tris(hydroxymethyl) rnethylamine; BDII) and lgm/1
(0.1%) or 10gm/l (1.0% of BSA were dissolved in distilled
water and the pH adjusted to 7.5 with hydrochloric acid
(HC1).
Physiological saline (0.9% (w/ ) NaCl; pH 7.2) :
9gm of sodium chloride (NaCl) were added to every litre of
distilled water.
Iodination of ovine prolactin
Ovine prolactin (o PRL) NIH-P-S-6 was labelled
12 5
with Na ' I (Radiochemicals Centre, Amersham) by the lacto-
peroxidase method (Thorrel and Johansson, 1971) at room
temperature, as described previously (Shin, Kelly and
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Friesen, 1973). The labelled prolactin was stored
at -20°C until used for assay, when it was diluted to
20,OOOcpm in lOOpl PBS + 1% BSA. ^
(b ) Standards
Standard prolactin solutions were prepared from
20pg of the hormone stored at -20°C in 1ml of 0.1% BSA-Tris-
1IC1 buffer. Dilutions with 0.01M PBS were prepared in the
range of 0. 4~200ng/m.l.
is
•(c) Antiserum
Anti-human prolactin 33-9 was stored at -20°C
in 1ml aliquots at a dilution of 1:100. For each assay
this was diluted to an initial concentration of 1:6000 with
PBS and 1% BSA. This dilution of antiserum bound between
30 and 50% of the labelled tracer (McNeilly and Friesen,
1978).
(d) Assay procedure
All samples were assayed in duplicate using
plastic 63 x 11mm tubes (Sarstedt). The protocol of each
assay included:
1) Total count tubes (TC):
1 9ri
I - PEL (100)11).
2) Non-specific binding tubes (NSB):
PBS & 1% BSA (450)il);
1
I - PEL (lOOjul).
3) Total bound tubes (TB):
PBS & 1% BSA (350pl);
antiserum (lOOjul);
125I - PEL (100)il).
4) Standards:
standard prolactin (50)il); ^
PBS & 1% BSA (300>il);
antiserum (lOOpl);
1251 - PEL (100)il).
5) Unknowns and quality controls:
Plasma (50j.il);
PBS & 1% BSA (300jul);
antiserum (lOOpl);
1 2 5X*°I ~ PRL (lOOjal).
Standards or unknowns, PBS + 1% BSA and antiserum
was added on the first day. The tubes were mixed and
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incubated for 24 hours. I-labelled prolactin was
added to all tubes which were mixed and incubated for 3
days at 4°C. Separation of antibody bound and free
hormone was achieved by adding lOOpl of normal guinea pig
precipitating serum (1:600 v/v in 0.01M PBS) and then
lOOpl of donkey anti-guinea pig gamma globulin (1:15 /
in 0.01M PBS; Burroughs Wellcome). Incubation was con¬
tinued at 4°C for another 16 hours. The unbound radio¬
activity was then diluted with 1.0ml of physiological
saline and the tubes centrifuged at 4°C for 30 minutes at
2500 rpm. The supernatants were discarded, the tubes
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dried with tissue paper, and»*the antibody-bound I-
labelled prolactin in the precipitate was measured in an
automatic gamma spectrometer (Model 1270, Rackgamma;
Wallac Decam).
(e) Precision
The inter- and intra-assay variation was 11%
(ri=10) and 7% (n=16) respectively for 3 pools of marmoset
plasma containing 4, 25 and 45ng/ml.
(f) Calculations
The procedure was identical to that in the LH
assay (section 3.3g).
(g) Assay validation
To provide biological validation of the
assay, marmosets were treated with agents known to raise
(Thyrotrophin releasing hormone, (TRII; Roch) and metaclo-
pramide (Maxalon; Beechams)) or lower (bromocriptine
(CB154)) prolactin levels in other species. To evaluate
cross-reaction with luteinizing hormone (LH) and follicle
stimulating hormone (FSH) marmosets were also treated with
luteinizing hormone releasing hormone (L1IRH, Hoechst).
Five cycling female marmosets were injected
with saline (0.5ml), bromocriptine (CB154) (2m5mg irn)
metaclopramide (2.0mg im) TRH (25ug iv) or LHRH (2u.g iv).
The changes in plasma prolactin levels following injection
are shown in Figure 3-3. Saline and LHRH had no signifi¬
cant effect on plasma prolactin levels. TRH and metaclo-
pra.mide caused a significant (p<0.001) increase in prolactin
30 minutes after injection. The increase in prolactin was
significantly greater (p<0.001) after metaclopramide than
after TRH. CB154 caused a suppression of plasma prolactin
to be'low the sensitivity of the assay. This observation
also provided evidence that marmoset plasma alone did not
125
have a non-specific effect on the binding of 1-labelied
ovine prolactin to the antiserum.
The slopes of the inhibition curves were not
significantly different for ovine prolactin standards,
dilutions of marmoset plasma and crude marmoset pituitary
extracto Therefore all samples were assayed against, and
were reported in terms of, ng ovine prolactin/ml plasma „
^8
Fig. 3-3: Plasma levels of prolactin in female marmosets
after the injection (4-) of a) saline, b) CB154 (Bromo¬
criptine, 2. 5rng im), c) TRII (25ug. i.v.) or d) metaclo-
pramide (2.0mg im). Five animals were used and each was
given all tests. The dotted line indicates the sensitiv¬
ity of the assay.
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CHAPTER 4 : PHYSICAL PARAMETERS AND HORMONAL PROFILES
DURING THE CYCLE, PREGNANCY AND LACTATION.
4.1 Introduction
(a) Cycle
Studies on the ovarian and pituitary endocrine
events during the menstrual cycle in sub-human primates,
including the rhesus (Neill, Johansson and Knobil, 1967
Hotchkiss, Atkinson and Knobil, 1971; Niswender and Spies,
1973 and others) and other macaque species (bonnet:
Stabenfeldt and Hendrickx, 1872; crab-eating: Stabenfeldt
and Hendrickx, 1973), baboons (Stevens, Sparks and Powell,
1970; Goncharov, Aso, Cekan, Pachalia and Diczfalusy, 1976;
Kling and Westy al, 1978), chimpanzees (Reyes et al, 1975;
Hobson, Coulston, Raiman, Winter and Reyes, 1976) and
orangutan (Pongo pygmaeus) (Collins, Graham and Preedy,
1975) demonstrated considerable qualitative similarities
among these species. These sub-human species have been
considered as appropriate models for studies on the endo¬
crinology of the human menstrual cycle.,
Increasingly, New World primates are being
studied as additional primate models for studies on human
reproduction. Some, such as the capuchin (Cebus apella)
(Castellanos and McCombs, 1968; Wright and Bush, 1977) and
squirrel (Saimlriscuireus) (Wolf, O'Connor and Robinson,
1977) show regular menstrual cycles. Others, including, the
owl monkey (Aotus trivirgatus) (Elliot, Sehgal and Chalifoux,
1976; Bonney, pers . coram ), the tamarins (Saguinas species)
IOO
(Preslock, Hampton and Hampton, 1973) and the marmoset
(Hearn and Lunn, 1975) show neither a conspicuous oestrus
nor a detectable menstrual cycle; although a clearcut
hormonal cycle is present.
A preliminary study in the marmoset indicated
a cycle length of 17 ± 1.7 days, with a LH, progesterone and
oestrad.iol pattern not unlike that observed for the human
(Hearn and Lunn, 1975). In order to compare the hormonal profi
in the nonfertile cycle with the conception cycle and with appar¬
ently long cycles" (19-30 days.^ in several females paired with
fertile males, it was necessary to use the same assay sys¬
tems for the cycle data as the pregnancy data. Therefore
the hormonal profile during the cycle was re-examined.
(b) Pregnancy
A preliminary study in the marmoset showed that
progesterone and oestradiol increased throughout pregnancy
in a manner more similar to women than to baboons or maca¬
ques (Hearn and Lunn, 1975). There is as yet no detailed
analysis of the hormona.1 changes occurring during pregnancy
»
for the marmoset. The first part of this study was init¬
iated to document the overall changes occurring during preg¬
nancy for several hormones utilising assays that were fully
validated for marmoset plasma (Chapter 3). The mean
trends and hormonal interrelationships were obtained by the
simultaneous measurement of several hormones in samples
taken throughout pregnancy. • The interanimal variation was
exemplified by hormonal measurements in serial samples
taken from several individuals. In addition,
selected stages of gestation were studied utilising a more
frequent sampling regime, but with the consequence that
fewer hormones were measured. Detailed profiles of
progesterone ; oestradiol and LH/CG for the conception
cycle/ and of progestero-ne and oestradiol for the first 70
days of pregnancy, 80 to 100 days and the last week of preg¬
nancy were studied in several individuals. It is inten¬
ded to relate this basic data on peripheral hormone levels
to ovarian and placental function (Chapter 5), fetal
hormones (Chapter 6) and the pattern of prenatal develop¬
ment (Chapter 7).
The physical factors that were assessed were the
growth of the uterus and fetal heads, the ovarian size and
the number and distribution of corpora lutea. •' ■ • *
(c) Prolactin values during lactation and the relat¬
ionship to the return to fertility in primates
Lactationin women is associated with a period of
amenorrhoea and infertility (see McNeilly 1979 for references)
Although the exact mechanisms involved in inhibition of
reproduction during the post partum period have not yet been
elucidated, both elevated levels of prolactin and the suckling
stimulus itself would appear to be involved. Lactation is
also associated with a period of infertility in other primates;
e.g. the gorilla (Gorilla gorilla) (Ilarcoutt, Fossey,Stewart
and Watts, .1980), chimpanzee (Tutin, 1980), baboon (Attman,
Aitman and Hausfater, 1978), rhesus monkey (Weiss, etal, 1973).
Among New World primates an effect of lactation on reproduction
has been observed in the spider (Ateles belzebuth) (Dempsey,
1939; Wolf, Harrison and Martin, 1975) howler (Alouatta
I 01
caraya) (Carpenter, 1934) and squirrel monkeys (Travis
and Holmes, 1974; Coe and Rosenblum, 1978),
In contrast to the above species, lactation in
the common marmoset monkey is not associated with any app¬
arent post partum infertility, in spite of continued suck¬
ling by the infant for up to 100 days (Lunn and Hearn, 1978;
Chambers and Hearn, 1979; Lunn and McNeilly, 1981). The
aim of the present study was to determine the changes in the
circulating levels of prolactin during lactation and to
relate the occurrence of lactation with the return to
fertility.
4 . 2 Procedures
(a) Uterine, ovarian and fetal head growth
ine fundus was measured by abdominal palpation. In animals
from which more than 1 measurement was taken in a week, the
mean value was used. ■ After the 15th week of gestation,
the numbers and size of the fetal heads were estimated by
palpation once weekly.
(1) and width (b) of the ovary was also measured at laparot¬
omy and hysterotomy (section 2.6a and b). The ovarian size
was estimated by the formula for the volume of an oblate
One to three times weekly, the width of the uter-





Two animals, paired with vasectomized
males, were bled daily for 30 days. A further 3 animals,
paired with another female, were bled 3 times weekly for
5 weeks. Preliminary samples were taken from the latter
3 animals to establish cyclicity. It was previously
shown that 1 female will continue to cycle normally when
paired with another female (Hearn, 1978). The sampling
duration of 5 weeks was chosen based on a previous report
of the cycle length being just over 2 weeks (Hearn and
Lunn, 1975). Progesterone and oestradiol were measured
in all samples. LH/CG and oestrone were measured on
samples when there was sufficient plasma.
(ii ) Pregnancy
Samples were taken 1-3 times weekly from
5 timed pregnancies throughout pregnancy. Two animals
aborted and blood sampling was discontinued. S'amples
were also taken from animals in whom the stage of gestation
was estimated by abdominal palpation and retrospectively
by the day of birth (section 2.4)
A summary of the serial weekly and 3-7
time weekly sampling regimes and the hormones measured is
given in Table 4-la and b. In some cases, the same animal
that was used for the earlier part of gestation was also
used for the latter part. .In all cases, more than 1 hormone
was measured in each sample.
Mean hormonal values for pregnancy were
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Table 4-la. The serial sampling regime during preg¬
nancy for the 5 steroid hormones, prolactin and LH/CG.
Samples were taken weekly.













Prolactin 2 * 1-10
4 12-20
All of the 2 1-20
above hormones
|0<b
Table 4-lb. The serial sampling regime during pregnancy
for progesterone, oestradiol and LH/CG, Samples were
taken 3 times weekly or daily*.



















calculated using all available hormonal data for each
week or period of gestation. In animals from which more
than 1 measurement was taken in a specified period, the
mean value was used. The hormonal ratios were calculated
using only samples in which both hormones were measured.
Only results from pregnancies carried successfully to term
were included.
(iii) Lactation
13 marmosets were bled 2-3 times weekly
during the last week of pregnancy. Sampling was continued
in 10 of these females, which had surviving young, for 90-
100 days post partum. For the 3 remaining females, whose
young had died within 5 days of birth, sampling was contin¬
ued for up to 70-77 days post partum. Prolactin and pro¬
gesterone were measured in all samples.
( c.) Statistics
Unless otherwise stated, mean hormonal values
at different stages of gestation were compared using the
students t-test and hormonal values from serial samples




(a) Uterine, ovarian and fetal head growth
. Figure 1 shows the growth of the uterus and
fetal heads for singleton, twin and triplet pregnancies.
By reference to this graph for uterine growth, pregnancies
of an unknown stage may be dated. There was no difference
IbT
Fig. 4-1: The diameter (±s.d.) of the uterine fundus (©)
and the width of the fetal heads (o), measured by abdom¬
inal palpation in marmosets bearing single, twin or
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in the growth of the uterus between triplet, twin and
singleton pregnancies until 13 weeks of gestation. A
decrease in the uterine diameter was observed at 15 weeks
of gestation and a decrease in the week preceeding birth
when the fetal heads engage with the pelvis. Two fetal
heads, as when there are twins, cannot be palpated and
measured until 17-18 weeks of gestation and 3 heads, as
for triplets, are not distinguishable until 19-20 weeks.
Abortion was clearly indicated by a significant decrease
of the uterine diameter and was confirmed by the drop in
progesterone concentrations to follicular-phase levels.
Uterine and ovarian size, and the distribution
and size of corpus luteum (CL) were obtained at laparotomy
or hysterotomy (Table 4-2). Abdominal palpation was gen- ■
erally similar to the direct measurement at hysterotomy.
CL were often distinguishable up to 90 days of pregnancy
and were distributed on either one or both ovaries. The
number of CL present generally corresponded with the number
of embryos present. The ovary associated with CL was
usually larger than the ovary with no CL and ovarian size
was similar when both contained CL.
(b) Post-partum ovulation
Within 3 weeks of giving birth, 74% of the animals
(N-31) had .ovulated,, The mean day of ovulation was
10.5 1 0.7 (s.d.) days post-partum. Of the 23 animals
that ovulated, 17 were suckling at least 1 young at the time
of ovulation. The range (5-17 days) from birth to first
ovulation was similar for both lactating and non-lactating
animals.
Table 4-2. The uterine diameter (cm) measured by
abdominal palpation (P) and at hysterotomy (H), the
number of fetuses, the number and size (cm) of corpus
luteum (C.L.) and the ovarian volume (cm) (Ov.V) for a
selection of pregnancies throughout gestation. N.M. =
not measured.
Gest. Uterine Size No. No. Size Ov.V
Stage P H fetuses C.L. C.L.
1 ' 1 0.3 0.079
1 0.4 0.064
10 1 0.5 0.118
1 0.5 0.092
30 0.6 0.7 2 1 0.4x0.6 0.118
1 0.4x0.5 0.151
50 1.5 1.5 2 2 0.5,0.3 0.150
0 0.025
70 1.9 1.95 - 2 1 0.3 0.048
1 0.4 0.118
90 3.4 3.3 3 3 0.4,0.3,0.3 0.176
0 0.035
110 3.7 4.3 2 1? N.M. 0.092
0.050
130 4.5 4.4 2 0 0.074
0 0.046
140 5.6 5.4 2 0 0.062
0 0.074
ho
78% (N=lS)of the ovulations resulted in
pregnancy. 14 of the animals were lactating and 4 were
not. Hormonal and interbirth interval. data.(s.Lunn, persl
comm. 0 showed that the remaining 5 animals conceived at
the subsequent 1 or 2 cycles„
Of the S animals in which ovulation did not
occur within 3 weeks, 5 animals were lactating and 3 were
not.
After spontaneous abortion, animals resumed
fertile cycles within the same time interval as those that
had given birth, and 71% (n=7) of the ovulations resulted
in pregnancy.
The gestation length was 144 1 2 (s.a., N=9)
days.
(c) The cycle
The 2 animals that were bled daily for 30 days
were both acyclic as indicated by continuous progesterone
values of «il0n'g/ml, 2 complete cycles and 1 complete luteal
phase were obtained from the remaining 3 animals (Figure
4-2) which were bled 3 times weekly for 5 weeks.
The total cycle length for the 2 animals was a
minimum of 24-27 days. The follicular-phase, defined as
progesterone ^10ng/ml, ranged from a minimum of 4-8 days.
The luteal phase ranged from a minimum of 19-24 days. The
mean was 21.3 ± 2.1 (s.d., N-3) days.
Maximum luteal phase progesterone values were
found around day 10-12 after ovulation. Progesterone
slowly declined over about the next 10 days and levels were
IM
Fig. 4-2: Progesterone (^0, oestradiol-17f?> (o), and
oestrone («) during the non-fertile cycle in 3 indiv
ual marmosets. Day o = estimated day of ovulation.
lower than the normal pregnancy range (<20ng/ml) by day
19-24.
There was a rise in oestradiol just prior to the
initial progesterone rise and a second rise during the
luteal phase coincident or just after the progesterone
peak (day 11-15). This was about 6-9 days prior to
follicular phase progesterone values.
11 apparent cycles were also obtained from 11
animals paired with fertile males, who were being bled 3
times weekly for another part of this study. The duration
of the lutea.1 phase was similar to that seen in the non-
fertile cycle. The mean luteal phase was 21.5 ± 2.0 (s.d,,
N=ll) days and the range was 19-24 days. Progesterone
values lower than the normal pregnancy range were reached
between 17 and 22 days followed by follicular phase levels
2-3 days later. The pattern of progesterone and oestrad¬
iol was also similar to that seen in the non-fertile cycle.
Oestrone and LH/CG were also measured in some
follicular and luteal phase samples. Mean oestrone follic¬
ular and luteal phase values were =lng/ml (N=6) and 3.8 ±
0.5ng/ml (s.d., N=10) respectively. LH/CG was markedly
elevated around ovulation in 3 samples coincident with the
elevated oestradiol values. LH/CG was unmeasurable in the
remainder of the samples which included samples taken
during the latter part of the luteal phase from animals
paired with fertile males.
(d) The post-partum period
Progesterone, oestradiol and oestrone were
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similar to follicular phase levels on the day of birth
following expulsion of the fetus and placenta. Since the
time of birth was not generally known, the interval bet¬
ween birth and blood sampling was not known.
(e) Pregnancy
(i ) General trends
The mean peripheral plasma levels of pro¬
gesterone and LH/CG are shown in Figure 4-3, of oestradiol-
17/3 and 'oestrone in Figure 4-4 and of androstenedione and
testosterone in Figure 4-5. The mean concentration
includes singleton, twin and triplet pregnancies as there
was no significant difference for twins and triplets at any
stage of gestation for progesterone, oestradiol or oestrone
Samples were obtained from only 1 singleton pregnancy. Th
mean concentration also includes pregnancies with male and
female fetuses, all female or all male fetuses as there was
no difference in hormonal levels related to fetal sex.
An example of the hormonal values for 2
individuals throughout pregnancy is shown in Figure 4-6a and
The hormonal trends and temporal relationships will be
reported with reference to the mean values. Results from
serial weekly samples illustrated the interanimal variation
(>a) LH/CG
LH/CG rose gradually for the first
4 weeks of pregnancy and then more steeply up to the 8th
week (Figure 4-3). Maximum values were found between the
8th and 10th week. Levels then gradually fell to the
detection limit of the assay at 15 weeks of pregnancy and
Fig. 4-3: The peripheral plasma levels (is.e.m.)of
progesterone (A) and LH/CG (^) during pregnancy in the
marmoset monkey. The number of samples per point was
8-28 for progesterone and 5-8 for LH/CG.
U5>
Fig. 4-4: The peripheral plasma levels (is.e.m.) of
oestradiol-17f» (o) and oestrone (±) during pregnancy
in the marmoset monkey. The 'number of samples per
point was 10-21 for oestradiol and 6-9 for oestrone.
Weeks of pregnancy BIRTH
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Fig. 4-5: The peripheral plasma levels (is.e.m.) of
androstenedione (®) and testosterone (©) during preg¬
nancy in the marmoset monkey. The number of samples
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Fig. 4-6 a Progesterone (■"&), LH/CG (A), oestradiol (o),
oestrone (a), androstenedione (®) and testosterone (©)
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Fig. 4-6 b • Progesterone (A), LII/CG (A), oestradiol (o),
oestrone («), androstenedione (a) and testosterone (©)














































































remained low thereafter. There was a similar pattern
in individual animals.
(i-b) Progesterone
Progesterone values rose after
ovulation and maximum luteal phase levels were found by
the 2nd week of pregnancy (Figure 4-3). There was a sig¬
nificant decrease in levels between the 3rd and 5th week
(P^0.02) with no further significant change occurring until
week 13. These stable levels were found during the period
of maximum LH/CG values.
Weekly sampl.es from 6 animals for
the first 12 weeks of pregnancy confirmed a significant
decline between the 3rd, 4th and 5th week (P<0.02) and
confirmed that luteal phase levels (62 t 5ng/ml, s.d.)
were significantly higher than levels from the 4th to 12th
week (48 t 4ng/ml, s.d.) (P^O.Ol).
At 13 weeks, when LH/CG values were
declining, there was a significant rise in progesterone
(PcO.Ol) which continued until maximum values were reached
at the 18th-19th week.
There was a decline in mean proges¬
terone values in the 1| weeks preceeding birth (P^O.Ol).
Levels at week 20! were similar to those at week 13 and
less than \ the maximum levels.
Weekly samples from 9 animals (weeks
11-20) showed a significant increase in levels for each
week for gestation between weeks 12 and 16 (P<c0.02).
Maximum values of 106~412ng/ml were found between the 15th
and 18th week. These maximum levels were 2-8 times the
110
level found at week 11.
In these same 9 animals, progest¬
erone declined to 50-200ng/ml in the last week of pregnancy
which was 30-60% of the maximum values and was not signif¬
icantly different from the values at week 13.
(i-c) 0estradiol-17&H—
There was a 2-fold increase in mean
oestradiol values during the first 9 weeks of pregnancy
followed by a further 24-fold increase between the 9th
and 12th week (Figure 4-4). A rise over luteal phase
values was not always observed in individuals during the
first 9 weeks but by the 12th week, levels were significant!
elevated over luteal phase levels (P^O.Ol, N=6).
At 13 weeks, coincident with the
rising progesterone values, there was a steep increase in
oestradiol. The increase was sustained and unlike proges¬
terone, the maximum values were found in the last week of
pregnancy.
Weekly samples from 9 animals (weeks
11-204) showed a significant increase in oestradiol for
each week between weeks 12 and 20 (P<:0. 02-0. 001). Maximum
oestradiol levels of 74-165ng/ml were found between 333
and 144 days. In 7 of 9 animals, the maximum value was
found in the last samples taken before birth (c2 days).
The maximum oestradiol values in these animals were 40-84
times the week 11 value.
More detailed description of the
progesterone and oestradiol pattern during the first 70 days
80--100 days and the last week of pregnancy is given in
section 4.-3e iii, iv and v.
( i-d ) Oestrone
After ovulation, oestrone levels
remained high (>5ng/ml) throughout pregnancy (Figure 4-4).
There was significant increase in oestrone between weeks
3 and 4 (P<0.02) which was coincident with the declining
progesterone and increasing L1I/CG values. Levels then
remained relatively constant until week 16, when levels
increased until the end of pregnancy. This increase in
oestrone occurred 3 weeks after the steep increase for
progesterone and oestradiol.
Although the mean concentration of
oestrone rose in the latter part of pregnancy, a rise in
oestrone values was observed in only 4 of 7 animals from
which weekly samples were taken (weeks 7-20) (compare
Figure 4-6 and 4~7a)» Oestradiol values and the oestradiol
to oestrone ratio (see section 4.3f) in all these 7 animals
were within the normal range.
The magnitude of the increase in
mean hormonal values from early to late pregnancy was app¬
roximately 4-fold for progesterone, 100-fold for oestradiol
and 5-fold for oestrone.
( i-e ) Androgens
Androstenedione and testosterone
both rose during the first half of gestation with the
highest mean values found between 6 and 10 weeks (Figure
4-5) coincident with maximal LH/CG values. Levels
V1.2-
Fig. 4-7(a): Oestradiol (o) and oestrone (#) levels in
an individual marmoset from the 8th week of pregnancy.
(b): Androstenedione (0) and testosterone (•)
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gradually declined during the latter half of gestation
to levels slightly higher (androstenedione) or similar
(testosterone) to those found in early pregnancy.
Weekly samples from 3 animals
confirmed a 2-3-fold increase in androstenedione and
testosterone between the 1st and 9th week of gestation.
Weekly samples from 5 animals (weeks 7-20) showed a decline
in androstenedione values after the 9th-10th week of ges¬
tation to less than 50% of the maximum values in 3 of the
animals. A decline was not evident in 2 of the animals,
(compare Figures 4-5 and 4-7b).
( ) Prolactin
The mean prolactin levels during
the second half of pregnancy are shown in Figure 4-8. •
There were insufficient samples from non-lactating animals
during the first half of pregnancy to calculate means.
Mean prolactin levels declined between weeks 12 and 19
(P^O.05) and increased between weeks 19 and 20 (PcO.02).
Individual animals showed a similar prolactin profile.
Prolactin was measured in 2 non-
lactating animals during the first and latter half of.
pregnancy. Levels during the latter half of pregnancy
were similar to those in the first half, inasmuch as there
was insufficient plasma to measure prolactin at weeks 11
and 12, a rise in prolactin at this stage of gestation was
not confirmed for these animals.
(ii) Hormonal ratios
The progesterone to oeslradiol ratio
Fig. 4-8: Mean (*s.d.) prolactin levels during the


















(Figure 4-9) declined during the first 14 weeks of gesta¬
tion. This was during the period of stable progesterone
values and gradually increasing oestradiol values. Dur¬
ing the 13th' to 18th weeks, the ratio remained relatively
constant (mean 4,3 t 0.3 s.d.) and there was a positive
correlation between these 2 hormones (regression analysis:
y = 0.232 x+ 4.705, r = 0.74, n = 57). This corresponded
to the period when both hormones were increasing. During
the last 1! weeks of pregnancy, the ratio declined nearly
4-fold. This was due to the decline in progesterone
values and the continuance of high oestradiol values.
The oestradiol to oestrone ratio was
relatively constant during the first 9 weeks of gestation
(Figure 4-10). A gradual increase between the 9th and 12th
week was followed by a steep increase between the 12th and
15th week of gestation. During the first 12 weeks of
gestation, oestradiol levels were always less than 50% of
oestrone levels; whereas after the 12th week, oestradiol
levels always exceeded oestrone levels. This was due to
the marked increase in oestradiol values which occurred
during this time. There was a decline in the oestradiol
to oestrone ratio during the last \ week of gestation.
The androstenedione to testosterone ratio
(Figure 4-11) gradually increased with advancing gestation.
Although both hormones showed a similar pattern during
pregnancy, the increase in androstenedione was relatively
greater than for testosterone.
Fig. 4-9: The ratio of progesterone to oestradiol (±s.d.)
during pregnancy in the marmoset.
Fig. 4-10: The ratio of oestradiol to oestrone (±s.d.)
during pregnancy in the marmoset.
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Fig. 4-11: The ratio of androstenedione to testosterone
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(iii) The first 70 days
Mean progesterone and oestradiol values
were calculated for 2 day intervals for the first 70 days
of pregnancy (Figure 4-12). The pattern for 3 individuals
is shown in Figure 4-13.
Maximum mean luteal phase progesterone
values were found at day 10-11 followed by a decline to
a nadir at day 29-30. In individual animals, there was
either an immediate decline after day 10-12 or fairly
constant levels for up to 12 more days (day 22 of the
conception cycle). ' A decline was most obvious if luteal
phase levels were high (Anim. 51W).in all cases, there
was a nadir in progesterone between 24-30 days.
Although mean progesterone levels were
significantly lower than luteal phase levels after the 30th
day, individual values fluctuated over a range of 22-70ng/ml
and sometimes exceeded luteal phase values. There was no
consistent temporal relationship between animals in the
peaks and troughs of progesterone.
There was a luteal phase rise in oestrad¬
iol just after the maximum progesterone levels. Levels
thereafter remained high. Oestradiol values varied con¬
siderably within an individual and there were occasional
peaks (4~Sng/ml) and troughs (.£,0. 21ng/ml) in "levels.
These oestradiol peaks were confirmed by
reassay and by the addition of a celite chromatography step.
Measurement of oestrone in these samples showed no compar¬
able "increase .
136
Fig. 4-12: Mean (Is.e.) progesterone (A) and oestradiol
(o) levels for the first 70 days of pregnancy.
Days of Pregnancy
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Fig. 4-13: Progesterone (A) and oestradiol (o) values for
the first 70 days of pregnancy in 3 individual marmosets.
Oestradiol and progesterone peaks and
troughs were not positively or negatively associated with
each other.
LH/CG was also measured in 6 animals
during the first 30 days. Simultaneous with the high
values of LH/CG ( lOOng/ml) and oestradiol (>0.5ng/ml)
around ovulation, were elevated progesterone values (10-15
ng/ml) in 3 of the 6 animals. There was a second sustained
rise in LH/CG 13-21 days following ovulation, which was
coincident with a levelling or a decline in. progesterone
values in these animals, (see Figure 4-14).
(iv) 80-100 days
Weekly samples showed a steep increase in
progesterone and oestradiol during this phase of pregnancy.
This period was therefore examined more closely. Mean
values and the progesterone:oestradiol ratio is given in
Figure 4-15. The first significant rise in progesterone
and oestradiol occurred simultaneously at 90-91 days. The
increase for oestradiol was relatively greater than for
progesterone as reflected in the declining ratio. Within
this 20 day period, the overall increase was about 3-fold for
progesterone and 50-fold for oestradiol. Oestradiol values
>10ng/ml were never found prior to day 88 and values <10ng/ml
were never found after day 92. Progesterone values prior
to day 90 were variable and an increase was best observed
by serial sampling.
•(v) The last week
Mean and weekly serial samples indicated
a decline in progesterone -and possibly an increase in
i
Fig0 4-14: The LII/CG (A ), oestradiol (o ) and
progesterone (A ) profiles for 2 animals for the first
30 days of pregnancy. Lv\/C<* (a") mecuur«c* c^u.Va.-b>vc5vo
ted cxn"V\ - ooi 0O biCuAw, o_*"vci»-
n) l A CA£>i> - x^ccfc ^ £z»C SV^-^acVci-^rxi_S . LU / Cij -^0 \yvv\aec-o-«-*j) c*































Fig. 4-U5(a): The mean (±s-. d. ) progesterone (^) and
oestradiol (o) levels from 80 to 100 days of pregnancy
in the marmoset.
(b): The mean ratio (±s.d.) of progesterone to
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13S
oestradiol during the last weeks of pregnancy. Figure
4-16 shows the daily mean values for the last 7 days of
pregnancy for 5 animals sampled daily and the hormonal
ratio. Figure 4-17 shows the pattern in 2 individuals.
Progesterone values on the day prececti ruj.:,
birth were significantly lower (P<0.001) and oestradiol
values significantly higher (P<0.01) than the values 7
days prece ding birth. Progesterone values were always
lowest on the day preceeding birth and were 20-60% of
the maximum values (-7 days) or 40-70% of the preceeding
days values (P<0.001). The highest oestradiol values
were found on the day preceeding birth in only 3 of the 5
animals and they were not significantly higher than the
previous days values.
There was a significant decline (P<(0.001)
in the ratio during the last week and in 3 of the 5 animals,
progesterone was lower than oestradiol on the day preceed¬
ing birth.
(vi) Conception cycle compared to the non-
fertile cycle
Figure 4-1$ compares the mean progesterone
and oestradiol values in the conception cycle with the non-
fertile cycle. The mean value for all cycles was used
(see section 4.3c). There was no difference in the prog¬
esterone values or pattern until 19-20 days after the
initial progesterone rise. . The decline in the conception
cycle was less marked and values did not fall below 20ng/ml.
The oestradiol pattern in the conception cycle diverged
\2Ao
Fig. 4-lC(a):' The daily mean (is.d.) progesterone
and oestradiol (o) levels during the 7 days preceeding
birth in the marmoset.
(b): The mean ratio (is.d.) between progester¬
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Fig. 4-17: The progesterone (A) and oestradiol (o)
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Fig. 4-1$: A' comparison of. the mean progesterone G&)
and oestradiol (©) values in the conception cycle to
mean progesterone (A) and oestradiol (o) values in the
non-fertile cycle, -ft- indicates the first day at which
hormonal levels were significantly different between


































from the non-fertile cycle at the same time. Levels
fell in the non-fertile cycle but remained high in the
conception cycle.
4.3 Prolactin levels during lactation
The changes in levels of prolactin during the last
12 days of pregnancy and during lactation are shown in
Figure 4-1S. Of the 13 marmosets being bled, 5 delivered
triplets, 7 delivered twins and 1 delivered a single infant.
Infant death within 5 days of birth resulted in the follow¬
ing groups: non-lactating (N=3), suckling 1 infant (N=3)
suckling 2 infants (N=7). There was no relationship
between the pre-partum levels of prolactin and the number
of young born.
In non-lactating mothers plasma levels of prolactin
remained low (<22ng/ml) and were within the normal range
for cyclic marmosets (McNeilly et al; 1981) for the duration
of the study (up to days 70-77 post-partum). There was
an increase in mean plasma levels of prolactin between days
8 and 14, due to transiently elevated prolactin levels
observed in one of the three non-lactating mothers.
Plasma levels of prolactin were higher in mothers
suckling single infants compared to non-lactating mothers
but this only achieved significance (P<0.05) immediately
after parturition. In contrast plasma levels of prolactin
immediately post-partum, and throughout lactation until
around day 65 post-partum were significantly higher (P<0.05
to P<0„001) in mothers suckling twins than both other groups.
\M0
Fog. 4-13 : Changes in the plasma levels (mean ±s.e.m.)
of prolactin during lactation in marmosets suckling no
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Ovulation occurred in all 13 animals post-partum
(Table 4-3). Plasma levels of progesterone and the
duration of the luteal phase were not significantly
different from those in the normal non-pregnant female.
Twelve animals became pregnant during the observa¬
tion period, 5 conceiving during the first and the remainder
during the second cycle post-partum. The time to first
ovulation was not significantly different between the
three groups but time of conception was significantly
delayed (1X0.05) in both groups of lactating mothers com¬
pared to the non-lactating group (Table 4-3). Plasma
levels of prolactin around conception were also signifi¬
cantly higher (P<0.05) in both lactation groups compared
to the non-lactating group (Table 4-3, Figure 4-13).
4.4 Discussion
(a) Cycle
Marmosets do not show a conspicious oestrous
cycle, characteristic of lower species, or a detectable
menstrual cycle, characteristic of higher species. However,
like other species, there was a clear hormonal cycle.
Progesterone values were several-fold higher than in women
(reviewed: Diczfalusy and Landgreen, 1977) and Old World
primates (see 4.1 for references). Although there is a
general lack of information regarding the circulating
levels of ovarian steroids in New World monkeys, it appears
that in some species in which levels were also determined,
such as the capuchin (Nagle et al, 1979) squirrel (Wolf et
a],, 1977) and tamarins (Preslock et al., 1973)^ comparatively
142-
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high levels of circulating progesterone were also found.
Although it may be postulated that this denotes a signif¬
icant difference between New and Old World monkeys, the
physiological significance of these differences remains
to be elucidated.
There was a definite luteal phase oestradiol
rise and in this respect the marmoset more resembles the
human and chimpanzee than the rhesus and baboon (section
4-1 for references). The hormonal patterns around ovula¬
tion also show general similarities to the human but the
exact relationship between progesterone, oestradiol, LH/CG
and ovulation has not been determined by direct ovarian
observations or by daily sampling regimes with measurement
of all 3 hormones.
The follicular phase of the cycle was relatively
short and the control of follicular development in this
species has yet to be studied to determine its similarity
to the human (Baird, Baker, McNatty and Neal, 1975). The
luteal phase of the cycle was not prolonged by hysterectomy
(Hearn, 1978) implying that the corpus luteum was not under
luteolytic control as in the sheep, guinea pig, cow and
other species (reviews: Short, 1969; Heap and Perry, 1974).
No definite estimation of cycle length was
obtained from this study. Although the duration of the
sampling should have resulted in at least 6 complete cycles
based on previous marmoset studies (Hearn and Lunn, 1975)
only 2 complete and 1 incomplete cycles were obtained.
Fewer cycles than expected were obtained due to the
\LH
acyclicity of 2 marmosets and to the relatively longer
luteal phase found in the present study. Urinary oestro¬
gen data (Lunn, 1981) and subsequent studies on serum
hormonal levels (McNeilly et al, 1981; Harding, pers'1
commun) support a cycle length similar to that reported
in this thesis.
The duration of and the hormonal profiles in
several cycles obtained from'females paired with fertile
males was similar to the non-fertile cycle and there was
no rise in LH/CG in the luteal phase as found in the
conception cycles. It was felt justified to calculate
mean cycle values including these animals for comparison
with the conception cycles, although conception and early
embryonic loss could not be definitely excluded. A high
percentage of early embryonic loss has been reported for
the human (James, 1970; Cutright, 1975; Karow'and Gentry,
1976) with either no change or a lengthening of only a few
days in the cycle length. However, in the human, concep¬
tion and subsequent embryonic loss were indicated by rise
and fall in LH/CG values during the luteal phase. This
was also found in some marmosets with apparently long luteal
phase lengths of more than 25 days (unpubl'd abservations)
and these animals were not included.
(b) . Pregnancy diagnosis and the dating of pregnancy
In the absence of a conspicuous menstrual or
oestrus cycle, clearcut cyclical vaginal cytology (Hampton
and Hampton, 1975; Hearn and Renfree, 1975) or mating
behaviour (Hearn, 1976), the most accurate means of detecting
14S
ovulation and dating subsequent pregnancies is by hormonal
measurement. Progesterone levels were used to indicate ovu¬
lation and pregnancy was confirmed 3-4 weeks later by contin¬
ued high progesterone levels and by abdominal palpation.
This method proved adequate for the investigations in this
thesis as several accurately dated pregnancies were obtained
by simply monitoring animals following birth or abortion.
Since a high percentage of animals ovulate and become preg¬
nant following birth, blood sampling needs to be continued
only for a short time. The method is not too time consuming
in this species as"blood sampling is easily manageable by 1
individual and the hormone assays are simple and quick. The
disadvantage is that only a limited number of animals may
give birth during any 1 time period and the method is more
time consuming than the methods used in other species in which
there is physical evidence of cyclicity. A disadvantage to
studies in early pregnancy is that there is as yet no means
available for confirming pregnancy until nearly 4 weeks after
ovulation. Although LH/CG may rise during the 3rd week, the
assay takes 5 days to complete. The mean progesterone and
oestradiol profile diverge near the end of the 3rd week in
the fertile and non-fertile cycle but considerable individual
variation in the hormonal profiles would not allow definite
confirmation of pregnancy at this time. Pregnancy diagnosis
kits have not proved successful prior to 4 weeks of preg¬
nancy (Poswillo et al. 19723; Mitchell and Jones, 1975; Hodgen
et al. 1976; Hobson et al. 1977).
The best and quickest means of estimating the
stage of gestation in animals already pregnant is by abdom-
\l4b
inal palpation. This could confirm pregnancy at about 4
weeks after ovulation and was thereafter reasonably accurate
particularly if done weekly by the same individual.
Comparison of the abdominal palpation with the uterine mea¬
surement taken at operation showed that the values obtained
were generally similar. An additional guide to the stage
of pregnancy during later pregnancy was measurement of the
fetal heads and hormonally, by the progesterone and oestrad-
iol rise which occurred at 90 days. Measurement of oestra-
diol .in particular may aid in dating pregnancies, as there
was a consistent interanimal relationship between the stage
of gestation and the initiation of a marked increase in
concentrationo
(c) Quantitative hormonal comparisons during preg-
nancy.
There are large quantitative differences and
differing relative amounts of plasma steroids secreted during
pregnancy in various primate species (Table 4-4). As in the
rhesus monkey and chimpanzee, progesterone was quantitatively
the most important steroid hormone in marmoset plasma and
progesterone levels at the end of gestation in the marmoset
resembled those in women more than those in the chimpanzee or
rhesus monkey. Relatively large amounts of oestrogens were
found in the marmoset compared to other primate species and
compared to the progesterone value in the marmoset plasma.
The cause or physiological significance of these exceptionally
high oestrogen values is not known. Free oestriol, which was
also found in large amounts in plasma during human pregnancy
(Tulchinsky et al. 1972) was not measurable in marmoset plasma
(< 0.125nq/ml ) .
m
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(Chambers, unpubl'd observations). Whether this is
due, as in the rhesus, to the failure of the fetal adrenal
and liver to produce sufficient amounts of 16-hydroxylated
intermediates for oestriol formation by the placenta
(Heinrichs and Colas, 1970) is not known. Androgen values
were similar to those in the human, but are the only 2
hormones in marmoset plasma for which the term or near-
term values do not reflect the maximum values seen during
pregnancy.
(d) Hormonal profiles during pregnancy
The hormonal profiles of other primate species
wfcee reviewed in Chapter 1 (see for references). The
present study showed that the hormonal profile of proges¬
terone and oestradiol resembled that in women (Figure 4-2.0)
in whom luteal phase levels were maintained for the first
quarter of gestation followed by a sustained gradual
increase (Tulchinsky et al, 1972; Tushinsky and Hobel, 1973).
In the marmoset, progesterone levels, generally slightly
lower than luteal phase levels, were also maintained; but for
a relatively longer time. The sustained increase in pro¬
gesterone did not occur until nearly 2/3rds of pregnancy was
completed. The magnitude of the increase was less than
in women, due to the comparatively high luteal phase values.
In both the human and marmoset, oestradiol
gradually increased during the period of relatively stable
progesterone values followed by a greatei' increase coin¬
cident with the greatez1 increase in progesterone.
Although the overall magnitude of the increase for oestradiol
Fig. 4-ZO: The mean progesterone and oestradiol
profile in the human (---) and marmoset (—) during preg
nancy. The human data was taken from Tulchinsky et
1972 and Tulchinsky and Hobel, 1972.
Percentage of gestation
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was similar for the human and marmoset, the increase dur¬
ing the first part of gestation was much more gradual and
the increase that was conincident with the progesterone
increase (90 days) was much steeper in the marmoset.
The LH/CG profile resembles that found in the
human in several respects. The life of the corpus luteum
is extended coincident with rising gonadotrophin levels,
thus distinguishing the fertile and non-fertile cycle.
Subsequently corpus luteum function declines (See Chapt.
5) simultaneous with the rapidly increasing CG levels.
Although peak CG levels were found relatively later in
gestation in the marmoset (40-50% of pregnancy completed)
than in the human (** 20%), the temporal relationship of
CG to progesterone and oestradiol was similar. Peak
values are found during the period when peripheral
progesterone levels are stable and oestradiol levels are
gradually increasing. In the marmoset, the decline in
LH/CG may be more advanced when the peripheral progesterone
and oestradiol levels increase.
It seems that although there are some similar
IS\
hormonal patterns overall and interhormonal temporal rel¬
ationships between the marmoset and the human, the profiles
found in the human during approximately the first trimes¬
ter of pregnancy are lengthened in the marmoset to nearly
two-thirds of pregnancy„ There may be an overall
slower development of the events that occur during the early
part of gestation,, This will be discussed further with
respect to ovarian and placental function, fetal hor¬
mones and development in Chapters 5, 6 and 7.
Although like the human (Tulchinsky et al, 1972)
mean oestrone values increased during pregnancy, there
was considerable interanimal variation in the oestrone
profiles, Some individuals showed no increase in levels
and there was no obvious explanation for the differences
in profileso The animals studied did not have either
unusual oestradiol values or profiles, or oestradiol:
oestrone ratios,, The difference between individuals also
could not be accounted for by the number of young born or
the outcome of the pregnancy,, Perhaps studies on the dynamics
of oestrone production and metabolism will illuminate the
reasons for interanimal variation,
Oestrone values in the marmoset were relatively
high for more than the first half of pregnancy and they far
exceeded oestradiol values. Research has mainly focused on
oestradiol as it is the more potent oestrogen and for other
primates it is the major plasma oestrogen (see Chapter 1 for
references). In the marmoset, oestrone is the major plasma
oestrogen during the first part of pregnancy due to
\ ST-
its greater secretion by the corpus luteum (see Chapter 5),
This indicates that it is not merely an inter-species
difference in peripheral hormonal inter-conversions or in
metabolic clearance rates, but a difference in secretion by the
pus luteum (human ;Baird and Fraser, 1974). Despite its
lower levels compared to oestrone, oestradiol probably still
has a physiological significance similar to the human. Its
profile shows marked similarities around ovulation (Hodges,
1977), during the cycle (Hearn and Lunn, 1975) and in early
pregnancy (Chambers and Hearn, 1979), A negative and positive
feedback effect of oestradiol on LH was also demonstrated
for the marmoset (Hodges, 1978) , The physiological significance
of oestrone has not been investigated.
Even in species in which oestrone is the major
urinary oestrogen (e,g, baboon, Townsley, 1972) oestradiol-
17 is still the major plasma oestrogen. It seems likely
that there are major differences between the marmoset and
human in their metabolism of both oestrogen and progesterone.
In the marmoset oestradiol-'17p and 6^-hydroxypregnanolone
are the major metabolites (Schackleton, 1974; Lunn, 1978)
whereas in woman, pregnanediol and oestriol are the major
metabolites (Bell and.Lorraine, 1971),
Like the human (Chapter 1 for references),
androgen levels increased during pregnancy but in the
marmoset the increase was not sustained. In fact, the
androgen profile in the marmoset was similar to the LH/CG
profile with maximum levels around 7-10 weeks. The factors
responsible for, or the physiological significance of,
increased androgen levels during pregnancy are not definitely
\S3
known for other species (see Chapter 1); however, mater¬
nal as well as fetal andogen precursors are utilised for
placental oestrogen production (Siiteri and MacDonald,
1966). Although androgen precursors may also be important
for placental oestrogen production in the marmoset
(Ryan et al', 1961; Ryan and Hopper, 1974) the relative
contribution of maternal and fetal androgen precursors
to oestrogen production is not known. Whether there is
a relationship between the declining maternal androgen
levels and the increasing oestrogen levels during the
latter part of pregnancy must await further studies. It
would be interesting to compare the effects of dexameth-
asone administration on androgen and oestrogen levels in
this species with the effects found'in the human (Ohrlander
et al. 1977) and rhesus (Chailis et al, 1974, 1975, 1977 b)
Bosu et al, 1974b ).
UriLike the human (Kletzky et al, 1980), there was
no overall increase in prolactin levels during pregnancy
and therefore prolactin levels did not parallel the oestrad-
iol or progesterone levels. A rise in prolactin at the
end of gestation, when maximum oestradiol levels were found,
was no higher than a transitory rise at 10-12 weeks of
gestation, which was prior to the steep increase of
oestradiol at 13 weeks.
There was no increase in prolactin levels except
possibly near the end of pregnancy in the rhesus, but this
correlated with the lack of a marked increase in oestrogen
or progesterone also found (Weiss et al, 1976). It appears
\s4
that a relationship between prolactin and either proges¬
terone or oestradiol is not found in the marmoset.
(e) Early pregnancy . .
Like other primate species so far studied,
there was an extension of luteal phase progesterone values
into early pregnancy concomitant with rising peripheral
LH/CG levels. A more sensitive LH/CG assay may be necess¬
ary to definitely establish the timing of the initial rise
in gonadotrophin and its relationship to the progesterone
profile in the conception cycle. However, there was no
difference in the progesterone profile between the concep¬
tion cycle and the non-fertile cycle until nearly 3 weeks
after ovulation when levels in the fertile cycle were dec¬
lining rapidly. Levels were also often declining in the
conception cycle although the decline was less steep.
Unlike the rhesus, there was no evidence of a progesterone
'surge' associated with rescue of the corpus luteum (Neill
etal, 1969; Hodgen et al, 1972) and unlike the human,
progesterone did not continue to increase during the init¬
ial period of corpus luteum 'rescue' (Tulchinsky and Hobel,
1973). The relationship of the progesterone profile to
corpus luteum function will be discussed further in Chapter
5.
. Hormonal values fluctuated considerably during
the first part of pregnancy. Detailed analysis in the
rhesus showed progesterone nadirs were associated with
oestradiol peaks and definitive peaks of progesterone were
associated with specific stages of gestation (Hodgen et al,
\5S
1972; Atkinson et al, 1975 and others)0 However, no such
temporal or interhormonal relationships were found in this
study in the marmoset.
Whereas the mean trends were fairly obvious,
serial samples from individual animals sometimes showed
considerable variability from these general trends and
levels. This factor must be borne in mind by an investi¬
gator when data is considered for a single individual,
(f) Late pregnancy
The marmoset is the first primate species so
far studied in which there is a significant decline in plasma
progesterone during the last weeks of pregnancy. In this
respect it more resembles the sheep, cow, pig, goat and
rat (reviewed: Thorburn et al, 1977), In contrast,
oestradiol trends are similar to those in women (Liggins,
Forster, Grieves and Schwartz, 1977; Fuchs, 1977) rhesus
monkeys (Challis et al, 1977b) and chimpanzees (Reyes_ et al,
1975; reviewed: Lauman, 1977) in which the maximum concent¬
rations are found in the last week of pregnancy and there is
no pronounced pre-partum increase as is found in the sheep
(Thorburn et al, 1977), Progesterone often declined to
values lower than o'estradiol an the day preceding birth
and the ratio between these 2 hormones was lower than for
any other primate species so far studied. The significance
of the changing peripheral plasma hormonal levels and ratios
in relation to parturition is not knownin the marmoset as
there have been no investigations in this species on the
factors influencing these late pregnancy hormonal changes,
\S<o
or on their significance for the timing of parturition (see
also Chapter 5.H), It is unknown whether the abolition of
the pre-partum decline in progesterone would delay part¬
urition in the marmoset,, In the sheep, a massive dose of
progesterone, at least twice the daily production, was
necessary to delay parturition (Hindson, Schofield and Ward,
1969; Liggins, Fairclough, Grieves, Kendall and Knox, 1973),
(g) Prolactin levels during lactation and the
occurrence of ovulation.
This study clearly showed that in the marmoset
high levels of prolactin and a maintained suckling stimulus
did not inhibit the resumption of ovarian acitivity and the
return of fertility post-partum. Lactation in the marmoset
was associated with elevated plasma levels of prolactin
similar to those in the rhesus monkey (Butler et al, 1975)
and in wom&n (Holland, Lequin, Schellekens and de Jong, 1975),
In contrast, to these primates, there was no delay in the return
to ovulation post-partum. Similarity, the luteal phase
associated with the first ovulation was of normal duration
and progesterone levels were normal. The first post-partum
cycle was also capable of maintaining a pregnancy unlike breast
feeding women, where lut'eal function after first ovulation is
usually inadequate (McNeilly, 1979, 1980; Duchen and McNeilly,
1980; McNeilly, Howie and Houston, 1980),
The time to conception was delayed in lactating
mothers compared to non-lactating mothers in this section of
the study. However, a delay in the time to conception related
to suckling is not a consistent finding as 3
\S1
marmosets suckling twins also conceived at the first
ovulatory cycle. Also, in a previous study (section 4.3b)
the majority of the animals who conceiv.ed at the first
ovulatory cycle were lactating. Birth interval data for
the whole colony confirms that lactation per sg does not
influence the time of conception post-partum (Lunn and
McNeilly, 1981). Whether C,. jacchus differs from other
callitrichid monkeys is uncertain, since it has been
reported that in the genus SaguinUs, mating and ovula¬
tion do not occur for 21 months post-pa.rtum (Wendt, 1964)
and lactation delays subsequent pregnancy (Wolf, Ogden,
Deinhardt, Fisher and Deinhart, 1972; P. Abbot and
C. Snowden, pers'l commun.).
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4.5 Chapter Summary
1) The gestation length was 144 +_ 2 (s.d. ,
N^) days.
2) Ovulation occurred 10.5 - 0.7 (s.d., N=23)
days following birth.
3) Lactation did not interfere with the return to
fertility although prolactin levels were significantly
elevated in mothers suckling twins.
4) The stage of gestation could be assessed
by a) the post-ovulatory progesterone rise (timed
pregnancies) b) abdominal palpation of the uterine
diameter after the 4th week of pregnancy and of the
fetal heads after the 15th week, and c) by the oestradiol
and progesterone rise at 88 to 92 days of pregnancy.
5) Corpus lutecL were generally distinguish¬
able up to day 90, were distributed either on 1 or both
ovaries, and were generally correlated with the number"
of fetuses present. :
6) The hormonal profiles of the 5 steroid hor¬
mones, LH/CG and prolactin were shown throughout pregnancy.
Both mean and individual trends were given. The concept¬
ion cycle and the first 70 days of pregnancy, 80 to 100
days and the last week of pregnancy were studied in
detail for some of the hormones. The mean profiles were:
a. Progesterone declined from week 3-5, remained
stable until week 13, increased rapidly at week 13 and
declined significantly in the last 11 weeks of pregnancy.
b. Oestradiol gradually increased until week 13.
I C.Q
Coincident with progesterone, levels increased rapidly
at week 13. Unlike progesterone, maximum levels
were found in the last week of pregnancy.
cc Oestrone levels increased after ovulation
and at 3-4 weeks. There was a sustained increase at . .
week 16.
do Androstenedione and testosterone levels
increased until week 8 and thereafter declined.
e. LH/CG increased during the 2nd-3rd week to
maximum levels at week 8 and thereafter declined. The
highest levels were found during the period of relatively
stable progesterone levels.
f. Prolactin levels declined between week 10
and 19^ and increased during the last week of pregnancy.
7) The conception cycle and the nonfertile
cycle diverged at day 19 for the progesterone and oestrad-
iol profiles.
8) The progesterone to oestradiol ratio declined
during the first 14 weeks of gestation, remained relatively
stable until week 18, and then declined during the last
2\ weeks of pregnancy.
The oestradiol to oestrone ratio increased
rapidly between the' 12th and 15th week of pregnancy.
Oestrone was the major plasma oestrogen for the first 12
weeks of pregnancy and oestradiol was the major plasma
oestrogen after week 13.
The androstenedione to testosteone ratio
gradually increased with advancing gestation.
(bo
CHAPTER 5 : OVARIAN AND PLACENTAL FUNCTION
5,1 Introduction
Hormonal trends in the human and other sub-human
primates, primarily the rhesus, have been related to
ovarian and placental function in these species. This
was reviewed in Chapter 1. There have been no previous
reports on ovarian and placental function in the marmoset.
There are some similarities between the marmoset (Chap,
and the human in peripheral hormonal trends, an obvious one
being the sustained increase in progesterone and oestradiol
during the latter half of pregnancy. However, there were
also major differences. The increase in progesterone and
oestradiol did not occur until relatively late in gestation
and it was suggested that there was a slower development
of events during the first part of pregnancy (see Chapter 4,
discussion). Hearn (1978) has shown that the
luteo-placental shift may not occur until nearly one-third
of pregnancy is completed, which is considerably later than
in other species. Oestrogen levels were also comparatively
high in this species and the oestradiol to oestrone ratio
was unusual among primates. The androgen profile was also
at variance with that reported for the human (human
references.: Chapter 1).
The studies in this chapter investigated the changes
in ovarian and placental function throughout pregnancy.
Is the ovarian contribution to hormonal levels important
for longer in pregnancy than in other species and when does
the placenta assume a major role in hormone production? What
lt>l
is the relationship between ovarian - placental func¬
tion? How does ovarian - placental function relate
to the maternal and fetal profiles? Also, what .are the hormon¬
al levels andratios in the utero-ovarian vein and placen¬
tal tissue and how do they compare with each other and
with the stage of gestation? Can an in vitro system be
established to look at changes in placental hormonal
secretion with advancing gestation and be used to investi¬
gate the regulation of the hormonal secretion?
In order to fulfill these aims, techniques were
chosen that allowed the maximum integration of data, mini¬
mised the occurrence of abortion during the experiment, did
not jeopardise further colony breeding and considered the
relatively small size of the marmoset. Maternal and utero-
ovarian vein blood, placental tissue and fetal samples
(Chapters 6 and 7) were obtained at laparotomy or hystero¬
tomy throughout pregnancy utilising primarily accurately
dated pregnancies. The multiple sampling sites and the
measurement of several hormones for each sample allowed
inter-compartmental hormonal comparisons within each
pregnancy.
The results section is divided into 3 parts. The
first part reports on the in vivo assessment of gestational
changes in ovarian and placental function by hormonal mea¬
surements in utero-ovarian plasma obtained throughout preg¬
nancy. The hormonal values were related to the presence
of absence of corpus luteum and of the feto-placental unit
and were compared with the maternal peripheral plasma
hormonal value.
H>2_
The second part reports on the gestational changes in
the hormonal concentrations and total content of placental
tissue. Placental hormonal values and ratios were estab¬
lished and then compared with those in the maternal,
utero-ovarian and umbilical vein plasma. Two placental
discs were always found,and the hormonal concentrations
were compared between the discs and related to the fetal
attachments and sex.
Part 3 reports on the establishment of organ cultures
of placental tissue, the secretion of progesterone and
LH/CG by placental tissue maintained in organ culture and
the influence of various factors on progesterone and LH/CG
secretion. The in vitro secretion was related to hormonal
trends in the maternal and utero-ovarian vein plasma and
to the placental content.
5.2 Procedures
(a) Part I: Utero-ovarian vein samples
The sampling regimes have been outlined in
Chapter 2-7and the procedure for obtaining utero-ovarian
vein (UOV) samples in Chapter 2.£>. Progesterone, oestrad-
iol and ©estrone were measured on nearly all the samples.
LH/CG was measured in samples when there was sufficient
plasma.
(b) Part II: Placental hormonal content
Placental tissue was obtained for hormonal
content measurements between days 40 and 140 as described
in Chapter 2.8. Progesterone, oestradiol, oestrone,
1L^>
testosterone, androstenedione were measured as described
in Chapter 3.2k and LH/CG as described in Chapter 3.3.
Except at day 40, each placental disc was
assessed separately., After day 60 at least 3 homogenates
were prepared from each disc. The mean value from each
homogenate was used to calculate the mean concentration
(ng/g) per placental disc or for 2 placental discs» The
total content was calculated by multiplying the cencentra-
tion by the placental weight (Chapter 7) and is expressed
as ng/placenta0
(c) Part III: Placental organ cultures
Placental tissue was obtained for culture foll¬
owing hysterotomies between 30 and 140 days of pregnancy as
described in Chapter 2.6 and 2.7.
The pieces of the placental disc for culture
were weighed. The weights used ranged from 0.15 to 0.25
grams on tissue obtained after day 50 of pregnancy. Due
to the small size of the placenta at 30 (0.03 grams) and
40 (0.20 grams) days, pieces for culture weighed less than
0.05 grams. The placental tissue was gently eased apart
and rinsed with saline.
The prepared tissue was cultured essentially
as described by Baker and Neal (1969). The tissue was
placed on a stainless steel grid covered by a piece of lens
paper, in a 3mm diameter petri dish (Figure 5-1) containing
2ml of Eagle's minimum essential medium with Earle's salts,
buffered with 20mm HEPES buffer, and was supplemented with
newborn calf serum (20% v/v), L-glutamin (2mM/L) and anti-
rio4
biotics (Amphotericin B, 1.5ug/ml; Kanamycin, 30ug/ml).
All the media used v/ase obtained from Flow Laboratories ,
Irvine, U.K.
•Racks of five of these petri dishes were
placed in modified 'Kilner' preserving jars (Figure 5-1)
p
which were gassed at 0.704kg/cm with 5% CO^, 38% Ng and
57% 0 and then incubated at 37°C.
The average time between removal of the feto¬
placental unit and the placental tissue being placed in
the incubator was approximately 3-4 hours. Every 24
hours the culture media«\was removed and replaced with fresh
median- The mediei<i)was stored at -20°C for radioimmunoassay.
The histology of the tissue following culture
was examined by Dr. 0 and Professor T.G. Baker, Department
of Obstetrics and Gynaecology, and in most instances the
tissue appeared viable with little evidence of cell death.
Any cultures that were not viable, or which had been con¬
taminated, were not included in the results.
Additions ■ A
The following preparations were added to the
cultures. All preparations were made up in culture mediurO■
a) Progesterone (Sigma). Concentrations of
50 and 200ng/0.3ml were prepared. 0.3ml was added to cul¬
ture to give a final concentration of 25 and lOOng/ml.
b) Pregnenolone (Sigma). Concentrations of
70ng/0.3ml were prepared. 0„3ml was added to culture to
give a final concentration of 35ng/ml.
c) Cholesterol (Sigma). Concentrations of
UG
Fig. 5-1: Diagrammatic representation of the "Kilner
jar" culture apparatus. Note that 5 petri dishes could
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500ng/0.3ml were prepared. . 0.3ml was added to cultures
to give a final concentration of 250ng/ml
d) hCG (Sigma). Ten fold dilutions rang¬
ing from 0.01 i.u./0.3ml to 1,000 i.u./0.3ml were prepared
0.3ml was added to cultures to give final concentrations
of 0.005-500i.u./ml.
e) Antiserum to hCG and serum. 0.01 to
0.1ml of plasma from non-pregnant marmosets, which were
actively immunised against hCG and had high circulating
levels of antibodies, (Hearn, 1978; Hearn et al, 1978) was
a.ddedo Similar quantities of plasma from non-pregnant
animals was added to cultures as controls.
f) Fetal gonads and adrenals. A section
(unweighed) of the fetal gonad (ovaries and testes) and the
fetal adrenal were placed next to the placental tissue.
Sections were also cultured without placental tissue using
the same methodology.
5.3 Results
Part I: Hormonal values in the utero-ovarian vein
(a) Follicular phase v
UOV samples were taken from 2 animals 3-4 days
after giving birth and 6 days prior to ovulation. Prog¬
esterone was less than the assay sensitivity ( 2-7ng/ml) in
C ct\aVejrr\>l pe/T1 pVuw-cxL q} .
both the UOV and MPV.v MPV oestradiol values were 1.5 and
l.lng/ml. UOV oestradiol values were 1.8 and 0.4ng/ml.
MPV oestrone values were 1.2ng/ml and UOV values were 6.7
and lng/rnl. Large developing follicles were apparent in
u/i
the animal with higher UOV oestrogen values.
(b) General trends during pregnancy
The UOV concentrations are reported for each
hormone as a total value for the right and left UOV. The
corresponding MPV value for each pregnancy is also given.
For all hormones the concentrations and changes in the
MPV were similar to those reported in Chapter 4.
(i) Progesterone
The UOV and MPV progesterone concentra¬
tions are shown in Figure 5-2. Just after ovulation
(day 1), there was an intermediate rise in progesterone
followed by luteal phase levels by the 5th to 10th day of
the conception cycle. This was clearly shown for 2
individuals. Luteal phase levels subsequently declined
in the UOV until day 60. Little change occured between
days 60 and 80, The mean progesterone level in the UOV
between days 60 and 80 was approximately 50% of the
luteal phase level and was significantly lower (P<0.001,
t-test, n=17).
These trends in progesterone values in
the UOV during early pregnancy were confirmed in UOV •
samples taken at serial laparotomies at 20, 40 and 60 days
of gestation in 2 animals. By day 60, progesterone
values in the UOV were less than 50% of the value at day
20 and in 1 of the animals, the levels in the peripheral
vein declined similarly.
There was a 3 fold increase between 80
and 90 days of gestation. Maximum values were reached
l
o
Fig. 5-2.: The sum of the progesterone values (ng/ml)
in the right and left utero-ovarian vein (f] ) and the
progesterone value in the maternal peripheral plasma
(B) throughout pregnancy. The arrows link pregnancies
from which serial samples were taken.
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between 105 and 130 days of ■ gestation. These maximum
levels were more than 2 times the mean luteal phase level
and 4 times the mean 60 to 80 day level. Maximum levels
were not correlated with either placental size or the
number of fetuses present (Chapter 7). UOV progesterone
values declined in the last 10 days of gestation and at
day 140 were similar to those found at 90 to 100 days,
(ii) 0estradiol-17fo'
The UOV and MPV oestradiol concentrations
are shown in Figure 5-3. There was no consistent change
in values for the first 50 days of pregnancy. There was
a gradual increase between days 50-85 followed by approxi¬
mately a 10 fold increase at day 90. Thereafter, levels
remained elevated and were highest at 140 days. The 140
day level was about 7 times the 90 day level.
(iii) Oestrone
The MPV and UOV oestrone concentrations
are shown in Figure 5-4. Immediately following ovulation,
oestrone levels were 9ng/ml. There was no significant
change in values during the first 80 days of pregnancy.
Mean oestrone values after day 90 of gestation were signif¬
icantly higher than those prior to day 90 (P 0.001, t-test, ^
n=31) although there was some overlap between the 2 periods,
(iv) LH/CG
LH/CG was measured in UOV samples from 6
animals between days 10 and 100. UOV values were similar
to the MPV values and there was no significant difference
between the UOV and MPV levels (paired t-test). Values
Mo
Fig. 5-3: The sum of the oestradiol values (ng/ml) in
the right and left utero-ovarian vein (H) and the
oestradiol value in the maternal peripheral plasma (S)
throughout pregnancy. . The arrows link pregnancies from
which serial samples were taken.
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Fig. 5-4: The sum of the oestrone values (ng/ml) in the
right and left utero-ovarian vein (H) and the oestrone
value in the maternal peripheral plasma ({3) throughout
pregnancy. The arrows link pregnancies from which serial
samples were taken.
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and trends in the MPV were similar to those reported in
Chapter 4.
(o) The relationship to the presence of CL
1 to 3 corpora lutea (CL) were found between
the 1st and 90th day of gestation. After 90 days it was
not generally possible to distinguish the CL (See also
Table 4-2). In 21 pregnanciesthe CL were distributed
as follows: 10 pregnancies had 1 CL on each ovary; 9 had
1-3 CL on one ovary and none on the other; 2 had 2 CL on 1
ovary and 1 on the other. In these 21 pregnancies, 3 had
a. total of 3 CL, 17 a total of 2 CL and 1 had 1 CL„ Since
the number of pregnancies with more or less than 2 CL was
small, it was not possible to compare the total hormonal
value from the 2 UOVs with the total number of CL present.
(i) Progesterone
The progesterone values in the individual
UOVs between days 1 and 90 are shown in Figure 5-5.
Progesterone values were similar in paired UOV if both
drained an ovary containing CL. The pattern for the
individual veins was similar to that for the total concen¬
tration (section 5.3b- i).-
In contrast, progesterone values were
nearly always lower (11 out of 12 cases) in the UOV drain¬
ing an ovary containing no CL than in the contralateral
vein draining either 1, 2 or 3 CL. The difference between
the 2 veins was significant for the first 50 days of preg¬
nancy (P<0.001, paired t-test, n=7) but not between 60 and
80 days. The pregnancy at day 90 was excluded because it
H3
Fig. 5-5: Individual progesterone values (ng/ml) in
the paired utero-ovarian veins.
(a) 1 vein associated with no corpus lut-
(E) paired with vein associated with 1 (H),
(g) C.L.
(b) both veins associated with 1 C.L. (T\).
(c) 1 vein associated with 1 C.L. (Tl) and
1 with 2 C.L. ($). The arrows link pregnancies from
which serial samples were taken.
eum (C.L.)
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was the only pregnancy in which the contralateral ovary
contained 3 CL. Progesterone values in the UOV adjoin¬
ing the ovary containing no CL were significantly higher
than the maternal peripheral levels.
The progesterone trends in the individ¬
ual UOVs were different depending on the presence or
absence of CL in the adjoining ovary. In the vein not
associated with corpus luteum, progesterone levels were
unchanged until day 40. A gradual increase occurred
between 40 and 60 days and at day 60,levels were signifi¬
cantly higher than those in the conception cycle (P<0.02,
t-test, n-6) . In contrast, progesterone values in the
vein associated with CL declined approximately 5-fold
between days 30 and 60 and at day 60, were significantly
lower (P^0.001, t-test, n=6) than those in the conception
cycle. A different pattern in the UOV between days 20 and
60, depending on the presence or absence of CL,was clearly
shown for serial UOV samples taken at days 20, 40 and 60
from 2 individuals.
The relationship between the 2 UOVs is
expressed as a percentage in Figure 5-6, In the vein
draining the ovary with no CL, progesterone levels were
only 10-20% of the contralateral vein until day 40.
Between 40-60 days there was an increase in the percentage
and after day 60 it was similar to the percentage found
in pregnancies where both veins drained an ovary contain¬
ing a CL.
ns
Fig. 5-6: The progesterone relationship between the 2
utero-ovarian veins expressed as a percentage. Preg¬
nancies with both utero-ovarian veins associated with
corpus luteum (C.L.) (lower/higher value) (o). Preg¬
nancies with 1 utero-ovarian vein associated with and
1 not associated with C.L. (®). Pregnancies in which
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The oestradiol concentrations in the
individual UOVs are shown in Figure 5-7. The presence
or absence of CL did not affect either the level of
oestradiol in the UOV or the pattern of oestradiol in the
individual veins with advancing gestation. This was
confirmed by samples taken at serial laparotomies.
The relationship between the UOVs,
expressed as a percentage, is shown in Figure 5-8.
Marked differences between the 2 veins were often observed
up to the 60th day of gestation. Whether the levels in
the 2 veins were similar or different did not depend on the
presence or absence of CL.
(iii) Oestrone
Figure 5-S shows the oestrone concentra¬
tions in the individual UOVs in relation to the number of
CL present. Oestrone values were similar in the paired
UOVs if both drained an ovary containing a CL. Oestrone
values were higher in the UOV associated with CL than in
the vein not associated with CL. Like progesterone, the
difference was significant up to day 50 of pregnancy
(P<0.01, t-test, n=6) but not between days 60 and 80.
Samples taken at serial laparotomies showed a slight
increase between days 20 and 40 and lower 60 day levels
th^an 20 or 40 day levels in both the UOV' associated with
and not associated with CL.
The relationship between the 2 UOVs is
expressed as a percentage in Figure 5-10„- Oestrone values
in the UOV not associated with a CL were 53.8t9.7% (s.e.m.,
\ni
Fig. .5-7: Individual oestradiol values (ng/ml) in the
paired utero-ovarian veins.
(a) 1 vein associated with no corpus luteum
(C.L.) (3) paired with vein associated with 1 (H),
2 (§) or 3 (9) C.L.
(b) both veins associated with 1 C.L. (H).
(c) 1 vein associated with 1 C.L. (H) and
1 with 2 C.L. (9). The arrows link pregnancies from

























Fig. 5-8: The oestradiol relationship between the 2
utero-ovarian veins expressed as a percentage. Preg¬
nancies with both utero-ovarian veins associated with
corpus luteum (C.L.) (lower/higher value) (o). Preg¬
nancies with 1 utero-ovarian vein associated with and
1 not associated with C.L. (©)'. Pregnancies in which
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Fig. 5-9: Individual oestrone values (ng/ml) in the
paired utero-ovarian veins.
(a) 1 vein associated with no corpus luteum
(C.L.) (B) paired with vein associated with 1 (fl), 2
(B ) or 3 (8 ) C.L.
(b) both veins associated with 1 C.L. (n).
(c) 1 vein associated with 1 C.L. (rj) and
1 with 2 C.L. ($). The arrows link pregnancies from



















Fig. 5-10: The oestrone relationship between the 2 utero-
ovarian veins expressed as a percentage. Pregnancies
with both utero-ovarian veins associated with corpus lut-
eum (C.L.) (lower/higher value) (o). Pregnancies with
1 utero-ovarian vein associated with and 1 not associated
with C.L. (©). Pregnancies in which the number of C.L.
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n=9) of the contralateral UOV. When both veins were
associated with 1 or more CL, the lower values were
87.0±1„8% (s„e.m., n=13) of the higher. The percentage
for the 2 groups tended to converge at 40-60 days of
pregnancy although considerable differences between the
paired veins persisted in some animals. After 100 days
oestrone values in the 2 UOVs were similar.
(d) Relationship between the UOV and MPV
The relationship between the UOV and MPV is
expressed as a ratio for each hormone in Figure 5-lla,b and
Hormonal levels were always higher in the UOV
than in the MPV. Except at 140 days of pregnancy, the
ratio was highest for progesterone. The oestradiol and
oestrone ratios were generally fairly similar. Whereas,
the progesterone ratio declined with advancing gestation,
there was no consistent overall trend for the oestradiol
and oestrone ratios. The initial decline in the proges¬
terone ratio occurred during the first 60 days of pregnancy.
There was a further decline in the ratio after day 120.
Correlations (regression analysis) were calcu¬
lated between the UOV and MPV concentrations for each
hormone. The only correlations (r^0.7) were for progester
one (90-140 days, r=0,79, n-8) and oestradiol (0-80 days,
r=0.78, n=22; 90-140 days, r=0,76, n=8).
Ce) The hormonal ratios
The progesterone to oestradiol ratio is shown
in Figure 5-12. Progesterone levels were higher than
oestradiol in both the UOV and MPV throughout pregnancy.
The ratio declined with advancing gestation but the decline
182.
Fig. 5-11 a: The ratio between the progesterone values
in the utero-ovarian vein (U.O.V.) and the maternal
peripheral plasma (M.P.V.) . The arrows link preg¬
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Fig. 5-llb: The ratio between the oestradiol values
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Fig. 5-1lc: The ratio between the oestrone values in
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Fig. 5-13 : The ratio of oes.tradiol to oestrone in the
utero-ovarian vein (•) and in the maternal peripheral
vein (o). The data from the 80 day pregnancy is re¬
peated for reference.
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Fig. 5 l'l: The ratio of progesterone to oestrone in
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was steeper in the UOV. The ratio was generally higher
in the UOV than in the MPV.
The oestradiol to oestrone ratio is shown in
Figure 5-13. Oestrone was the predominant oestrogen in
the UOV up to day 80 of pregnancy. There was no consis¬
tent trend in the UOV ratio prior to day 80 and no
consistent relationship to the MPV ratio. After day
80 there was a sustained increase in the ratio and oestrad¬
iol was the major oestrogen.
The progesterone to oestrone ratio is shown in
Figure 5-1H . The ratio in the UOV declined between
approximately 30-80 days of pregnancy and then gradually
increased during the latter half of gestation. The ratio
in the UOV was generally higher than that in the MPV.
There was no correlation between progesterone
and oestradiol, between oestradiol and oestrone or between
progesterone and oestrone before or after 90 days of
pregnancy.
(v) The effect of removing the feto-placental unit
The hormonal values in the paired UOVs before
and after removal of the feto-placental unit (f.p.) is
expressed as a percentage (post/pre f.p.%) in Figure 5-15.
Only pregnancies from which samples were taken from both
UOVs before and after unit removal are included.
For progesterone, the percentage was>90% up to
day 50. There was a gradual decline in the percentage
between 50-80 days to around 60%, with 1 pregnancy at day
60 having a lower percentage of 30%. A steep decline
Fig. 5-15: The percentage of progesterone (a), oestraciiol
(b), and oestrone (c) remaining in the utero-ovarian vein
following removal of the feto-placental unit. 100%
equals the pre-removal value.
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-H—
30 40 50 60 70 80 90 100 110 120 130 140
Days of Pregnancy
1 r
30 40 50 60
(c) Oestrone
BO 90 100 110 120 130 140
Days of Pregnancy
ISO
between days 80-90 resulted.in the percentage dropping
to<20%. The decline continued until the end of preg¬
nancy .
The oestradiol percentage was variable for
the first 80 days of pregnancy (range 30-90%). There
was a sharp decline in the percentage at 80-90 days and
the percentage was<6% for the remainder of pregnancy.
The oestrone percentage remained high (75-130%)
for the first 90 days. After day 90, the percentage
declined.
The actual hormonal value in the UOVs following
removal of the feto-placental unit were similar to those
in the MPV following unit removal after day 90 for proges¬
terone and oestradiol and after day 100 for oestrone.
These UOV values were also similar to the UOV values not
associated with CL in early pregnancy for progesterone
and oestrone.
Part II: The hormonal concentration and content in
placental tissue
(a) Progesterone
The placental progesterone concentration and
content is given in Figure 5-lb. With the exception of 1
pregnancy at day 60, there was little change in concentra¬
tion between 40-80 days. The progesterone concentration
in the 60 day pregnancy was about 5 times the mean value
for the other 40-80 day pregnancies. This was the same
animal which showed a relatively low post/pre f.p.% (Fig¬
ure 5-1B).
Fig. 5-16: The progesterone concentration (±s.e.m.)^a
(ng/g), and the progesterone content in the
placenta (ng/placenta) (US
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In contrast to the concentration, the content
increased approximately 10-fold between days 40-80, The
pregnancies with the higher values showed the lower post/
pre f.p.%
The concentration and content increased about 4
to 5-fold respectively at 80 to 90 days. Maximum values were
found between 105 and 120 days. The low content value at
115 days was from a singleton pregnancy, in which the placen¬
tal weight was less than for multiple pregnancies (Chapter 7).
The concentration and content at 130 to 140 days was similar
to day 90 values. Values were significantly higher after
day 90 than before day 90 (PcO,001, t-test, n=19),
(b) Oestradiol
The placental oestradiol concentration and con¬
tent is given in Figure 5-17, The concentration increased
about 3 to 8-fold and the content about 25 to 85-fold between
40 to 80 days. However, there was considerable interanimal
variation in values. Between 80 to 90 days, there was app¬
roximately a 18 to 21-fold increase, which was about 4 times
the progesterone increase which occurred at this time. The
highest concentrations and contents were found at 140 days,
when values were 3-5 and 3-8 times respectively the mean
90-130 day values. Values were significantly higher after
day 90 than before day 90 (P^O.OOl, t-test, n=18).
Cc) Oestrone
The oestrone concentration and content is shown
in Figure 5-18. There was approximately a 3 and 30-fold
increase in concentration and content respectively between
40 and 80 days. Like oestradiol, there was considerable
m
Fig. 5-17: The oestradiol concentration (±s.e.m. i£)
(ng/g), and the oestradiol content in the total placen¬
ta (ng/placenta) .Ge>)
Days of pregnancy
Fig. 5-18: The oestrone concentration (±s.e.m.) (ng/g),C3^
and the oestrone content in the total placenta (ng/placenta)(_lo)
Days of Pregnancy
\<*5
interanimal variation in the oestrone values0 There was a
steep increase in the concentration and content between 80-
100 days of pregnancy and thereafter values remained high
until the end of pregnancy,, Values were significantly
higher after day 90 than before day 90 (P-c 0.01, t-test, n=18)„
(d) Androstenedione
Figure 5-19 shows the androstenedione concentra¬
tion and content in placental tissue,, The concentration
before day 90 was significantly lower (P«c0.05, t-test, n=20)
than that found after day 90 although there was some overlap
between the 2 groups. Although there was a definite increase
at 90 days, within each period (days 40-80 and 90-140) there
was no consistent change in values with advancing gestation.
The content increased gradually between 40-80
days followed by a sharp increase at 80-90 days. Thereafter
levels followed a similar pattern to the concentration and
were significantly higher (P<0. 001, t-test, n=20) than the
levels before day 90.
(e) Testosterone
Figure 5-20 shows the testosterone concentration
and content in placental tissue. There was a gradual in¬
crease in both the concentration and content until approxi¬
mately day 100. The concentration and total amount was
significantly higher after- day 90 than between 40 and 80
days (P<:0.01, t-test, n-18)„
Cf) LH/CG
The LH/CG concentration and content is given
in Figure 5-21. The concentration declined 4000-fold
Fig. 5-11: The androstenedione concentration (is.e.m.
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Fig. 5-20: The testosterone concentration (±s.e.m.)(a^




Fig. 5-2 1: The LH/CG concentration (Is.e.m.) (ng/gX^f)
and the LH/CG content in the total placenta (ng/placenta )Go)
between 30 and 90 days.Concentrations remained low after day
90 and were undetectable in a few instances. The content
of LII/CG did not decline until after day 70 when maximum
values were found. Thereafter, the LH/CG content followed
the same trend as the concentration although the decline
was less steep.
(g) Comparison of the placental discs
The hormonal concent-rat ion and content between
the 2 placental discs were compared after day 60 (t-test)„
Prior to day 60, there was too little tissue available from
each disc for statistical comparison. Since the results
were similar for concentration and content, the data hereafter
will refer only to concentrations. Table 5-1 shows the preg¬
nancies in which there was a significant difference between
the discs for any of the hormones. The majority of preg¬
nancies did not show a significant difference and there was no
consistent association of hormones. In order to confirm
these results, new homogenates were prepared and extracted from
8 pregnancies; 4 with a signficant difference and 4 without a
significant difference. The results were confirmed in all
cases.
The fetal attachments were analysed and are
given in Table 5-2 for pregnancies in which there was a
significant difference. No consistent relationship is
evident. Although females were associated with the disc
with higher progesterone and oestradiol concentration, the
presence of a female(s) did not necessarily result in
higher values (e.g. day 140 and 115). The disc with the

































































































































































































































































































male, or female fetus, both or none at all.
(h) Comparison with maternal values
The overall profile of progesterone and oes-
tradiol in the placental tissue resembled that in the
peripheral plasma with a steep increase at 90 days and a
decline (progesterone) or increase (oestradiol) at 140
days.(see Chapter 4). The increase in oestrone placen¬
tal values was not necessarily reflected in peripheral
values.- The androstenedione and testosterone profiles
in the placental tissue differed from the MPV. Maximum
values in the placenta occurred during the latter half
of pregnancy whereas they occurred at 6-10 weeks in the
MPV.
The ratio between the hormonal concentration
in the placenta and the MPV is shown in Table 5-3. Hor¬
monal levels were generally higher in the placental tissue
than in the MPV for all hormones after 90 days. The mean
ratio after 90 days was significantly higher (P<0 . 001-0 . 05 ,
t-test) than before 90 days for all hormones. The ratio
varied between hormones and was highest for testosterone
after 90 days.
There was no correlation between the placental
concentration and MPV for any of the hormones either
before or after 90 days. The placental content was corre¬
lated with MPV levels for progesterone and oestradiol after
90 days. (r = 0.75, P<0.01, n = 11; r = 0.80, P<0.01,
n = 11 respectively.)
Table 5-3 The ratio between the placental concentration
and the maternal peripheral plasma for progesterone (P4),
oestradiol (0E2), oestrone (0E1), androstenedione (A) and
testosterone (T).
Day P4 OE2 OE1 A T








































































105 9.48 3.74 1.57 0.72 18.10
110 4.81 1.71 2. 13 0.96 1.07
115 4.21 1.82 6.25 2.87 24.00
120 6.89 1.42 6.09 0.63 18. 60
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(i) Comparison with the utero-ovarian and
umbilical vein
Figure 5-22 shows ratio between the placental
and UOV hormone concentrations. Whereas progesterone and
oestradiol were lower in the placental tissue than in the
UOV, oestrone was generally higher after 100 days of preg¬
nancy. The progesterone and oestrone ratio was signifi¬
cantly higher after 90 days than, before 90 days (P<0.02,
t-test). There was no consistent change in the oestrad¬
iol ratio.
Placental hormonal concentrations or content
were not correlated with UOV values before or after 90
days for any hormones.
Umbilical vein (UV) samples were available
only after 90 days (Chapter 6). The ratio between the
hormonal concentration in the placenta and the UV is
shown in Figure 5-23. The ratio declined with advancing
gestation for all 3 hormones. The ratio was generally
highest for oestradiol and except at 140 days, lowest for
progesterone. The ratio of the placental concentration
to the UV was greater than the ratio to the UOV for prog¬
esterone and oestradiol. The reverse was found for
oestrone.
The placental content or concentration were not
correlated with UV values for any of the hormones.
(j) The hormonal ratios
The ratios between the hormones in the placental
tissue and MPV is shown in Table 5-4. Progesterone levels
2 OS
Fig. 5-22: The ratio between the placental (ng/g) andthe utero-ovarian vein (ng/ml) values for progesterone,oestradiol and oestrone.
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Fig. 5-23: The ratio between the placental (ng/g) and
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Table 5-4 The hormonal ratios in the placental tissue
(plac) and maternal plasma (MPV) for progesterone to
oestradiol (P4:OE2); oestradiol to oestrone (0E2:0E1)
and androstenedione to testosterone (A:T).
Day of P4: OE2 OE2:0E1 A: T
gest. Plac MPV Plac MPV Plac MPV















































































105 23 9 1.11 0 ..46 2.16 9
110 10 3 3.97 4.93 2.15 7.78
115 14 6 0.51 1.70 4.75 10.00
120 17 3 1.52 6.42 2.15 9.00
















exceeded oestradiol levels with only 1 exception (MPV:
day 140). The progesterone ratio in the placenta was
generally higher, but showed similar changes, as that for
the peripheral plasma (Chapter 4) with an overall decline
with advancing gestation. Unlike the MPV, placental
oestradiol levels did not necessarily exceed oestrone
levels after 90 days. The placental oestradiol to oes¬
trone and androstenedione to testosterone ratios were
generally lower than those in peripheral plasma after day
90.
Like the peripheral plasma, progesterone and
oestradiol. levels in the placenta were correlated between
90-130 days (r = 0.75, P<0.02, n = 9) and androstene¬
dione and testosterone were correlated after 90 days
(r = 0.74, P<0.02, n = 20). Oestradiol and oestrone
were not correlated.
Part III: Placental secretion of progesterone and
LH/CG in vitro
The secretion is expressed as concentration (ng/g or
units/g of placenta tissue) or as total amount (concentra¬
tion times placental weight).
The progesterone secretion during the 1st 24 hours
of culture is shown in Figure 5-21}. Progesterone was not
measurdtWVfc. in the 30 day culture. The concentration
remained relatively constant until day 70 followed by a
gradual increase at day 80, a steep increase at day 90 and
a decline at the end of pregnancy. The total amount
2 OS
Fig. 5-2t|: The secretion of progesterone per gram of
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secreted showed a similar pattern except that there was
a gradual increase during the first 70 days followed by a
steeper increase at 70-100 days. The placental secre¬
tion at day 140 was similar to that at day 90.
The secretion of LH/CG during the first 24 hours
of culture is shown in Figure 5-25. There was a decline
in the concentration between 30 and 80 days. The total
amount secreted remained relatively constant until 70 days
followed by a decline. LH/CG was not measurable after
day 80.
Progesterone and LH/CG were measured for up to 5
days of culture. An exmple of the secretion pattern
is shown for 2 placentae in Table 5-5a and the mean
percentage of hormone secreted relative to the previous
day is shown for all placentae in Table 5-5b. There was
a decline in the progesterone secretion with successive
days of culture. The steepest decline, occurred between
the 1st and 2nd day. LH/CG levels also declined during
the first 3 days in culture and then tended to stabilise
and increase during the 4th to 5th day. The changes in
progesterone and LH/CG secretion with advancing gestation
were similar on days 2 to 5 of culture as for Day 1
(Figure 5-24,25) except that the actual levels were lower and
that progesterone was not measurable on days 3 to 5 of cul¬
ture from 40 day placentae.
The pattern of progesterone secretion during the
1st and 3rd day of culture for 2 stages of gestation is
shown in Figure 5-26. Two sets of cultures were used; one
set for the first 12 hour 'period and another for the 12 to
211
Fig. 5-2 5. The secretion of LH/CG per gram of tissue (ts.e.
(a) and per placenta (b) on the -first day of culture.
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Fig. 5-26: The secretion of progesterone per gram of
tissue at 4 hourly intervals during the first day of















Table 5-5(a) The progesterone (P4) (ng/g ± s.d.) and
LH/CG (units/g + s.d.) secreted during the 1st 5 days




































Table 5-5(b) The mean percentaqe (±s.d„) for progesterone
(P4) and LH/CG on successive days of culture compared to
the previous day. P4: n512; LH/CG: nS9.
Days of culture
1 2 3 4 5
P4 100% 31±4 45±6 57±5 68±4
LH/CG 100% 77±20 65+5 81±7 116±30
21M
24 hour period. This was to minimise disturbance to the
system and cumulative errors. Previously an hourly
sampling regime had been used but the coefficient of var¬
iation within each set of cultures was very high. There
was an accumulation of progesterone in the mediatfjwith time.
During the first day, the steepest increase occurred
during the first 4 hours of culture. The increase was
more steady by the third day 'of culture.
To test if removal of the media/^would affect prog¬
esterone secretion, either by removal of progesterone or
other products in .the mediator by the renewal of the
medittt<\; the culture mediej^was changed every 4 hours. The
results in Table 5-6 show that the amount of progesterone
secreted during 1 day of culture is.similar for the 2
groups.
To see if increasing the amount of progesterone in
the rnedi«*¥\has an effect on progesterone or LI1/CG secretion,
exogenous progesterone was added to 70, 80 and 140 day
cultures. The results for 70 and 80 days are given in
Table 5-7. There was no effect on progesterone secretion.
4 hourly samples taken during the 1st and 3rd day of
culture at 140 days also showed no difference in progester¬
one secretion. LH/CG was significantly depressed during
the first 4 days of culture for the 70 day placenta. No
effect on LH/CG secretion was found at 80 days of pregnancy
although the amount of progesterone added was similar.
LH/CG was unmeasurable in the 140 day cultures.
The long and short term effect on progesterone
secretion of pregnenolone in shown in Table 5-8. The
2 IS
Table 5-6 Comparison of the amount of progesterone
(ng/g - s.d., n = 5)' secreted with the culture media
completely renewed every 4 hours and the undisturbed
controls (n = 5). Placental tissue was from a preg¬
nancy at 110 gestation.
Hours of culture








Table 5-7 The LH/CG (units/g ± s.d., n=4) and proges¬
terone (P4)(ng/g ± s.d., n=4) secretion with (+P4) and
without (control) exogenous progesterone (50ng/culture)
at 2 stages of pregnancy (day 7-0 (a) and 80 (b)). In
day 70 cultures, the media was completely renewed at +4
hours, a control sample was taken 2 hours later (+6 hours)
and media either with or without progesterone was added.
The day 80 placenta was cultured continuously with or
without added progesterone.



































control 30 + 2 50 + 9 30±7 15+6 1014 105
+P4 28±2 47i8 3216 17 + 3 1112 106





























control 142121 66 + 6 47 + 9 24l9 279
+P4 160±20 70 + 8 46l8 22 + 7 298
?_n
Table 5-8 The effect of exogenous pregnenolone (Preg)
(70ng/culture) on the progesterone secretion (ng/g + s.d.,
n=4).
(a) 110 days: The media was removed and renewed at +4
hours. 2 hours later (+6 hours) a control sample was
taken (0.3ml) and the media was replaced (0.3ml) with or
without added pregnenolone. The percentage difference
between the treatment and control cultures is given for
each day.
(b) 130 days: An 0.3ml control sample was taken 2 hours
before the complete daily media change on day 2 and 4.
0.3ml of media with or without pregnenolone was added.
The percentage increase for the 2 hour interval is given.
(a) 110 days
Control
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Preg. 44+13 76+10 173112
Cont. 62+10 72112 116110
Sig. P-40.02 N.S. P4 0 . 0 2
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amount of progesterone secreted from day 1 to 5 (a) was
significantly greater when pregnenolone was added. Con¬
trol samples showed no significant difference between
the groups prior to treatment. The short term effect
(2 hours) was examined in 130 day placental cultures (b).
Although there was no significant difference in the final
progesterone secretion between the treatment and control
group either on day 2 or 4; the control group was secre¬
ting significantly more progesterone prior to the initia¬
tion of treatment. Therefore, the amount and percentage
of increase was significantly greater for the treatment
group.
Additional treatments which showed no effect on
progesterone secretion either over the short term (2
hours) or long term (24 hours) were the addition of exogen¬
ous cholesterol (250ng/ml) and hCG (dosages 0.01 to 1000
i.u. per culture). hCG was tested between days 60 and
140. Antibodies to hCG, raised in the marmoset (Hearn,
1978) also did not affect progesterone secretion.
Culture media with these exogenous substances added
gave undetectable results in the progesterone assay.
Placental tissue was also cultured in the presence
of adrenal or gonadc\l tissue in cultures at 90-140 days
of gestation. The oestrogen secretion from these cultures
compared with the control cultures. Oestrogen
secretion from placental tissue cultured with either
adrenals or testis was always greater than the controls.
The percentage increase ranged from 180 to 720%. There
was no relationship between the percentage increase and
the stage of gestation. There was no difference in the
oestrogen secretion from placental tissue cultured with
fetal ovaries. Androstenedione and testosterone were
present in considerable amounts in cultures in which
there was adrenal or testicular tissue. The amounts
were not quantified per gram of tissue, as the weight of
the cultured organ was not taken. Androgens were gener¬
ally not measurable in the control placental cultures.
5 o4 Discussion
This study comprises the first report of ovarian
and placental function in the marmoset monkey. This was
studied both in vivo and in vitro. It is the first study
in any primate species in which ovarian and placental
function has been assessed for several parameters in an
integrated investigation throughout pregnancy. In view
of the fact that the whole of pregnancy was studied,
numbers at any one stage were limited. Interanimal varia¬
tion could possibly indicate or obscure trends which more
data at a specific stage would clarify. However, this
drawback was minimised by the trends being fairly definitive,
by the maximum interval between samples being 10 days (all
timed pregnancies), by additional samples being taken at
some stages, by serial sampling for UOV samples and by the
interrelating of data from the various compartments.
Furthermore, 'the use of the techniques chosen did not com¬
promise further successful pregnancies which was an
220
important aspect, as larger numbers of animals could be
used without drastically affecting the colony's breeding.
As seen in the following discussion, the techniques chosen
were able to. define ovarian-placental function and relate
it to a known gestational age.
Measurement of progesterone, oestradiol and
oestrone in the UOV throughout pregnancy, and the relat¬
ionship of the UOV levels to the presence or absence of
CL and feto-placental unit, and to the MPV, was used to
assess ovarian-placental function in vivo. Unfortunately,
it v/as not possible to obtain uterine vein blood for com¬
parison with the UOV, which would have given a more pre¬
cise estimation of the relative ovarian and placental
contributions.
(3) Early pregnancy; CL function
Higher UOV progesterone, oestradiol and
oestrone levels than peripheral levels indicated ovarian
and/or placental secretion of these hormones during preg¬
nancy. The order of importance of the 3 hormones in
quantitative terms in the UOV until day 80 was progester¬
one, oestrone and oestradiol, the same order as found in
the MPV (Chapter 4).
The lack of a difference in the LH/CG
level between the UOV and MPV in the samples measured was
surprising in view of the high placental content and
secretion in vitro. A similar finding was also reported
for the rhesus monkey (Walsh et al, 1977k) and it may be
22. \
related to a considerably longer half life of this hormone
as opposed to the steroid hormones.
CO Progesterone and oestrone
The CL was the primary source of prog¬
esterone and oestrone after ovulation and for at least the
first 50 days of pregnancy. Levels were elevated follow-
owing ovulation. Significantly higher levels were assoc¬
iated with the presence of the CL up to day 50 of pregnancy
whereas similar values were found in paired veins if both
were associated with CL. Also, prior to day 50,the post/pre
f.p.% was greater than 90%.
Higher UOV than MPV values were also
found in the vein not associated with the CL. This may
be due to vascular connections between the ovaries poss¬
ibly via the uterine circulation (Riesen, Koering, Meyer
and Wolf, 1970) that were not sufficiently clamped. The
marmoset ovary is extensively luteinised (Hampton and Taylor
1971) which may also contribute to hormone levels.
Declining CL function between 20 and 60
days of pregnancy was indicated by declining UOV proges¬
terone values. This trend was confirmed by samples taken
at serial laparotomies. Furthermore, progesterone values
declined only in the UOV associated with CL. In contrast,
values in the contralateral UOV, which were not associated
with a CL, increased slightly. The decline in the proges¬
terone UOV values was not reflected in the MPV as seen in
the declining UOV to MPV ratio. Peripheral levels may
have reflected the initial decline in CL-function as mean
222
levels declined between the 3rd and 5th week of pregnancy
(Chapter 4). Thereafter, peripheral levels stabilised
during the period of further declining CL function and of
increasing placental progesterone production (see section
5.4b).
Conceivably, the dramatic decline in
UOV progesterone values which occurred between days 20 and
60 could be attributed to changing blood flow which
increases in the pregnant rhesus monkey (Lees, Hill,
Ochsner, Thomas and Novy, 1971). Lower hormonal concen¬
trations secreted from the placenta could be diluting the
high UOV levels from the CLj resulting in a decline, and
increasing the values in the vein not associated with the
CL. To some extent, this may also account for the stab¬
ilisation of the maternal peripheral plasma levels after
the 5th week of pregnancy. However, if this was the sole
explanation, one might expect an earlier decline in the
post/pre f.p.%, which in fact is not observed until day
60o Further studies are necessary to assess the effect of
blood flow on the UOV values. Measurement of
17-hydroxyprogesterone, which is commonly used for the
human (Yoshimi et al, 1969; Tulchinsky and Hobel, 1973;
Mishell et al, 1973 and others) to reflect CL function
during the first part of pregnancy, would help further
define the decline in CL function.
A decline in CL function during early
pregnancy has been well documented for both the human and
rhesus. This was also not necessarily reflected in the
peripheral plasma although a plateau or nadir in
22?>
progesterone values}during the period of declining CL
function and prior to the full takeover of placental pro¬
gesterone production(was often observed (Chapter 1 for
references).
Between days 50 and 80, the CL was
probably becoming less important in contributing to prog¬
esterone levels. Although levels still generally remained
higher in the vein associated with the CL, the difference
was not significant. Also the post/pre f.p.% gradually
declined during this period. However, some ovarian contri¬
bution was indicated by the percentage remaining higher
than that seen after 90 days of pregnancy.
A decline in CL oestrone secretion was
less obvious than that seen for progesterone. That the
trends were not of similar magnitude for progesterone and
oestrone was reflected in the declining UOV progesterone
to oestrone ratio. The oestrone trend may be partly
obscured by the lower levels of oestrone and the greater
interanimal variation in levels. A small placental con¬
tribution to oestrone levels may be more obvious than for
progesterone and may partly account for the slightly
lower oestrone post/pre f.p.% found for the first 50 days.
Also, additional non-placental sources of oestrone may be
important. This may obscure a decline in CL oestrone
secretion and partly account for the longer persistence of
the higher post/pre f.p.% for oestrone. In the human,
oestradiol and oestrone are interconvertible and 15% of
the oestradiol produced may return to the
1XH
circulation as oestrone (Longcope, Layne and Tait, 1968).
Conversion from androstenedione is yet another source
of plasma oestrone (McDonald, Rombaut, and Siiteri, 1967;
Longcope, Kato and Horpon, 1969) „
CO Oestradiol
In contrast to progesterone and oestrone,
UOV oestradiol values were not related to the presence or
absence of the CL„ In the human, during the normal
menstrual cycle, the CL secretes oestradiol (Mikhail, 1970).
Presumably in the marmoset, ovarian tissue other than the
CL or extra-ovarian sources, contribute substantially to
oestradiol levels. Follicles, which were often evident
in early pregnancy (Hearn P^unpubl'd data),may contribute
to oestradiol levels ,and preliminary observations in the
marmosettduring the follicular phase; showed higher UOV
oestradiol levels in animals in which developing follicles
were evident. This may be a factor which obscured any
relationship between the presence of CL and oestradiol
levels and may also partly account for the marked differ¬
ence in levels between the UOVs that was found during the
first part of pregnancy.
(b) Placental Function " 1
CL function during early pregnancy was discussed
in section 5.4a. UOV data suggested that it was the major
source of progesterone for the first 50 days of pregnancy;
its importance thereafter declined until day 80 and it
was relatively unimportant by day 90. A placental influ¬
ence was becoming increasingly evident between 60 and 80
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days as reflected in the declining post/pre f,p,% and
the similarity in UOV hormonal levels.
The gestational changes, in the placental
progesterone content and the secretion in vitro,
reflected the proposed increases in placental function.
There was a gradual increase in the placental prog¬
esterone content and total secretion between days 40
and 80, which can be attributed primarily to placental
growth during this period, as the concentration and
secretion per gram of tissue did not increase.
In contrast to progesterone, the placental
concentration of oestradiol and oestrone increased
between 40 and 80 days of pregnancy;therefore, the
increase in total content was greater for these 2
6
hormones than for progesterone. In addition, lower
amounts of oestrogens than progesterone are produced
by the ovary in early pregnancy and therefore,
the placental secretion may cause a greater percentage
increase for oestrogen than for progesterone.
By 90 days of pregnancy, the placenta was
undoubtedly the major source of progesterone and oestradiol,
and was responsible for the steep increases which occurred
in the UOV and MPV, This was evident by the steep decline
in the post/pre f,p, %„ In addition, the placental concentra-
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tion and secretion per gram of tissue increased markedly,
and combined with placental growth, resulted in a steep
increase in the total amount of hormone in,and secreted
by, the placenta.
The relationship between ovarian-placental
function and the hormonal profiles in the maternal plasma
(Chap. 4) show some similarities to the human (see Chap.
1 for human references). In both'species, placental steroid¬
ogenesis is becoming established during the period of the
highest peripheral CG levels, of relatively stable proge¬
sterone levels, and gradually increasing oestradiol levels.
After completion of the luteo-placental shift, peripheral
progesterone and oestradiol levels increase rapidly. Also,
the more rapid increase in hormonal levels due to the.
increasing placental function occurs soon after completion
of the embryonic period of development. (Phillips, 1976;
See also Chap. 6.4). Differences from the human are that
the decline in peripheral CG in the marmoset is more advanc¬
ed when the more rapid increase in progesterone and oestra¬
diol are initiated. Also, the increased placental secretion
of these hormones occurs later in gestation in the marmoset
(^66% of pregnancy completed) than in the human (^25%
of pregnancy completed).
The declining progesterone and increasing
oestradiol values in the MPV.found at the end of gestation.
/ '
may be related to changes in placental secretion ;as
comparable changes were found in the UOV, the placental
content and secretion in vitro. The factors responsible for
22- *7
a change in placental function -at this time,and the signifi¬
cance to the onset of labour, are unknown.
As seen above, an in vitro assessment of placent¬
al hormone content and/or secretion were related to the chang¬
ing placental function with advancing gestation. This has
not previously been shown for any species. If an in vitro
placental culture system can be established and validated
for a species (See section 5,3), it may then provide a good
means for investigating factors influencing placental function.
Unlike the rhesus, there was no evidence for
any recrudescence of CL function in the marmoset during
late pregnancy. After 100-110 days of pregnancy, levels in
the UOV}following removal of the feto-placental unit;were
similar to those in the MPV immediately post-operative and
to those in early pregnancy (less than 20 days) in the UOV
not associated with CL. There was also no indication of an
increase in the hormonal values in the UOV following re¬
moval of the feto-placental unit or of an increase in the
post/pre f.p.%. These post removal levels were however
higher than those in the follicular phasejand there may be some
ovarian contribution persisting until the end of gestation^
such as found in the human and rhesus (human: Mikhail and
Allen, 1967; Mikhail, 1970; Le Maire et al, 1970;
Guraya, 1972; Crisp et al, 1973; Weiss and Rifkin,
1975. rhesus: Treloer et al, 1972; McDonald et al,
1973; Koering et al, 1973; Sholl et al, 1976; Walsh
et al, 1974, 1979b)c An ovarian contribution persist¬
ing until the end of gestation may also relate to the
higher post/pre f.p.% found for progesterone and
oestrone than found for oestradiol during the latter
part of pregnancy. However, if there is any ovarian
secretion, the funtion of such a low level of secretion
in the face of the relatively massive placental
secretion is not known. The renewal or continuance of
CL function which occurs in the rhesus (loc cit)
apparently extends into the post partum period (Weiss
et al, 1973). This certainly does not appear to be
true for the marmoset, and would seem to be incompat¬
ible with the immediate return to ovulatory cycles
and fertility following birthtwhich occurs in this
species.
However, a likely alternative explanation for the
persistence of elevated post-removal hormonal values,
would be a biphasic disappearance rate. The half-life
of progesterone in pregnant macaques was 4 mintues for
the initial phase of disappearance and about 30 mintues
for the slower component of disappearance (Sholl and --
Wolf, 1974). Variations between the disappearance
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rates of the hormones could account for the differences
in their percentages,,
Interpretation of hormonal values in the UOV
following removal of the feto-placental unit must
take account of certain possibilities. First,
mentioned above, was the half-life of the hormones,
However, the changes in each hormone's post/pre f„p.%
are of such magnitude with advancing gestation that
it seems unlikely to be the sole explanation and,
in fact, for the human, the metabolic clearance rate
(MCR) of progesterone, expressed as the biological
half-life, is similar throughout pregnancy (Fylling,
1970b). Second, removal of the feto-placental unit
undoubtedly changes the blood flow, probably to
different extents during pregnancy. Third, the
immediacy of a CL reaction to feto-placental removal
is not known. It was assumed to be unaltered for
10 minutes following feto-placental unit removal,
which was about the time it took for the UOV samples
to be taken„ This seemed likely in view of the
greater than 90% post removal levels found in early
pregnancy and was similar to results obtained in the
human (Holmdahl, etal, 1971 )„ , -
(i) The luteo-placental shift
Lutectomy experiments by Hearn (1978) suggested
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that the CL was not dispensable until after the 6th week,
which is nearly one-third the way through pregnancy.
Although the present study did not define the stage of
gestation at which the CL is "actually dispensable, it did
indicate that there is a substantial ovarian progesterone
contribution and relatively little placental contribution
for the first 50-60 days of pregnancy. It seems that
the CL is important for relatively longer in pregnancy than
in the human or rhesus. In the human, it is dispensable
about one-seventh (Csapo et al, 1972); and in the rhesus
one-eighth, (Bosu et al, 1174) the way through pregnancy.
This is yet another aspect in which the events occurr¬
ing during early pregnancy in the marmoset are prolonged
compared to other species.
The present study indicated that at the 40th
day (approximately 6 weeks) of gestation, there was still
a substantial ovarian progesterone contribution and rela¬
tively little placental contribution,whereas Hearn (1978)
suggested that the luteo-placental shift occurred around
this time. Several explanations are possible for the
apparent discrepency. Lutectomy is not entirely satisfac¬
tory in the marmoset as it is difficult to ensure removal
of entire CL,and the ovary seems to contain extensive
areas of luteal-like tissue (Hampton and Taylor, 197}).
In fact, lutectomy in this species during the early luteal
phase did not result in non-luteal phase progesterone
values until more than 10 days following the operation
(Hearn ,3unpub'd observations). The exact timing of the
dispensibility of the CL would need to be confirmed by
23\
ovariectomy on' timed pregnancies.
However, it may be that the timing of the luteo-
placental shift can preceed the predominance of progester¬
one production by the placenta (Holmdahl et al, 1971) and/
or that the placenta may assume a relatively greater pro¬
duction of progesterone earlier than normal if the ovarian
source declines earlier. Normal inter animal variation
in the timing of increasing placental function or an earlier than
'normal' onset of increased placental function due to
undefined causes may be suggested by the data from day 60
pregnancies. A comparatively low post/pre f.p.% was
associated with a relatively high placental content of
progesterone. UOV progesterone values for this animal
were similar to others at this stage of gestation; however,
a larger percentage was perhaps due to a placental contri¬
bution. It is not known whether the placenta can assume
a greater proportion of progesterone production slightly
earlier in pregnancy than 'normal' if for instance, the
ovarian source declines. Presumably the placenta must be
developed sufficiently for steroidogenesis to increase
which no doubt puts a time limitation in pregnancy during
which this can occur. Also, there must be some stimulus
or feedback relationship. The idea of a feedback relation¬
ship between the placenta and ovary is not new^but it was
postulated to work in the opposite direction (Lanman et al
1975). In fact, little work has been done on ovarian- '
placental interrelationships. The marmoset may be a good
subhuman species for such studies, as the 'transitional'
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period of ovarian placental■function has been well defined
in the present study. (See also Chap 8).
(c) Placental hormonal content
The changes in progesterone, oestradiol and
oestrone placental values have already been discussed in
relation to ovarian and placental function (section 5-4b)„
Interspecies comparison of the placental content of pro¬
gesterone shows that fairly comparable amounts are found in
man (Zander and von Munstermann, 1956; Runnebaum et al,
1975a and b), chimpanzee (Hobson, 1971) and marmoset; and
much lower amounts in the rhesus (Short and Eckstein,
1961; Hagemenas and Kittinger, 1974 )„ This corresponds
to the variation in peripheral hormonal values found between
these species (Chapter 1 for references).
However, the pattern of progesterone concent¬
ration with advancing gestation in the human is different
from the marmoset in that higher or similar placental con¬
centrations are found during the first half of pregnancy
rather than the second. Whereas it was due solely to sub¬
stantial placental growth that the total placental proges¬
terone content increased in the human during the period of
increasing peripheral levels, it was due both to placental
growth and increased concentrations in the marmoset. The
reason for- the difference is not known. The relative
placental to fetal weight ratio is lower in the marmoset
than in the human (see Chapter 7 for data and references)^
and it may be advantageous for a small primate which
regularly produces more than 1 young but requires high
hormonal levels, to minimise relative placental size.
Placental concentrations of LH/CG, andros-
tenedione and testosterone were compared only with per¬
ipheral plasma levels. The growth of the placenta during
the first half of pregnancy modulated the steep decline
in the placental concentration of LH/CG0 Nevertheless/
peripheral concentrations were still increasing steeply
(between 30 and 50 days; Chapter 4) when the placental
content of LH/CG was already in the uppermost part of
the range. This could perhaps be due to an increasing
secretion rate due to an increasing blood volume through
the tissue. By 100 days of gestation the low amounts
of placental LH/CG were reflected in the periperal plasma.
The placental LH/CG concentration shows an inverse patt¬
ern to progesterone or oestradiol. . Any further relat¬
ionship must await more dynamic studies as have been rec¬
ently pursued (Wilson et al. 1980b; see Chapter 1).
The pattern of the androgens in the placental
tissue was different from that in the MPV. The higher pla¬
cental androgen levels found in the latter part of pregnancy
were not reflected in the MPV. Other sources of these hor¬
mones (e.g. adrenal and ovary) or peripheral conversions may
be more significant to MPV levels than a placental contribu¬
tion (Horton and Tait, 1966). The effective aromatase
system of the placenta (Ryan, et al, 1961)
-2.3H
may also serve to protect the maternal
compartment from receiving large amounts of placental
androgens. Although measurement of placental content
gives no idea of placental utilisation of these hormones,
the increase in androgens in the placental tissue coin-
cids with the increased oestrogen placental content and
MPV levels. The marmoset placenta, in common with that
from several other primate species, utilises C^g substrates
for oestrogen production; all being unable to utilise
precursors (reviewed; Ryan and Hopper, 1974).
Hormonally, there was no evidence for a major
and minor placental disc, as in the majority of instances
each placental disc contained similar amounts of hormones.
Either each disc produced similar amounts, or placental
anastomoses abolished any differences. An explanation
for the difference in hormonal values found in some
instances is not available. The methodology did not
appear to give a false result and there was no consistent
association between hormones. In other species, fetal
sex may affect placental hormone production and gonado¬
trophs content (Hagemenas and Kittinger, 1973, 1974; Hobson
and Wide, 1974). Support for this idea, or even just the
presence or absence of a fetal attachment, was not defini¬
tive in the present study. This is perhaps not surprising
in view of the considerable overlap observed in other spec-
^es (loc cit). There did not appear to be a relationship^
but analysis' in the present study was complicated by the
occurrence of singleton, twin and triplet pregnancies and
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that fetuses were attached to either one or both discs
(Chapter 7). Gestational changes, with the fetal effect
more pronounced at one stage than another, may further
complicate the matter. ..
(«±) Placental hormone' secretion' in vitro
Comparison of the secretion of progesterone by
placental tissue maintained in organ culture with the
stage of gestation supported the suggested pattern of
relative ovarian and placental function(and has been dis¬
cussed in section 5.4b. •
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The secretion of progesterone in vitro was sim¬
ilar overall to the progesterone content in the tissue. .
A similar'finding was made for the human placenta in that
Wilson and Jawad (1980) found that human placental tissue
from late gestation spontaneously produced less progester¬
one in the media than tissue from early pregnancy, a simi¬
lar pattern to the content.
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The secretion of LH/CG was similar to the
peripheral hormonal pattern and the placental contentjwith
maximum secretion during the first half of gestation
followed by a decline to low or undetectable levels during
latter half. Undetectable levels of LH/CG in the culture
media during the latter half of gestation compared to
measurable amounts in the placental tissue was probably
due to the dilution of any LH/CG secreted by the placen¬
tal tissue to below the detection limit of the assay by
the volume of culture media used.
The pattern of LH/CG and progesterone secre¬
tion observed in this study with successive days of
culture is similar to that reported by other authors also
utilising organ culture for human placental tissue
(Golander, Barrett, Tyrey, Fletcher and Handwerger, 1978;
Huot, Foidart and Stromberg, 1979; Wilson et al, 1980 '
Wilson and Jawad, 1980). This is a pattern of declining
progesterone secret ion(and an initial decline in hCG
secretion followed by an increase.
All of the studies have.provided evidence of
in vitro hormonal synthesis by either comparison of the
amount of hormone secreted in culture compared to that in
the placental tissue^ conversion of radioactive or non-
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radioactive precursors to progesterone, H leucine incorp¬
oration into hCG, or stimulation of hCG by agents such as
3'5'dibutyrylcyclic AMP. Inhibition of hormone secretion
by agents such as cyclohexamide and aminoglutethimide has
also been shown. Golander and associates (1978) suggested
that hCG released into the medium during the first 24 to
48 hours was almost all preformed and that the increase in
hCG secretion after 3-4 days of culture was due to the
disappearance in time of an inhibitory factor on hCG syn¬
thesis that was present at the time of placental removal
(Golander et al, 1978). Huot and coworkers (1979) are
exploring the relationship to DNA synthesis and the pattern
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of hCG secretion observed in vitro.
The steepest increase in the progesterone
secretion in vitro occurred during the first 4 hours of
culture and quite possibly represented a release of pre¬
formed steroid, some possibly due to tissue damage by the
processing procedure. A continual decline in the prog¬
esterone secretion with successive days in culture was
possibly due to the lack of a factor which maintains
steroidogenesis in vivo. This factor did not appear to
be cholesterol, which was available in high concentra¬
tions in the culture media^JiBaker, pers^l common) and
additional cholesterol did not boost secretion. Proges¬
terone secretion also was not affected by exogenous
progesterone or by media renewal. Pregnenolone did boost
secretion, and this may be a limited precursor in vitro.
Despite changes with successive days of
culture of what the secretion in vitro probably represents,
e.g. from a degree of preformed hormone to increasing
in vitro synthesis; the gestational changes in LH/CG
and progesterone were seen throughout the culture
period.
The culture system was primarily employed to
compare the secretion of LH/CG and progesterone by plac¬
ental tissue in vitro with the stage of gestation and
to relate its its in vitro function to the results
obtained in vivo and with the placental content. This aspect
was fulfilled. It was also desired to assess its capabilities
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as a system for investigations of the factors regulating
hormone secretion. Experimentation with a few possible
factors met with little success. This may be that the
treatments tried would really have no effect on placental
hormone secretion. There is no concrete evidence to
suggest that there is an interrelationship between proges¬
terone and CG. The inverse relationship between the 2
hormones that is found in several species (Chapter 1) and
the occurrence of recurrent abortions in animals immunised
against ^)hCG during 4 to 10 weeks of gestation when
placental steroidogenesis was presumably being established
in the marmoset (Hearn, 1976), initially led to the investi¬
gation between the 2 hormones. The lack of an effect may
also be due to the dosages used (although a wide range
was tried), or to the lack of significant biological effect
on marmoset placental tissue of a human CG preparation and
of an antibody, which although raised in the marmoset, was
an antibody to human CG. Marmoset CG is not yet available.
In addition to pregnenolone, the only positive
result in the regulation of hormone secretion was possibly X
the depression of LH/CG secretion at(70 days of gestation
with the addition of exogenous progesterone. However,
attempts to repeat this at a slightly later stage of ges¬
tation were unsuccessful. That there may well be such an
effect on LH/CG production by progesterone was recently
shown by Wilson et al, (1980 '). The effect seemed to be dose-
dependent. The difference between the 2 experiments in
the present study may well be related to the dosage of
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progesterone used compared to the LII/CG secretion, and/or
to a change in the sensitivity of the tissue to exogenous
progesterone with the change in gestational age, LH/CG
secretion in vitro had declined sharply by 80 days of
pregnancy.
This lack of correlation in the results from I
the 70 and 80 day placenta highlighted a problem in the
present set up for investigating hormonal regulation.
Samples were taken from different stages of gestation due
to the other requirements of the study. This will no
doubt affect the responsiveness of the tissue to various
treatments, and possibly the dosages needed. It was also
necessary to use several sets of culture to define the
optimal culture conditions, the hormonal patterns with
advancing time, the testing regimes and to validate the
system. Marmoset placental tissue may not be suitable
for extensive organ culture studies during the first half
of pregnancy due to the small amount of tissue available
(<2 grams), the high interculture variation in hormone
secretion, the low progesterone secretion prior to day 80
and the low LH/CG secretion after day 90.
The secretion of oestradiol from placental
tissue in vitro was increased when the placental tissue was
cultured either with adrenal tissue or gonad al tissue
(testis only). This result ties in with previous studies
in the iris monkey (Davies et al, 1970) and the observa¬
tion that the marmoset placenta utilises C^g precursors for
placental oestrogen production (Ryan et al, 1961). It
would be of interest to know if the marked increase in
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placental oestrogen production at 90 days is related to
an increased availability of fetal adrenal precursors.
Although this increase in placental oestrogen (and proge¬
sterone) secretion occurs relatively later in gestation
in the marmoset than in the human, it occurs at a similar
stage of fetal development (See also Chapter 6-4)yand the
findings in this thesis showed that the marmoset fetal
adrenals and testis secreted large quantities of androgen
in vitro after day 90.
5 o 4 Chapter summary
1) Corpus luteum and placental function were assessed
throughout pregnancy by a) hormonal measurements in the
paired utero-ovarian vein, and their relationship to the
presence or absence of the corpus luteum and of the feto¬
placental unit, b) the placental hormonal content and c)
the placental hormone secretion in vitro.
2) Progesterone and oestrone values were related to
the presence or absence of the corpus luteum in early
pregnancy, whereas oestradiol values were not.
3) Corpus luteum function declined between days 20
and 60 with the steepest decline between days 40 and 60.
It makes little contribution to hormonal values by day 90
of pregnancy.
4) The placenta is an insignificant source of proge¬
sterone and oestrone prior to day 50. Between days 50 and
80; there is a transitional period from ovarian to placental
dominance. By day 90, the placenta is definitely the major
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source of progesterone and oestradiol.
5) The trends for the placental content of proge¬
sterone, oestrogen,and LH/CG were similar to those in the
maternal peripheral plasma, whereas the androgen placental
content profile was distinct from the maternal profile.
Placental androgen content is increased coincident with
the increased oestrogen placental content.
6) A placental organ culture system was validated
and utilised for measurement of endogenous hormone secre-
■f
tion. It appeared to reflect the relative capacity of
the placenta for progesterone and LH/CG production at
different stages of gestation.
7) The placental hormonal content is generally
similar in each placental disc.
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CHAPTER 6 : FETAL HORMONES
6.1 Introduction
Fetal hormones, some of'which show a sex difference,
may be important for fetal maturation (possibly the onset
of labour), sexual differentiation and placental hormone
production). These topics have been extensively reviewed
for the human and rhesus (Jost 1970a and b; Reyes,
Winter and Faiman, 1976; Winter, Fairman and Reyes, 19"77;
Resko, 1977; Beling, 1977; Zondek and Zondek, 1979.)
The marmoset is unusual among primates in that it
regularly produces dizygotic twins. There is apparently
an early devlopment of a shared placental circulation and
hematopoietic chimerism, but females born cotwin to a
male are normal (Wislocki, 1939; Benirschke and Layton,
1969). Although anatomical sexual differentiation
occurs prenatally, the extent to which brain or behavioural
sexual differentiation occurs prenatally is not known.
For the first time for a primate species, a post-natal in¬
fluence was indicated by the study of Abbott (1979).
Whether in this respect, the marmoset is unique among
primate species is yet to be established.
In view of these unusual characteristics of the mar¬
moset^ it was of considerable interest to define the
hormonal environment in which male and female marmoset
fetuses develop normally. This study was designed, in
conjunction with the studies outlined, in Chapter 5.
to delineate the fetal hormonal changes occurring with
advancing gestation and to compare hormonal values in
male and female fetuses. Measurement of several hor¬
mones and multiple sampling sites (e.g. peripheral plasma,
umbilical vein plasma, fetal plasma and amniotic fluid)
allowed intercompartmental comparisons of the hormonal
values and ratios. Hormonal values were also related to
placental function which was reported in Chapter 5. In
conjunction with other studies which utilised material from
these fetuses, the fetal hormonal levels were also compared
with fetal gonadol development and fetal gonadol and
adrenal secretion in vitro.
6.2 Procedures
Fetal samples were obtained following hysterotomy.
(Chapter 2.6). The sampling regime is given in Chapter
2.7.
Amniotic fluid was collected after day 70 of preg¬
nancy using a 21-25 gauge needle. The fluid volume was
estimated. Fluid was not always obtainable, because the
sac ruptured on removal from the uterus, particularly in
late pregnancy.
The umbilical cord was clamped at the fetal side and
blood was taken from the umbilical vein after day 90 using
a 21-27 gauge needle. No umbilical arterial blood was
taken due to the small size of the artery. Fetal plasma
was obtained"after day 90 by cardiac puncture using a 21-
27 gauge needle.
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All blood samples were centrifuged and stored at
-20°C until assayed (Chapter 2.3). Amniotic fluid was
stored at -20°C until assayed.
6. 3 Results
(a) Samples
Details of the number of pregnancies, the
fetal sex and the samples obtained•for fetal and umbilical
vein plasma and amniotic fluid aire, given in Table 6-1,
Maternal plasma was taken from all pregnancies. Amniotic
fluid was also obtained at day 70 but the fetal sex was
not determined. The volume of amniotic fluid obtained
'ranged from 0.06ml at day 70 to 4ml at day 110. Small
sample volumes often precluded the measurement of all
hormones. There were more female than male fetuses and
after day 90, 4 pregnancies had only female fetuses (1 or
2), 2 had female and male co-twins and 4 had 2 female and
1 male fetus.
(b ) Hormonal values
(i ) Progesterone
Figure 6-1 shows the individual proges¬
terone values in the maternal fetal and umbilical vein
plasma and in the amniotic fluid. Table 6-2 gives the
mean value for each pregnancy and the mean value before
and after day 90. Progesterone was measured in the fetal
plasma only after 100 days of pregnancy. In the other 3
compartments, there was a severalfold increase "in progester¬
one values between 90 and 100 days of pregnancy. Maximum
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Table 6-1 The number (No.) of female (F) and male (M)
fetuses and the samples obtained for the fetal serum (F.S.)
umbilical vein (U.V.) and amniotic fluid (A.F.) between
80 and 140 days of pregnancy. The overall total and
total from 100-140 days is also given.
Day No. F.S. U.V. A.F.
M. F. M. F. M. F. M. F
80 1 1 0 0 0 0 1 1
80 1 1 0 0 0 0 1 1
85 1 1 0 0 0 0 1 1
8W 90 1 2 1 0 0 1 1 2
57W 90 1 2 0 0 1 2 1 ■ 2
100 1 1 1 . 1 1 1 1 0
100 0 2 0 2 0 0 0 2
105 1 2 1 2 1 2 1 2
110 0 2 0 2 0 2 0 2
115 0 1 0 1 0 1 0 1
120 1 2 1 2 1 2 1 2
130 1 1 1 1 1 1 1
130 1 2 1 2 1 2 1
140 1 2 1 2 1 2 0 0
28V/ 140 0 2 0 2 0 2 0 0
Total
(day 80-140) 11 24 7 17 7 18 9 18
(day 100-140) 6 17 6 17 6 15 4 10
Fig. 6-1: Progesterone values (.ng/ml) in the maternal
peripheral vein (M.P.V.) (oa\ amniotic fluid (A.F.),
fetal serum (F.S.) and umbilical vein (U.V.) in females
(0,A) and malesC©,^). Circles (0,0) and triangles
(A,&) distinguish between fetuses from different preg¬
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Table 6-2. Mean progesterone values (ng/ml) in the
fetal serum (F.S.), umbilical vein (U.V.), amniotic
fluid (A.F.) and maternal peripheral vein (M.P.V.).
The number in parenthesis gives the number of samples
included in each mean value. Only one M.P.V. sample
was taken. The mean value before and after 90 days of





F.S • U. V. A.F • M.P
28W 140 T 421 (2) 382 CD 196
60W 140 301 (3) 339 (3) 97
33W 130 754 (3) 978 (3) 104 (D 190
34W 130 T 712 (2) 878 (2) 289
low 120 T 633 (3) 956 (3) 174 (3) 156
11w 115 707 (1) 1352 (D 144 CD 167
23W 110 T 827 (2) 1997' (2) 152 (2) 255
24R 105 T 844 (3) 1285 (3) 485 (3) 311
6R 100 T 312 (1) 94 (2) 118
44W 100 375 (1)
57W 90 T 104 (2) 48 (2) 54
8W 90 T 93 CD
.
28 (3) 63
51W 85 T 32 (2) 56
46W 80 22 (2) 70
21R 80 T
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fetal, umbilical vein and amniotic fluid values were found
between 105 and 130 days of pregnancy. Fetal and umbili¬
cal vein values at 140 days were similar to those found at
90 to 100 days of pregnancy.
If all the data dice considered, female
and male fetal serum progesterone values are not signifi¬
cantly different from each other. However, in 6 pregnan¬
cies in which there was both a male and female fetus
(gestation range 105-140 days), progesterone levels in the
female fetus (mean - 636 ± lOOng/ml, s.d.) always exceeded
those in the male fetus (479 t 75ng/ml, s.d.). The differ¬
ence was significant (p<0,02; paired t~test). There was
no significant difference in the umbilical vein values in
these pregnancies. Table 6-3, which gives the umbilical
vein-fetal serum difference, shows that in 4 of these 5
pregnancies, the values were lower for the female than the
male, and similar between female co-twins. In all cases,
umbilical vein values exceeded fetal serum values although
the difference decreased as. pregnancy advanced (p<0.G01,
paired t-test)
(ii) Oestradiol
The individual oestradiol values in the
maternal fetal and umbilical vein plasma are shown in
Figure 6-2, ana the mean values for each pregnancy are
given in Table 6-4.
Amniotic fluid and umbilical vein oestrad*-
iol values were low prior to 90 days of pregnancy.
Levels increased gradually after 90 days and maximum
Table 6-3. The difference (ng/ml) in the progesterone
value between the fetal serum (JF.S.) and umbilical vein


































Fig. 6-2: Oestradiol values (ng/ml) in the maternal
peripheral vein (M.P.V.)(°a) , amniotic fluid (A. F. )
fetal serum (F.S.) and umbilical vein (U.V.) in females
(0,A) and males (©,&). . Circles (0,0) and triangles
(A, A) distinguish between fetuses from different preg¬
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Table 6-4. Mean oestradiol values (ng/ml) in the fetal
serum (F.S.), umbilical vein (U.V.), amniotic fluid (A.F.)
and maternal peripheral vein (M.P.V.). The number in
parenthesis gives the number of- samples included in each
mean value„ Only one M.P.V. sample was taken. The mean





Gest. F.S. up A. F. M.P.V
28W 140 80 (2) 189 (2) 71
60W 140 218 (3) 310 (2) 131
33W 130 20 (3) 40 (3) 35 (1) 49
34W 120 28 (2) 29 (2) 30 (1) 92
10W 120 20 (3) 29 (3) 23 (3) 45
11W 115 26 (1) 82 (1) 17 (1) 49
23W 1.10 51 (2) 129 (2) 11 (2) 28
24R 105 16 (3) 10 (1) 10 (3) 25
6R 100 24 (2) 12 (2) 51
44W 100 32 (2) 10 (2) 43
57W 90 ~4. 9 (2) 1.3 (3) 5
8W 90 1.1 (1) 0.9 (3) 14
51W 85 0.8 (1) 1.2
46W 80 <£0.7 (1) 1.1
21R 80 3.7
48W 70 1.4




52162 81 +77 19± 11 58±32




values were found at 130-140 days. Fetal serum oestrad-
iol values did not increase between 100 and 130 days, but
like the umbilical vein levels, there was an approximately
6-fold increase between 130 and 140 days of gestation.
Such a marked increase was? not reflected in the maternal
peripheral plasma.
There was no sex difference in oestrad-
iol levels either overall or in pregnancies in which there
was both a male and female fetus.
(iii) Oestrone
Oestrone values in the maternal, fetal
and umbilical vein plasma and the amniotic fluid are given
in Figure 6-3, and mean values for each pregnancy are given
in Table 6-£\. Levels in the maternal plasma were in
the range generally observed for these stages of gestation
(see Chapter 4), Although the highest maternal values
were found in 2 pregnancies at 140 days, there was no
general increase between 90 and 140 days. In contrast,
oestrone values in the fetal serum, umbilical vein, 'and
amniotic fluid showed a sustained increase after 90 days
of gestation and maximum values were found at 140 days.
The overall increase was approximately 10-fold between the
100th and 140th day of pregnancy in the fetal and umbilical
vein plasma and about 25-fold between the 90th and 130th
day in the amniotic fluid. Prior to 90 days, the amnio¬
tic fluid values were relatively low and constant.
Similar to oestradiol, there was no sex ,
difference either overall or in pregnancies in which both a
female and male fetus were present.
ZB3
Fig. 6-3: Oestrone values (ng/ml) in the maternal
peripheral vein (M.P. V. ) <c^6), amniotic fluid (A.F.),
fetal serum (F.S.) and umbilical vein (U.V.) in females
(0,A) and males(©,&)* Circles (0,@) and triangles
(A,A) distinguish between fetuses from different preg¬
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Table 6-t>. Mean oestrone values (ng/ml.)) in the fetal
serum (F.S.), umbilical vein (U-.V.), amniotic fluid (A.F.)
and maternal peripheral vein (M.P.V.). The number in
parenthesis gives the number of samples included in each
mean value. Only one M.P.V. sample was taken. The mean





Gest. F.S. U.V A.:F. M.P
28W 140 185 (2) 130 (1) 23
60W 140 273 (3) 180 (3) 23
33W 130 74 (3) 83 (3) 89 (1) 15
34W 130 69 (2) 77 (2) 74 (1) 12
low 120 31 (3) 25 (3) 51 (3) 7
11W 115 33 (1) 63 (1) 55 (1) 16
23W 110 24 (2) 28 (2) 14 (2) 15
24R 105 18 (3) 13 (1) 10 (3) 7
6R 100. 16 (2) 13 (2) 11
44W 100 18
57W 90 3.2 (3) 19
8W 90 3.4 (3) 20
51W 85
46W 80
2"1R 80 1.6 (2) 7





86 + 93 75 + 57 44 + 31 15





Figure 6-4 shows the androstenedione
values in the maternal peripheral, fetal and umbilical
vein plasma and in the amniotic fluid. Table 6-6 gives
the mean hormonal values for each pregnancy. Maternal
values remained relatively constant between 70 and 140
days and were similar to those reported in Chapter 4.
In contrast, the low androstenedione values found prior
to day 90 were followed by a 2-3 fold increase after day
90 in the fetal serum, umbilical vein and amniotic fluid.
There was no sex difference in andros¬
tenedione values either overall or in the 5 pregnancies
with both a female and male fetus.
(v) Testosterone
The maternal peripheral, fetal and
umbilical vein plasma and amniotic fluid testosterone
values are shown in Figure 6-5. Mean values for each
pregnancy are given in Table 6-7. Prior to and including
90 days of pregnancy, testosterone levels were low in the
maternal, fetal and umbilical vein plasma and in the
amniotic fluid. Only 2 of the 9 70 to 90 day amniotic
fluid samples and neither of the 90 day umbilical vein
samples contained measurable testosterone (>0.2ng/ml).
Between 90 and 100 days, amniotic fluid, fetal serum and
umbilical vein levels increased and thereafter remained
elevated.
There was no overall sex difference in
fetal testosterone values and in fact, the highest fetal
(and umbilical vein), testosterone values were found in a
25 b
Fig. 6-4: Androstenedione values (ng/ml) in the maternal
peripheral vein (M.P.V.) (o), amniotic fluid (A.F.),
fetal serum (F.S.)and umbilical vein (U.V.) in females
(0,A) and males (©,&.). Circles (0,©) and triangles
(A,&.) distinguish between fetuses from different preg¬
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Fig. 6-5: Testosterone values (ng/ml) in the maternal
peripheral vein (M.P.V.) (ot$amniotic fluid (A.F.),
fetal serum (F.S.) and umbilical vein (U.V.) in females
(0,-A) and males(©,A). Circles (0,©) and triangles
(A,A) distinguish between fetuses from different preg¬
nancies at the same stage of gestation. The arrows
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pregnancy with' 2 female fetuses. These high levels were
not reflected in the maternal peripheral plasma. However,
in the G pregnancies in which both a female and male fetus
was present, the male testosterone values were significantly
higher than the closest values from the female counterpart
(P<0.025, paired t-test). There was no corresponding
difference in umbilical vein values. Even in these 6
pregnancies, there was overlap between males and females;
with the female values ranging from 1 to 4.2ng/ml and the
males from 1.3 to 5.5ng/ml.
Table 6-8 shows the umbilical vein-fetal
plasma difference., In 5 of 6 instances, there was a
larger positive difference (favouring the fetal compartment)
for the male than the female counterpart within a pregnancy
although overall the differences overlapped. Fetal serum
testosterone values were significantly higher than umbili¬
cal vein values for male fetuses (P<0.01, paired t-test,
n~6) but not for female fetuses. Male fetal serum values
were always higher than umbilical vein values whereas-
female fetal serum values were both higher and lower,
(vi) LH/CG
LH/CG was measured in a few samples in
which there was sufficient plasma. In all. cases the
LH/CG values were undetectable. The following stages of
gestation were sampled: 90 to 120 days: amniotic fluid;




Table 6-8-.. The difference (ng/ml) in the testosterone
value between the fetal serum (F.S.) and umbilical vein
(U.V.). A negative number indicates a higher value in
the U.V.
Day of Anim. Female Male
Gestation No. ng/ml ng/m'l
100 44W 0.15 1.456





120 10W -0.369 0.32
0
130 34W -1.01 1.21
130 33W 1.93 3.23
1.68




(g) The hormonal relafcionships between the com--
partments
The relationships between the various compart¬
ments changed with advancing gestation and was not the same
for all the hormones. The mean ratios for each pregnancy,
calculated from individual values, between the compartments
for progesterone, oestradiol and oestrone are given in
Figure 6-6 and for androstenedione and testosterone in
Figure 6-7, Fetal serum levels exceeded maternal levels
for all the hormones (P<0.01-0„001, paired t-test) except
oestradiol, Feta] serum oestradiol levels were higher than
maternal levels only at 140 days of gestation. The relat¬
ively highest fetal to maternal ratio was found for testos¬
terone and oestrone.
Amniotic fluid hormone levels were lower or sim¬
ilar to maternal plasma levels prior to 90 days of pregnancy.
They remained lower than maternal levels for the remainder
of pregnancy for oestradiol and generally for progesterone.
(PcO , 02-0 . 05, paired t~test). In contrast, amniotic "fluid
oestrone, androstenedione and testosterone levels were higher
than maternal levels after 100 days (P<0.01-0.001, paired t-
test) and the ratio was in the same range as that for the
fetal plasma. Progesterone and oestradiol fetal serum
levels generally exceeded the amniotic fluid level (PcO.Ol,
paired t-test) but there was no consistent relationship
between fetal serum and amniotic fluid values for the other
3 hormones. Maternal values were not correlated with
either the amniotic fluid or fetal serum values. Fetal
serum values were not correlated with amniotic fluid values
Fig. 6-6: The progesterone (a), oestradiol (b) and
oestrone (c) ratios between the fetal serurn and maternal
peripheral plasma (©) and between the amniotic fluid and
maternal peripheral plasma (o). The mean value for each



























































Fig. 6-7: The androstenedione and testosterone
ratios between the fetal serum and maternal peripheral
plasma O) and between the amniotic fluid and maternal
peripheral plasma (o). The mean value for each preg¬
nancy is given. The dashed line ( ) gives the 1:1
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except for testosterone (r = 0.839, P<(0.01, n=14) and
oestrone (r = 0.794, P<0.01, n-13).
The mean fetal serum-umbilical vein ratio
for each pregnancy is given in Figure 6-8. Progesterone
and oestradiol (after day 100) fetal serum levels were
always lower than umbilical vein levels but whereas proges¬
terone fetal values became increasingly more similar to
umbilical vein va.lues with advancing pregnancy, oestradiol
values did not. The difference between the compartments
was significant for progesterone (P<0.01, n-18) and oest¬
radiol (P<0.01, n=18) (paired t-test). Fetal serum
oestrone values were generally lower or similar to umbil¬
ical vein values except at day 140 when they greatly
exceeded umbilical vein values. In contrast, mean
androstenedione values generally exceeded umbilical vein
values, the difference being significant (P<0.02, paired
t-test, n-16). The testosterone relationship was more
variable and the relationship for testosterone (and prog¬
esterone) may have been affected by fetal sex (see sect¬
ions 6-3rri and v).
(d) The hormonal ratios
The ratios between the hormones were calculated
using individual values in all cases and a mean value for
each pregnancy was calculated.
(i ) Progesterone to oestradiol
The mean progesterone to oestradiol ratio
in the maternal, fetal and umbilical vein plasma and the
amniotic fluid for each pregnancy is given in Figure 6-9.
Fig. 6-8: The progesterorie$(0), oestradiol^o), oestrone
(•), testosterone/T( A) and androstenedione,A(A) ratios
between the fetal serum and umbilical vein. The mean
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Fig. 6-9: The progesterone to oestradiol ratio in the
maternal peripheral plasma (#), amniotic fluid (o), fetal




















































Progesterone values always exceeded oestradiol values.
The maternal ratio was generally similar to that reported
in Chapter 4. The ratio in the amniotic fluid, fetal
and umbilical vein plasma always exceeded the ratio in
the maternal plasma although.the ratios were similar at
140 days of gestation. The ratio showed a steady decline
in the amniotic fluid with advancing gestation whereas no
marked decline occurred in the fetal or umbilical vein
plasma until 130-140 days of pregnancy. Progesterone
and oestradiol were not correlated in the fetal>
umbilical vein plasma or in the amniotic fluid.
(ii ) The oestradiol to oestrone ratio
Figure 6-10 shows the mean oestradiol
to oestrone ratio in the maternal, fetal and umbilical
vein plasma and in the amniotic fluid for each pregnancy.
The maternal ratio was similar to that reported in Chapter
4, with oestradiol predominating over oestrone after 100
days of gestation. With the exception of the pregnancy
at 110 days, the ratio was lower in all 3 compartments
than in the peripheral plasma and generally oestrone was
the major oestrogen between .100 and 110 days. The ratio
in the umbilical vein was variable but always exceeded the
ratio in the fetal plasma after day 105. Oestrone predom¬
inated over oestradiol in the fetal plasma except at 1.00
days of gestation and the ratio tended to decline with
advancing gestation.
(iii) The progesterone to testosterone ratio
The progesterone to testosterone ratio
lb4)
Fig. 6-10: The oestradiol to oestrone ratio in the
maternal peripheral plasma (3fc), amniotic fluid (o),
fetal serum (©) and umbilical vein (4). Mean values
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for the fetal plasma and umbilical vein is shown for
individual animals in Figure 6-11. The ratio was higher
for females than males within a pregnancy (P<0.01, n=6,
paired t-test) and tended to be higher for females than
males overall, although there was considerable overlap
and the difference was not significant. There was not a
comparable sex difference in the umbilical vein.
6.4 Discussion
This is the first study to report on the fetal hor¬
monal environment in the marmoset monkey. Hormonal values
ratios and trends were reported for the maternal, umbilical
vein and fetal plasma and the amniotic fluid.
Marmoset amniotic and fetal samples were not obtain¬
able until mid-gestation which is considerably later
than in the human or rhesus. The relatively slow develop¬
ment of the marmoset fetus during the first half of gesta¬
tion (Phillips, 1976; Chapter 7) quite likely means that
samples have been taken from comparable stages of develop¬
ment. Hampton and Taylor (197j) reported on gonadal
development in marmosets and related their data to crown-
rump lengths (CRL-). Relating their CRL measurements to
ours, which were obtained from accurately dated pregnancies,
(Chapter 7), allowed the gonadal development to be approx¬
imated to a gestational age. The earliest time at which
sex could be differentiated was at about day 75 of gesta¬
tion. This finding was confirmed by 0 (pers> comm. )
utilising gonacoJ- tissue obtained from the fetuses in the
1.11
Fig. 6-11: The progesterone to testosterone ratio in
the fetal serum , and umbilical vein in female
(0,&) and male (@,A) fetuses. Circles (0,0) and triangles
(A,A.) distinguish between fetuses from different pregnan¬
cies at the same stage of gestation.
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present study.- Interstitial cells, the presumed source
of testicular steroi d hormones, (Nierni, JKonen and Hervonen,
1967; Pelliniemi and Niemi, 1969), made up a major portion
of the testis and appeared glandular after 90 days of
gestation. Organ size increased with glandular inter¬
stitial cells becoming the major cell type present between
90 and 100 days of gestation. Glandular tissue persisted
until birth with a gradual loss occurring shortly there¬
after and which was complete by 1 month of age. Amniotic
fluid samples were obtained after 70 days and fetal plasma
after 90 days, and therefore probably encompassed the per¬
iod of sexual differentiation.
(a) Progesterone
y
Progesterone in the fetal plasma followed the
same pattern as the maternal peripheral plasma with an
increase in levels after 90 days of gestation and a decline
during the last week of gestation. The placenta was the
most likely source of progesterone in the maternal plasma
after 90 days of gestation (see Chapter 5) and in the
fetal plasma as umbilical vein levels were significantly
higher than fetal levels. .A similar finding was made in
the human (Hagemas and Kittinger, 1973) and the rhesus
(Hagemas and Kittinger, 1972). Infusion of tritiated
progesterone in the human (Escarcena, Clark and Gurpide,
1978) and sheep (Tseng, Adamsons, Gaziano, Roberts and
Gurpide, 1978) confirmed that the direct secretion of
placental progesterone into the umbilical vein accounted
for over 90% of the hormone found in the fetus. The
213
decline in marmoset fetal plasma progesterone before birth
was also likely to be related to a lower placental con¬
tribution as indicated by lower umbilical vein levels
and by the relatively lower placental progesterone content
and progesterone secretion in vitro that was found at this
time (Chapter 5). Changes in blood flow probably would
not account entirely for the decline as both oestrogens
increased at this time.
An additional source of fetal progesterone
during late pregnancy may be the fetal adrenal. Fetal
adrenal conversions of pregnenenolone to progesterone have
been shown (Solomon and Leung, 1972) and the increase in
amniotic fluid progesterone values in late pregnancy in
the rhesus was suppressed by betamethasone although
maternal progesterone levels were not affected (Challis
et al, 1977b).
The difference between umbilical vein and fetal
plasma indicates a metabolism of progesterone by the
marmoset fetus. Human and rhesus fetal tissues, particu¬
larly the liver and adrenals, extensively metabolise prog¬
esterone (human: Bird, Wiqvist, Diczfalusy and Solomon,
1966; Solomon, Bird, Ling, Iwamiya, and Young, 1967;
rhesus: Leung and Solomon, 1972). The products formed in
these 2 species varies and it is not known to what degree
the marmoset would resemble either species. In addition,
the fetal testis metabolises progesterone. A major in
vitjro progesterone metabolite in fetal (Coffey and Johnsonbaugh
1979) immature (Mizutani, Tsujimura, Akashi and Matsumoto,
1977) and adult (Hoschoian and Brownie, 1967) rhesus
21H
monkey testis is 17-hydroxy-4-pregnene-3,20,dione,
This steroid is also the chief in vitro progesterone
metabolite in adult marmoset testis (Preslock and
Steinberger, 1977b),
There was not an overall sex difference in
marmoset fetal progesterone, but comparison between
fetuses within the same pregnancy showed higher fetal
plasma levels associated with a female than a male
fetus„ The lack of an overall sex difference in levels
may partly be due to gestational hormonal changes which
were reflected in both fetuses. There was no corres¬
ponding sex differnce in umbilical vein progesterone
levels either overall or within a pregnancy. In
view of the shared placental circulation and/or the
attachment of both male and female fetuses to one
placental disc (Chapter 7), it is perhaps not sur¬
prising there is no sex difference in umbilical vein
plasma in male-female pregnancies.
Higher progesterone levels were also found
in the female fetal rhesus than in the male, but unlike
the marmoset, these higher female levels were also
associated with higher umbilical vein progesterone
levels (Hagemenas and Kittinger, 1972), a greater
metabolism of progesterone by the female fetus (Hagem¬
enas and Kittinger, 1972; MacDonald, et al, 1973),
and a greater in vitro secretion of progesterone by
placental tissue from a pregnancy with a female fetus
than with a male (Hagemenas and Kittinger, 1974), Thus,
21 5
a sex influence on placental progesterone biosyn¬
thesis or metabolism, and on fetal metabolism was indi¬
cated for the rhesus monkey, • Results from studies
in the human are equivocal: a somewhat similar
finding to the rhesus was made by Hagemenas and Kittinger,
(1973), but not by others (Tulchinsky and Okado, 1975;
Effer et al, 1973 ; Dawood and Helmkamp, 1977),
Since the data in the present study did not show a
sex difference in the amount of progesterone in the umbilical
vein, or a higher placental secretion of progesterone in
vitro from placental tissue taken from pregnancies with
only femal.e fetuses (days 100,110,115,140, Figure 5-24),
it seems likely that the higher female fetal progesterone
levels may be due to a lower, rather than a higher
progesterone metabolism by female fetuses ; although other
factors may play a role, An ovarian progesterone source is
an obvious candidate, and there are repo its of fetal ovarian
progesterone synthesis (Rice, Jacks, Smith and Sternberg,1971)
Wilson and Jawad, 1979) „ However, marmoset fetal ovaries
taken after 80 days of gestation and maintained in organ
culture, did not secrete measurable amounts of progesterone
(unpubl'd data), and the general conclusion of most workers,
is that most, if not all, of the circulationg progesterone
in the fetus is derived from the placenta (Diczfalusy, 1974),
Whether there is a sex difference in the progesterone-binding
protein, transcortin, which is a likely mechanism for
maintaining the higher fetal than maternal progesterone
levels (Klopper and Fuchs, 1977) is not known.
Progesterone values in the fetal plasma and in the
amniotic fluid followed the general trend as the maternal
2-7 (o
plasma although fetal plasma values were severalfold
higher than those in the maternal peripheral plasma and
amniotic fluid values were generally lower than those in the
maternal plasma. Fetal plasma values also exceeded
maternal plasma values in the human, baboon and rhesus,
but in the rhesus, fetal plasma values declined as preg¬
nancy progressed (human: Kagemenas and Kittinger, 1973;
baboon: Dawood and Fuchs, 1980; rhesus: Thau , Lanman
and Brinson, 1976). Some specie's, e.g. the rat, show
higher maternal than fetal progesterone values (Weisz and
Ward, 1980) and this may reflect differences between
species in the relative ovarian-placental importance to
progesterone levels and/or differences in the fetal and
maternal level of progesterone binding protein.
Comparison of the progesterone pattern and
levels between the amniotic fluid and the fetal and mater¬
nal compartment reveals considerable variation among the
primate species. In the human, amniotic fluid progester¬
one values declined with advancing gestation and were
significantly lower than maternal levels after mid-gestation.
(Johansson and Jonasson, 1971; Warne et al, 1977;
Nagamani, McDonough, Ellegood and Mahesh., 1979). In the
rhesus, the amniotic fluid levels were also significantly
lower than maternal values but showed an increase that
was greater than the corresponding change in the maternal
peripheral plasma (Challis, et al, 1977b). In the marmoset
amniotic fluid values were also generally lower than
maternal values but were severalfold higher than the human
at the end of gestation although peripheral values were
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similar. This is because marmoset amniotic fluid values
increased after 90 days of pregnancy and remained high.
The reason for these differences between the
species is not known. Common to all these species though
is a lack of correlation between amniotic fluid values
and maternal or fetal values. This may be related to
the route of entry of hormones into the amniotic fluid,
which has not been firmly established. The different
patterns in the amniotic fluid between the hormones may
relate to different routes of entry and the hormone's
solubility and degree of conjugation^ In addition, the factors
involved probably change with advancing gestation
(Behrman, Parer and de Lannoy, 1967; Klopper, 1970; Dawood,
1977).
(b) Oestrogens
Concentrations of the 2 oestrogens, oestradiol
and oestrone, in marmoset fetal plasma were not related to
their concentrations in the maternal peripheral vein. In
addition, whereas fetal oestradiol levels were lower than
maternal peripheral levels between 100 and 130 days of
gestation, oestrone levels generally greatly exceeded
those in the maternal peripheral plasma. This'resulted
in a shift in the oestradiol to oestrone ratio between the
maternal and fetal compartments in favour of oestrone; and
in the majority of cases the ratio was reversed between
the 2 compartments. Similar findings have also been
reported for the human (Tulchinsky, 1973; Shutt, Smith and
Shearman, 1974; Reyes, Boroditsky, Winter and Faiman, 3 974)
1.7%
and rhesus (Resko, 1974 {3; Resko, Ploem and Stadelman,
1975; Novy, 1977), despite the large interspecies
differences in oestrogen concentrations.
The placenta may be the major source of fetal
oestrogens and be partly repsonsible for the reversal of
the oestrogen ratio in the fetal plasma. Umbilical vein
oestrogen values were generally higher than the fetal
plasma values and compared to the utero-ovarian vein and
maternal plasma, the oestradiol to oestrone ratio shifted
in favour of oestrone in the umbilical vein. Larger
quantities of oestrogen in the umbilical vein than umbili¬
cal artery, containing greater amounts of oestrone than
oestradiol was also found in the human (Tulchinsky, 1973;
Kenny et al, 1973; Shutt et al, 1974) and rhesus (Resko
et al, 1975). In vivo and in vitro perfusion studies in
the human also showed a greater secretion of oestrone
than oestradiol from the placenta, to the fetus (Bolte
et al, 1964a,d)0 In the rhesus also,'there may
be an adjustment in favour of oestrone production by"
placental tissue during late pregnancy (Dierschke, Wehrenberg,
Wolf, Clark and Robinson, 1978). The shift in ratio
between the umbilical vein and the utero-ovarian vein may
also be indicative of a selective secretion of oestradiol
or oestrone either to the maternal or fetal compartment.
A preferential secretion was found in the rhesus monkey;
vhereas oestradiol was selectively secreted to the maternal
compartment, oestrone was not (McCarthy et_ jal, 1980).
Although the marmoset placenta contained more oestradiol
ail
than oestrone in late gestation, the ratio was lower in
the placental tissue than in the peripheral plasma (Chapter
5).but higher than in the umbilical vein, which may suggest
that an explanation similar to the rhesus may be applicable
to the marmoset.
Other factors may also be involved in the diff¬
erences in ratio between the 2 compartments. In the
marmoset the difference between the umbilical vein and
fetal plasma concentrations was greater for oestradiol
than for oestrone and the oestradiol:oestrone ratio was
lower in the fetal plasma than the umbilical vein. Oes¬
tradiol may be more rapidly metabolised or conjugated
than oestrone, in the fetal compartment than the maternal.
Differences between the 2 hormones in their metabolic
clearance rates between the 2 compartments was shown for
the rhesus (McCarthy et al, 1980). Higher levels of
oestrogen binding protein, which has a greater affinity
for OGSt Teldiol than oestrone (Westphal, 1971), in the
maternal than in the fetal plasma may also aid in main¬
taining higher maternal oestradiol values.
Interconversions of oestrone and oestradiol
may account for the difference between the oestradiol:
oestrone ratio in the umbilical vein and fetal serum.
Fetal ovarian or adrenal secretion were also suggested to
be of possible significance in the rhesus (Resko et al,
1975; Resko, 1977). These -factors are probably more
negligable in the marmoset due to the comparatively greater
amounts of oestrogen secreted by the placenta to the fetus.
2£0
Also, oestrone and oestradiol were not correlated in
either the fetal or maternal plasma in the marmoset,
whereas they were correlated in the rhesus. No oestrogen
was measurable in marmoset fetal ovarian cultures
(unpublished observation).
Marmoset maternal peripheral oestrogen levels,
particularly oestradiol, were highest during the last
week of gestation (Chapter 4). Significant changes also
occurred in the fetal compartment. Fetal plasma oestrone
values greatly exceed umbilical vein values and there was
an increase in the umbilical vein and fetal plasma oestrogen
values between 130 and 140 days, which was of much gi~eater
magnitude than that in the peripheral plasma. This
resulted in both oestrogens exceeding maternal peripheral
plasma levels and a larger decline in the progesterone to
oestradiol ratio in the fetal than in the peripheral plasma.
Human (Shutt et al, 1974), rhesus ( .ffesko et al, 1975) and
sheep (Challis, 1971; Strott, Sund el and Stahlman, 1974)
fetal oestrogens also increased at the end of pregnancy.
The increase appeared to be associated with maturation of
the fetal pituitary-adrenal axis (Bedford et a 1, 1972) and
the rise of corticosteroids which was related to the onset
of parturition in the sheep (Challis, Kendall., Robinson and
Thorburn, 1977) although not necessarily in the primate
(Novy, Walsh and Kittinger, 1977; Novy, 1977). There
was no corresponding increase in marmoset fetal androgens
during the last week of gestation when oestrogen levels
increased. It was suggested that the oestrogen increase
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in the sheep resulted from the effects of fetal Cortisol
on placental enzymes rather than an increase in production
of androgen steroids (Challis et al, 1977; Challis, 19S0).
The cause and significance of the changes in fetal oestro¬
gen values in late pregnancy, the functioning of the mar¬
moset pituitary-adrenal axis and any role of the fetus in
the timing of parturition must await further studies in
the marmoset.
(c) Androgens
Testosterone and androstenedione values in the
fetal serum and amniotic fluid did not follow the same
pattern as the maternal peripheral plasma. This probably
reflects to an extent the different sources of androgens
in the maternal and fetal compartment. In addition to
the placenta, the maternal and fetal gonads and adrenals
contribute substantially to androgen levels in other
species (reviews: Diczfalusy, 1974; Gandy, 1977; Resko,
1977; Winter et al, 1977).
Although detailed information is not available
on marmoset gonadal development, the increase in fetal
testosterone levels after 90 days of gestation probably
correlated with the appearance of glandular interstitial
cells (Hampton and Taylor, 1971). Testosterone levels
remained high until birth and interstitial cell development
persisted until birth (Hampton and Taylor, 1971). Prior
to 90 daj^s of gestation, it may be inferred that fetal
testosterone levels would also be low as fetal plasma and
amniotic fluid levels were low at 90 days and amniotic fluid
282-
levels were low prior to 90 da.ys. Amniotic fluid tes¬
tosterone levels reflected fetal serum levels during later
gestation in the marmoset and they have an unequivocal sex
difference and reflect circulating levels reasonably well
in the human (Dorner, Stahl and Baumgarten, 1972; Giles,
Lox, Heine and Christian, 1974; Dawood and Saxena, 1977;
Warne et al, 1977). It is possible that a relatively
short lived rise in testosterone, which in the rat results
in distinctive male levels for only 2 days (Weisz and Ward,
1980), was missed in the present study. Other primates
have a longer period of sexual differential and divergent
hormonal levels during fetal life.
However, despite the possible correlation
between testosterone levels and gonadal development, the
increase in fetal and amniotic fluid testosterone levels
that occurs after 90 days of gestation may not be primarily
due to a gonadal, secretion but to the increased placental
secretion of androgens to the fetus. This was indicated
by the increased umbilical vein values, the lack of a sex
difference ana that fetal values did not necessarily
exceed umbilical vein values. The high testosterone
level secreted by the placenta was unlikely to be due
primarily to androgen secretion by the male gonad that had
not been aromatised by the placenta to oestrone (Bolte e_t a I
1964a-d) inasmuch as the highest umbilical vein (and
fetal) testosterone levels were found in a pregnancy with
only female fetuses. Also, in 2 other pregnancies with
only female fetuses, testosterone levels were similar to
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those with male fetuses.
This contrasts with the situation found in
man and rhesus monkey. Although the placenta secreted
androstenedione and testosterone to the fetus (Lamb,
Mancuso, Dell 'Acqua, Wiqvist and Diczfalusy, 1967), the
bulk of the fetal testosterone in the male is from the
fetal gonad. This results in a significant sex diff¬
erence in testosterone levels at least during the period
of sexual differentiation (see reviews) which is abolished
by fetal castration (Resko, Malley, Begley and Hess, 1973),
This difference either disappears in late gestation or is
of small magnitude (Resko, 1970; Abramovich, 1974; Forest,
Cathiard and Bertrand, 1973; Diez D'Aux and Murphy,
1974; Reyes et al, 1974; Dawood and Saxena, 1977),
The relatively small amount of testosterone
in the female fetal rhesus was attributed to other sources,
such as the placenta and peripheral conversions of andros¬
tenedione (Resko, 1977), Androstenedione-testosterone
interconversions have been reported for the human (Horton
and Tait, 1966; Blaquier et al, 1967), In addition, the
rhesus fetal ovary and adrenal probably contributed to
androstenedione levels (Solomon et al, 1967; Resko, 1977),
These factors may also have a role in the fetal
marmoset. Relatively high fetal androstenedione values
were found and a conversion factor similar to the human
could account for all of the circulating testosterone.
There may be increased fetal adrenal androgen
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secretion, particularly androstenedione, at 90-100 days
of pregnancy. Marmoset fetal adrenal cultures secreted
androstenedione after 90 days of gestation (Chapter 5).
Also, androgen levels increased only in the fetal compart¬
ment bg-V not^the maternal compartment; and androstenedione
we"'®'
fetal serum values^generally higher than umbilical vein
values.
Fetal androgens, of adrenal origin, are known
precursors for placental aromatisation to oestrogens
(reviews: Beling, 1977; Levitz and Young, 1977; and others).
Although there was no overall correlation between androgen
and oestrogen values, the animals with apparently high
androgen values also had unusally high oestrogen values.
Also, androgen which was not aromatised to oestrogen in
the placenta may be secreted to the fetus (Bolte et al,
196 4a~d)o
A small source of testosterone in the) fetal
male that was not in the fetal female, presumably the fetal-
test is, was however suggested in the present study. -
Although there was no overall sex difference, testosterone
levels were higher in male fetuses compared to their female
counterpart in pregnancies in which both sexes were present.
Males also had higher fetal plasma testosterone values than
umbilical vein values, whereas females more often had
similar or lower values in the fetal plasma than in the
umbilical vein. However, some females did show differences
similar to those in the male and more data would be necess¬
ary to confirm these results. . Marmoset testis also
secreted large quantities of testosterone in vitro after 90
is?"
days of gestation, whereas no testosterone was measure-
able in fetal ovarian cultures (unpublished observations).
Although appreciable quantities of testosterone were
secreted in vitro at 90 days of gestation, amniotic fluid
and fetal serum levels were low. Gonads were cultured in.
the absence of exogenous hormones, and these hormones may
alter gonadal production and secretion of androgen
(Matsumato, Mahajan and Samuels,'1974; Kalla, Nisula,
Menard and Loriaux, 1980). Also, there may be testoster¬
one contained within the gonad prior to its detection in
the fetal serum as in the human (Reyes, Winter and Faiman,
1973; Winter et al, 1977). Thus it seems likely that
although there probably is a fetal testicular component
to testosterone levels, it is low compared to other sources
in the fetus. Any secretion earlier in gestation was
insufficient to be reflected in the amniotic fluid,
which is unlike the human and rhesus (see reviews)-> species
in which all other hormonal levels tended to be lower than
those in the marmoset. In fact, although fetal testoster¬
one levels may appear relatively high compared to those
in the human and rhesus, they are relatively less elevated
than are the fetal oestrogen and progesterone values
compared to these species. A comparison of the amniotic
fluid values illustrates this point (Table 6-9).
The increase in androgen levels in the fetus
coincided with the increased levels of other steroid hor¬
mones. This temporal relationship may be important. As
seen in Table 6-9, relative to other hormonal levels, the
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Table 6-3 Comparison of the hormonal concentrations in
the amnniotic fluid for the human, rhesus and marmoset.
Data was obtained from Warne et al, 1977; Dawood, 1977;
Nagamani et al, 1977 for the human, Challis et al, 1977a
for the rhesus and the present study for the marmoset.
P4 - progesterone, OE2 = oestradiol, OE^ = oestrone,
A = androstenedione, T = testosterone.
' P4 0E2 0E1 A T
Human 5^69 1.2-3.1 2.5-4.4 0.01-1.02 0.01-0.73
Rhesus 0.5-1.4 0.05-0.2 0.05-1.2 0.1-1.3
Marmoset 32-650 0.7-34 1-89 0.8-45 0.2-1.5
fetal marmoset is not exposed to particularly high tes¬
tosterone levels„ However, if fetal testosterone levels
increased prior to day 90, the marmoset fetus would be ex¬
posed to comparatively high levels0 A coincident eleva¬
tion in progesterone and oestradiol may be important as
antagonis-Hio actions of these 2 hormones have been shown
in several instances (reviewedj_ Resko,1974; 1977), Resko
also suggested that the ratio of androgen to antiandrogen
may be important in sexual differentiation and there was
a significant sex difference in the testosterone to prog¬
esterone ratio in the rhesus„ Although there was some
overlap overall, there was a significant sex difference
in this ratio in the marmoset' in pregnancies with both
male and female fetuses„ The coincident rise in oestrogen
may be important also as there may be an oestrogen-
mediated rise in binding proteins which may inactivate
much of the circulating testosterone(Pearlmen et al,1967)
Since testosterone has been implicated for
certain aspects of fetal sexual differentiation in
other primates (reviews;Sect06„1), the similarity between
male and female fetuses in androgen profiles suggest that
either testosterone does not have a comparable role in
the marmoset, or that other factors are relevant„ These
factors may include, in addition to the hormonal onSs
discussed above, that there is a local effect on sexual
differentiation prior to day 90, when circulating levels
appear to be low„ Females may differ from males in their
critical period for sexual differentiation and it may
occur prior to the increase in circulating testosterone
levelso Females may .differ in their threshold of
sensitivity to androgen and/or ability to convert it to
its more active metabolites* The placenta may also
serve a protective function by converting androgen to
oestrogen (Ryan et al, 1961), Certainly androgen levels
are comparatively low whereas oestrogen levels are
comparatively high.
Although there is pre-natal anatomical sexual
differentiation, the marmoset may also undergo a post¬
natal period of sexual differentiation (Abbott, 1979)
The relative role of pre- and post-natal behavioural sexual
differentiation was not ascertained and there have not
been comparable studies in other primates to assess whether
the marmoset is unusual among primates in this respect„
The marmoset may be unique in its hormonal method of
imprinting sexual differentiation because of its unusual
embryology* Dizygotic twinning is very common and yet
despite the early development of a shared placental
circulation and haemtopoietic chimesism, females born
cotwin to a male are totally unaffected (See Chapters*5-5
and 6-1 for references)* This study has further shown
that male and female fetal marmosets develop normally
in a similar androgen environment* Whether marmosets can
be masculinized in vivo by androgen administration
during critical periods of development, such as has been
done in other species, is not known (human : Wilkins,
Bongiovanni; Clayton, Grum .bach and Van Wyk, 1955; Wilkins,
1960; rhesus; VanWagenen and Hamilton, 1943; Goy,
Wolf and Eisele, 1977; sheep: Short, 1974; Clarke,
Scaramuzzi and Short, 1977)*
Phillips (1969) found no effects when androgen
a Q°[
was administered to pregnant females, but the dosages
used were low and infrequent and the stages of
gestation were not given. (See also Chap. 8).
(d) LH/CG
CG is widely implicated as having a role
in stimulating fetal testicular testosteone secretion,
and its pattern during pregnancy has been correlated
with sexual differentiation (see reviews Section 6-1).
The earliest sexual differentiation in the marmoset
probably occurs around 70-80 days of gestation when
maternal peripheral LH/CG levels in the maternal plasma
are still high but beginning to decline. Amniotic fluid
LH/CG levels were not measurable. ^ at this time, which is
perhaps not surprising in view of the large concentration
gradient found in the human between the maternal and
fetal compartment (Reyes et al, 1974; Geiger, Kaiser and
Franchimont, 1971). But unlike the human and rhesus,
maternal LH/CG had declined to low levels and amniotic
and fetal LH/CG levels were unmeasurable when interstitial
cells and testosterone appear between 90-100 days of
gestation. Gonadal development and testosterone secretion
possibly occurs later in gestation relative to maternal
CG values than is found in the human. In the human, levels
of hCG are high enough throughout gestation in the fetal
circulation to maintain testicular steroidogenesis (Clements,
Reyes, Winter and Faiman, 1976; Kaplan and Grumbach, 1978),
whereas in the rhesus, at least in the latter part of
gestation, a more likely gonadotrophic stimulus was
7.^0
suggested to be the fetal pituitary (Hodgen, Niemann and
Tullner, 1975). The assay used in the present study may
not be sensitive enough to measure low levels of
marmoset fetal LH/CG and to elucidate the gonadotrophic
control of gonadal development in the marmoset,it
would be desirable to have assays that fully distinguish
between marmoset LH and CG„ It would also be necessary
to confirm gonadal hormone secretion in relation to the
stage of gestation, to gonadotrophin stimulation, and
to gonadal development,, The gonadal tissue obtained from
the timed pregnancies in this study have yet to be fully
analysed.
6.5 Chapter summary
(1) All hormonal values in "the amniotic fluid and
umbilical vein increased at 9"0 to 100 days of pregnancy
coincident with the increased placental content of all
these hormones and with the increased maternal peripheral
progesterone and oestradiol levels. Fetal serum hormonal
values were also elevated at day 100, and it was suggested
that a coincident increase in hormonal levels may be
physiologically significant.
(2) Fetal serum values and the hormonal ratios were
dissimilar to those in the maternal peripheral plasma.
All fetal serum values, except oestradiol, were higher
than those in the maternal peripheral vein. Like other mcui-O
species, the fetal oestradiol to oestrone ratio shifted
in favour of oestrone.
(3) Hormonal values in the amniotic fluid changed
independently of each other and except for testosterone
and oestrone, were not correlated with the fetal serum
values. None of the amniotic fluid hormonal values
correlated with the maternal peripheral plasma.
(4) Fetal utilisation and production of each hormone
probably varied as indicated by variations in the fetal
serum-umbilical vein relationship.
(5) Overall, male and female fetal marmosets develop
in a similar hormonal environment and any gonadal contribution
to male testosterone levels was probably small compared to
the placental contribution. There was a sex difference for
proge.sterone and testosterone* and for the progesterone
to testosterone ratio between male and female fetuses
within a pregnancy.
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CHAPTER 7 : PLACENTAL AND PRENATAL DEVELOPMENT
7.1 Introduction
Studies on placental and prenatal development have
been confined mainly to man, the rhesus monkey and baboon
(reviews: Tanner, 1978; Hendrickx, 1972, 1971; Schultz,
1956, 1969y and others). Early studies in the Callif-nchidae.
species utilised specimens mainly caught in the wild,
(Wislocki, 1929, 1932, 1938; Hill, 1926, 1932; Hill and
Hill, 1927) and the data from later studies was not gener¬
ally associated with a precise gestational age (Phillips,
1976; Hampton, 1975). These studies suggested that the
embryology of the marmoset was unusual and that the time¬
table of embryonic development may be different from other
primate species.
Does the marmoset have a distinct prenatal growth
pattern from other primates or does it fit in with some
of the generalised concepts of prenatal development? How
does the prenatal development timetable relate to the
hormonal changes occurring during pregnancy? Can a set
of growth standards be established for utilisation by other
investigators? In order to answer these questions, a sys¬
tematic study of prenatal development was undertaken in
conjunction with the hormonal studies already reported.
7.2 Procedures
Samples were obtained following hysterotomy (chapter
2.61.- The sampling regime was given in Chapter 2.7.
2^2)
(a.) Placental measurements
There were two placental discs in every preg¬
nancy. Each disc was weighed and measured separately.
The major (a) and minor (b) axes were measured and the
placental area was estimated using the formula for an
oblate spheroid, A ab^.
H
(b) Embryonic and fetal measurements
All measurements were taken 2-3 hours follow¬
ing removal of the feto-placental unit. Measurements
were taken prior to fixation in specimfins after 80 days
of pregnancy. Embryos before day 70 of pregnancy were
fixed in 10% buffered formalin just prior to measurement.
The dimensions of the yolk sac (length x width)
were taken between 30 and 100 days. The length, width and
thickness of the 30 day embryo was taken from post-fixation
sections. The greatest length (day 40) or crown-rump
length of 50-80 day embryos was taken in their natural
position using a grid under a dissecting microscope (Wild
M5 stereo dissecting microscope). Crown-rump length of
fetuses more than 90 days old was taken with calipers.
19 other body dimensions were taken and some measurements
were calculated from these basic measurements (Table 7-1).
A diagramatic representation of those measured (based on
the human fetus) is shown in Figure 7-1. These skeletal
measurements were possible only after 90 days of pregnancy.
The definition of these measurements is given in full
detail by Schultz (1929) and the techniques used were similar.
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Table 7-1. Body measurements (taken according to the
technique of Schultz, 1929) and calculated measurements.




2. Trunk height (T.H.)
3. Shoulder breadth (S.B.)
4. Hip breadth (H.B.)




6. Thigh' length (T.L.)
7. Knee heel (K.H.)
8. Leg length (L.L.)
9. Foot length (F.L.)
10. Upper arm length (U.A.L.)
11. Forearm length (F.A.L.)
12. Hand length (H.L.)
HEAD
13. Head width (H.W.)
Head length (H.L.)
14. Head height (H.H.)
15. Total face height (T.F.H.)
16. Upper face height (U.F.H.)
Tail length
CALCULATED MEASUREMENTS:
(U.L.L.) Upper limb length
(L.L.L.) Lower limb length =
(A.H.D.) Average head diameter
2SS
U.'A.L. + F&L. + H.L.
T.L. + K.H.
- (H.W. + H.L. + H.H.) v 3
Fig. 7-1: Diagrammatic representation of measurements.
Human fetus with skeletal parts shown on the right halfof body. The numbers refer to the particular measure¬
ment. (See Table 7-1.)-(taken from Schultz, 1929)
A
The accuracy of the measurements was assessed in 2 instances
by triplicate determinations' (taken on the same day). The
coefficient of variation was less than 6% in all cases.
All body and organ weights were taken on an
Oertling balance which weighed to the fourth decimal place.
The body weight was taken after 70 days of gestation and
organ weights after 80-90 days.
Most results are presented as mean values for
each pregnancy as there was little difference between
fetuses within one pregnancy and there was no apparent
sex difference in any of the measurements. The timed
pregnancy at 100 days consisted of triplets, one fetus of
which was abnormal in appearance and size. Mean values
for the 2 normal fetuses have been given and where applic¬
able, individual values from the abnormal fetus.
(c) Birth and adult measurements
Body weight and dimensions were taken on 4
sets each of normal triplets and twins on either the day
of birth or on day 1. Newborn organ weights were taken
from still births or from animals dying within 1 day of
birth.
Adult body weight and dimensions were taken in
6 males and 6 females more than 500 days of age. The ani¬
mals were anaesthetized with 0.4ml of Saffc^p prior to
measurement.
Adult organ weights were taken from autopsy
records of 7 males and 7 females. (S.F.Lunn, pers'1 commun.
Animals with obvious organ abnormalities or infections were
^.°n
excluded. The body weight of these animals was lower
than the mean colony body weight.
The singleton, twin and triplet birth weight
and the adult body weights used in this paper are the
mean from 20, 226, 122 and 64 animals respectively.
(S. F. Lunn, pers comm )
7. 3 Results
(a) External description
The data for the individual embryos from timed
pregnancies between 30 and 80 days CJne given in Table 7-2.
There was a distinct growth in the crown-rump length (CRL)
during the 10 day intervals but individuals within a preg¬
nancy or from the same time in gestation had similar
measurements. The yolk sac was prominent after the 50th
day and continued to increase in size until the 80th day.
By 110 days, only vestigal amounts remained. All embryos
were enclosed by their own amniotic membrane in a common
exo-coelom enclosed by a common chorion.
The axis of the embryonic disc was defined in
the 30 day embryo by the primitive streak. The embryo
measured approximately 0.06 x 0.05 x 0.02cm. in the 40 day
embryo, the neural folds were forming over the cranial
end and the body stalk was prominent at the caudal end.
The greatest length of the embryo was 0.10m.
By 50 days of gestation, there was a marked
cranial and dorsal flexure. 7 to 9 somites and the
neural tube had formed. The optic primordia formed bulges
ZH8


















































in the cranial region and the heart formed a bulge on the
ventral surface. The yolk sac was nearly 3 times the
embryo length.
At 60 days of gestation, there were 3 visceral
arches separated by 3 visceral grooves. The optic
vesicles were on the lateral side of the head and appeared
as opaque circles with transparent centres. The otic
vesicle opened on the surface adjacent to the 1st visceral
groove. The oral fossa were large and opened wide.
Somites were visible from below the otic pit. The cervical
sinus was present in the caudal arch region. The heart
was prominent. There were forelimb buds but no hind linib .
buds. The tail was rounded, blunt, untapered and pointed
cranially.
By 70 days of gestation, the forelimbs had
differentiated into hand and arm regions and were starting
to curve over the body. The hind limbs were beginning to
show division into foot and leg-thigh regions and were
pointed craniomedially. There were no digital rays. The
cervical flexure was approximately 30°. The heart was
comparatively large. The mandibular and hyoid arches were
prominent. There was no development of the external
acoustic meatus. Retinal pigmentation was beginning.
At 80 days of gestation, there was no cervical
flexure. The limbs had lengthened with the. hands over¬
lapped and palms pointed caudally. The interdigital
tissue between the fingers and toes had decreased. The
eyelids had developed and covered approximately two-thirds
3O0
of the eye. The tragus and antitragus were evident in
the auricle. The tail was pointed.
The external features had more fully devel¬
oped by 90 days of gestation. The ear had developed,
the nasal palate had closed, the nose and mouth were
separated. By 100 days of gestation, hair follicles
were beginning to appear, particularly around the face.
Nails and teeth had developed. By 110 days of pregnancy
hair follicles were evident over the whole body. Fur
growth had started by 120 days of gestation. By 130 days
of pregnancy, the fetus resembled a newborn marmoset.
The attachment of the fetus to the placental disc
varied from marginal to central. In some instances the
umbilical veins divided before reaching the placenta. The
umbilical veins from the fetus attached to one or both of
the placental discs or even to the placental anastomoses.
A placental disc may have had 0 to 3 fetuses attached to it.
(b) Placental growth
There were 2 placental discs present in every
pregnancy which were connected by prominent blood vessels.
The attachment of the placental discs to the uterine wall
was dorsal and vential.
There was no obvious primary and secondary
placental disc as the 2 discs were similar in size and
weight. The mean percentage of the size and weight of
the smaller disc to the larger disc was. 93.4 ± 6 (s.d.
n = 25) and 93.0 t 5 (s.d., N = 25) respectively. In
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pregnancies in which there were a different number of
fetuses attached to each placental disc, the 2 placental
discs did not show any greater difference in size or
weight (range 88-98%) than those with an equal number of
fetal attachments (range 88-100%).
The total placental weight and area from all
pregnancies between 30 and 140 days of pregnancy is shown
in Figure 7-2. The placenta was approximately 25% heav¬
ier and 40% larger from a triplet than a twin pregnancy.
The placenta (2 discs) obtained from a singleton pregnancy
was lighter and smaller than from a twin pregnancy.
The increase in placental weight (Figure 7-2a)
followed a sigmoid cvJTve. The maximum increments in
weight gain (1-1.5g /10 days) were found between 60 and
90 days of gestation and thereafter declined to 0.15gm/10
day between 130 and 140 days of gestation. The rate of weight
gain was maximal at the earliest period in gestation, declin¬
ing from 757g /g /10 days between days 30 and 40 to
0.023g /g /10 days between days 130 and 140.
The area growth (Figure 7-2b) was greatest and
nearly linear (lOcm^/10 day) between 40 and 90 days of
gestation. It thereafter declined to 4cm^/10 days between
days 130 and 140. The rate of area growth was greatest
at the earliest period of gestation and declined from
23.5mm^/cm^/10 days to 0.5mm2/cm^/10 days.
The percentage of the term (140 days) placen¬
tal growth (in terms of weight) that is achieved at 10
day "intervals during pregnancy is shown in Figure 7-3.
302-
Fig. 7-2: The total placental weight (a) and area (b)
from triplet (o), twin (•) and singleton (a) pregnanc¬
ies. A line has been drawn for the data from the twin
pregnancies.
Days of pregnancy Days of pregnancy
30"2>
Fig. 7-3: The. percentage of the 140 day placental weight
that is achieved at 10 day intervals from 30 days of
pregnancy. A triplet and twin pregnancy each were
obtained at 140 days and the percentage for each triplet
or twin pregnancy was calculated using the appropriate
triplet or twin 140 day placental weight.











50% of its fipal growth was achieved between 70 and 80
days of pregnancy and nearly 90% by 100 days.
(c) Fetal weight
Fetal weight is shown in Figure 7-4. Twins
were heavier than triplets after 130 days of gestation.
A weight difference between triplets, twins and single¬
tons was also found at birth. The body weight increased
throughout pregnancy with a relatively steeper incline
after day 100. The fetal growth was greatest in the last
10 days of pregnancy, increasing from 0.65g /10 days
between day 70 and 80 to 6.64g /10 days between day 130 and
140. The rate of weight gain declined approximately 15
fold with advancing pregnancy, from 4850mgm/gm/10 days
to 320mgm/gm/10 days.
The percentage of the term (newborn) fetal
weight that is achieved at 10 day intervals during pregnancy
is shown in Figure 7-5. Nearly two thirds of pregnancy
is occupied in achieving the First 10% of the ultimate
weight. The achievement of each succeeding decile in
growth takes 10 days or less and 50% of the ultimate
weight is achieved between 120 and 130 days.
The specific growth velocity (<^) of the fetal
marmoset was calculated using the generalised mathematical
formula W^ = cx(t-to). (Huggett and Widdas, 1951) The
cube root of the fetal weight (W^») is plotted against the
fetal age (t) to give a regression line with the slope (<x)
and intercept (t0 ) on the time axis. The data cite plotted
in Figure 7-6 and the formula obtained was 0.039(t-56).
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Fig. 7-4: The mean body weight (grams) of fetuses and
newborns from triplet (o), twin (•) and singleton (a)
pregnancies. B = birth.
Fig. 7-5: The percentage of the newborn' body weight
that is achieved at 10 day intervals during pregnancy.
The percentages for triplets and twins were calculated
using the appropriate triplet or twin birth body weight.
Days of pregnancy
(
Fig. 7-6: The relationship between the cube root of the
fetal weight (grams) and the stage of pregnancy. Triplet
(O), Twin (•) and Singleton ( O ).
Days of pregnancy
The correlation coefficient was 0. 99. ( «jw\ W (x*xd<> "0
(d) Relationship between fetal and placental growth
The placental to fetal weight ratio is shown in
Figure 7-7a. The ratio was highest (5:1) at day 70, fell
precipitously to 1:1 at day 90 and to less than 0.5:1
after day 100. The ratio declined more slowly during the
latter part of gestation and the placenta was about one
tenth of the total fetal weight at day 140.
The weight of the placenta per fetus (Figure
7-7b) was greater for singleton pregnancies than twin and
greater for twin pregnancies than triplet pregnancies.
The more rapid initial growth of the placenta
than the fetus was also shown by the fact that the placenta
reached 50% of its final weight at the same time (about
day 80) as the fetus reached only 3% of its final weight.
(Compare Figure 7-3 and 7-5). Likewise, the slowing of
the placental growth at the end of pregnancy was more
marked because, while the fetus achieved 90% of its final
weight about 1 week before term (day 130), the placenta
achieved nearly 90% of its final weight about 30 to 40
days before term.
(e) Organ weights
Table 7-3 gives the mean organ weight from each
timed pregnancy from 80 to 140 days of gestation. The
mean birth and adult organ weights are given in Table 7-4.
There was an increase in organ weight with increasing fetal
age and weight. With the exception of the brain and lungs,
308
Fig. 7-7: (a) The ratio between the total placental
weight and the total fetal weight in triplet (o), twin
(®) and singleton (□)• pregnanoies.
(b) The weight (grams) of placenta per fetus




























































































































































































































Table 7-4. The mean (± s.d) birth (N = %) and adult
(N = IH ) organ and body weights (grams).
Organ Birth Adult
Brain 3.817 ± 0.240 7.12 ± 0.44
Liver 1.633 1 0.489 15.2 z 5.4
Lungs 0.557 ± 0.178 2.68 ± 0.59
Thymus 0. 076 ± 0.0245 -
Heart 0. 334 ± 0.085 1.84 ± 0.43
Spleen 0.027 ± 0.006 0.324 ± 0.157
Adrenals . 0.091 ± 0.014 0.1816 ± 0.064
















287 + 46 (N=64)
3\\
the largest increase in fetal organ weight increments
was between 120 and 140 days of gestation. The maxi¬
mum weight increment in brain and lung growth was at 100
to 110 days. In contrast, the maximum growth rate was
always during the earliest period measured, which was 80
to 100 days of gestation. \
The percent of the total body weight accounted
for by each organ (relative growth rate) is given in Table
7-5. The liver was about the same proportion of the total
body weight throughout fetal life. The spleen and thymus
showed an increase and the gonads and adrenals a decrease
in their relative growth rate. The relative growth rate
of the brain, lungs and heart decreased after 110 days of
gestation. Compa.rison of the birth and adult percentage
showed a marked decrease for the brain and adrenals, and an
increase for the testes. The percentage generally decrea¬
sed for the other organs.
Table 7-6 shows the percentage of each organ's
birth weight that is achieved between 80 and 140 days of
gestation. Generally, 50% of the birth weight was reached
by 120 to 130 days of gestation, the same period at which
50% of the fetal body weight was reached. The adrenals
and gonads were 50% of their birth weight relatively earl¬
ier in gestation^ between 100 and 110 days of pregnancy.
Most organs and the total body weight had accomplised
10-20% of the final adult weight by full-term gestation.
The exceptions were the brain and adrenals, which were more
than 50% of their full adult size, and the testes which were
only 2%.
3\7-






















































































































































































































































































































































(f ) Body dimensions
(i) Crown-rump length
The crown-rump length (CRL) from day
50 to 140 of pregnancy and at birth is given in Figure 7-8.
There was very little difference (less than 3%) between
the crown-rump length of fetuses from twin and triplet
pregnanci'es. The difference was not significant at birth.
The maximum growth increments were found between 70 and
110 days of gestation. The mean increase during this
time period was 1.2 - 0.15cm/10 days (s.d.),. Between 50
and 70 days and between 110 and 140 days, the increment
in growth was from 0.38 to 0.70cm/10 days. The rate of
growth is greatest early in gestation. There was approx¬
imately a 25 fold decline in the rate from 14.7mm/cm/10
days at 50 to 60 days to 0.63mm/cm/10 days at 130 to 140
days.
There was a linear relationship between
the CRL and the cube root of the fetal weight (W^>). The
y
regression line was y = 0.38x + 0.09 (y = WJ, x = CRL) and
the correlation coefficient was 0.95 (n-15).
( ii ) Trunk, limb and head measurements
The trunk, limb and head measurements from
90 to 140 days of pregnancy are given in Table 7-7, The
birth and adult measurements are given in Table 7-8. All
fetal dimensions increased with advancing gestation. The
maximum increment in growth per 10 day interval was found
between 90 and 120 days of gestation in all 20 actual mea¬
surements and in the 3 calculated measurements. In 10 of
3\S
Fig. 7-8: The mean crown-rump length (CRL) of fetuses
and newborns from triplet (o), twin (•) and singleton
(a) pregnancies. B = birth.
Table 7-7. The mean trunk, limb, head and tail measure¬
ments (cm) in fetal marmosets from 90 to 140 days of
gestation from timed twin (TW) and triplet (TR) pregnancies.
* gives a composite measurement calculated from individual
measurements (see Table 7-1 for abbreviations). The
pregnancy at 100 days consisted of 2 apparently normal and
1 abnormal fetus. The mean of the 2 normal fetuses is
given on the left and of the abnormal fetus, on the right.
Day of Gestation
Measure- 90 100 110 120 130 140
ment TR TR TR TW TR TW TW
TRUNK
C.R.L. 3.50 3. 35 4.57; 2.70 5. 85 6.42 7.25 7. 70
T.H. 1.85 1.90 2.70; 1.62 3.42 3.77 4.27 4.70
S.B. 0.83 0. 84 1.17 1.50 1.83 1.90 2. 05
H.B. 0.48 0.50 0.75 0.90 1.06 1.25 1. 45
C.B. — 0. 62 0. 75 1.01 1. 15 1.30 1. 45
C.D. — 0.63 0.80 1.08 1.29 1.49 1.58
C.C. - 2. 10 3.20 4.60 4.60 4.95 5. 10
LIMB
T.L. 0.68 0.67 1.07; 0. 70 1.40 1.67 1.95 2.15
K.H. 0.62 0.61 1.07; 0.65 1.31 1.67 1.95 2.27
L.L. — 0.54 0. 99 1.10 1.53 1.75 2.10
F.L. 0.61 0.60 1.05 1.50 1.97 2.29 2.60
U.A.L. 0. 73 0.73 1.12 1.45 1.65 1.98 2.50
F. A. L. 0.65 0.66 1. 00 1.32 1.55 1.80 2.05
H.L. 0.43 0.46 0.84 1.20 1.60 1.64 1.67
#U.L.L. 1.81 1.85 2. 36 3.97 4.80 5. 42 5.79
*L.L.L. 1.30 1.28 2. 14; 1. 35 2.71 3.34 3.90 4.42
HEAD
H.W. 0.90 0. 93 1.23; 0.68 1.51 1.63 1.80 2.02
H.L. 0.19 1. 18 1.55; 0.88 1.90 2.30 2.67 2. 77
H.H. 0. 90 0.90 1.13 1.15 1. 45 1.66 1.65
T.F.H. — 0.41 0.50 0.75 0. 83 0.90 1.00
U.F.H. — 0. 30 0. 37 0.45 0. 53 0.58 0.60
♦A.H.D. 1.00 1.00 1.30 1.52 1.79 2.04 2.14
Tail 1.91 3. 70 5. 75 7.23 8.70 9.70
length
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Table 7-8. The (±s.d.) trunk, limb, head and tail
measurements (cm) in newborn marmosets (N = 8; Day 1)
and adults (N = 12). * gives a composite measurement
calculated from individual measurements (see Table 7-1).
Measurement Birth Adults
TRUNK
Crown-rump 7.70 + 0.40 20. 36 + 0.60
Trunk height 4.81 + 0.41 12.54 + 0.91
Shoulder breadth 2. 40 + 0. 10 4.66 + 0.23
Hip breadth 1.52 + 0.07 3.73 + 0. 16
Chest breadth 1.65 + 0.07 3.95 + 0.29
Chest depth 1.61 + 0.08 4.32 + 0. 35
Chest circumference 5.50 + 0.80 12. 62 + 1.31
LIMB
Thigh length 2. 18 + 0. 10 6. 45 + 0.32
Knee heel 2. 36 + 0.11 6.60 + 0.21
Leg length 2.17 + 0.08 6.18 + 0.27
Foot length 2.83 + 0.12 5.56 + 0.27
Upper arm length 2. 15 + 0.09 5.31 + 0.21
Forearm length 2.00 + 0.08 4.89 + 0.26
Hand length 1.80 + 0.12 3.76 + 0. 18
* Upper limb length






Head width 2.00 + 0.08 3.15 + 0.82
Head length 2.93
a.
0.06 4.29 + 0. 10
Head height 1.85 + 0.10 2.00 + 0.15
Total face height 1.01 + 0.20 1.68 + 0.53
Upper face height 0.61 + 0.10 1.08 + 0. 12
* Average head diameter 2.26 + 0.08 3.15 + 0.07
Tail length 9.9 + 1.01 25. 3 + 1.9
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of the 20 actual measurements and in all 3 of the calcu¬
lated measurements, the maximum increment was found bet¬
ween day 90 and 100. The growth increment from 130 to
140 days of gestation was a mean of 48.1 ± 6% (s.e.rv\.
n=20) of each measurement's own maximum growth increment.
A combination of smaller growth incre¬
ments and increasing body size with advancing gestation
resulted in a marked decline in the rate of growth between
90 and 140 days of gestation. The mean decline in the
rate was 6.1 t 2 (s.d.) fold between 100 and 140 days.
Table 7-9 shows the mean percentage of
the trunk, limb and head birth body dimensions that was
achieved at 10 day intervals from day 90 to 140. By 100
days of gestation, the fetal body dimensions achieved about
one half of their birth size. The head measurements
reached a larger percentage of their birth size earlier in
gestation and at birth was substantially larger compared
to its ultimate adult size thcvn the trunk or limb measure¬
ment .
7;4 Discussion
(a) Standards of growth
This chapter gives the first report on normal
prenatal growth and development in the marmoset which util¬
izes material from pregnancies in which the stage of gesta¬
tion was accurately determined by the post-ovulatory rise
in progesterone.
3\c\


















































































Probably the most commonly used and easily
measured parameters of fetal growth are the fetal weight
and crown-rump length (Watts,.1977). The present study
indicated a clearcut demarcation in these measurements
for 10 day intervals of pregnancy, a linear relationship
between the 2 measurements, and a linear relationship
between the weight (to the Jg power) and gestational age.
Consideration should be given to the number of fetuses
present for later pregnancy for the weight measurements.
Although crown-rump measurements showed considerable
variability with the developmental horizon during early
pregnancy in the human (Streeter, 1951; Nishimura, Takano,
Tanimura and Yasuda 1968), crown-rump measurements in the
marmoset were similar in timed pregnancies from the same
stage of gestation. Combined with a study of the external
characteristics, these parameters should prove to be a
fairly accurate guide to the stage of gestation.
The value of having a standard of prenatal
growth that can be easily utilised by other investigators
has already been evident in this thesis. There is consid¬
erable literature on various aspects of marmoset development
but other than stating early, mid and late pregnancy, it
was not possible to interrelate the various studies or to
relate them to the new work being done on the marmoset.
Application of these standards allowed data on adrenal and
gonadal development, embryonic and placental development,
to be correlated to a gestational age and related to the
hormonal changes occurring during pregnancy as outlined
in this thesis. Furthermore, gonadal, adrenal and
placental tissue was preserved from the timed pregnancies
taken in this study for future histological examination
to supplement the existing observations.
(b) Placental and fetal development
In all cases in the present study, 2 plac¬
ental discs of similar size and weight were found whether
there were 1, 2 or 3 fetuses. The presence of 2 placen¬
tal discs nearly equal in size, even in the case of a
singleton, was suggested by Hampton (1975) to be the res¬
ult of the large blastocyst enlarging and completely filling
the uterine lumen before invasion of the uterine tissue
begins. Fusion of the placental discs must occur
during the initial stages of development as there were
only 2 discs even in the case of triplets. The present
study also confirmed previous reports of the embryos
being situated in a common exo-coelom enclosed by a common
chorion. Chorionic fusion of the twin placenta was obser¬
ved in at least 3 species of the Callitr^t .c:Y\c(.ae - The
Golden Lion marmoset (Leontocebus rpsalia) (Benirschke and
Layton, 1969), the Geoffroy rs tamarin (Oedipomidas geoffroyi)
(Wislocki, 1932; 1938) as well as the common marmoset
(Callithrix jacchus) (Hill 1926, 1932; Hill and Hill 1927).
Chorionic fusion occured very early in gestation, prior to
the bilaminar disc stage (Hill, 1932), which is earlier in
pregnancy than any of the stages examined in this study
(4.30 days of pregnancy).
2TL2.
Fetal attachments are generally reported to
be either with both fetuses attached to the same placental
disc, which presumably was the result of both blastocysts
implanting side by side; or with fetuses attached to
different placental discs, which resulted from each blasto¬
cyst implanting on a different uterine surface (Wislocki,
1929; Hampton, 1975; Phillips, 1976). Similar findings
were made in the present study but in addition, some fetuses
also appeared to be attached to both placental discs.
Interplacental and even interfetal attachments of the
umbilical vein after an initial surface connection on the
fetal surface of the placenta wgte previously reported by
Hampton (1975). The data in the present study encompassed
more pregnancies from later stages which may account for
the present observation.
The marked abnormal development of one of the
three fetuses at 100 days of gestation is not an unusual
finding. Similar observations were reported by other
authors and in our own colony of animals (Wislocki, 1939;
Hampton and Hampton, 1965) (S. F. Lunn, per v comm ).
Fetal death and resorption of the fetus was also indicated
by the finding of blood chimerism in isosexual twins and
in single born animals. Presumably a second or third
embryo, opposite in sex to the other 2, died and was
resorbed after contributing hemopoietic stem cells to its
littermates (Gengozian, Batson, Greene and Gosslee, 1969-;
Gengozian, 1971; Gengozian and Patton, 1972).
(I) Fetal and placental weight
This study showed that unlike the
human, there was no slowing down of growth in the last
weeks of gestation, which resulted in a sigmoid growth
curve for the human fetus. (Hendricks, 1964; Gruenwald,
1966; Brenner, Edelman and Hendricks, "1976). In
fact, for the marmoset, the weight increments were great¬
est during the last 10 day interval sampled during preg¬
nancy (day 130 to 140). Abbott (1979) has further
shown that for the marmoset, the weight increments continue
to increase for the first 100 days following birth.
In the human, a comparison of the pre-
and post- natal growth curves showed a post-natal resump¬
tion of the linear period' of growth that was seen from
30 to 36 weeks of fetal life (McKeown and Record, 1953;
Tanner, 1978). Therefore, a restriction to fetal growth
was implied during the latter weeks of pregnancy. Several
factors were suggested to influence fetal growth (reviews
include: Dawes, 1976; McKeown, Marshall and Record, 1976);
one factor being the placental size. There was a corre¬
lation between placental and fetal weight for the human
(Dawes, 1968? Aherne, 1966) and experimental reduction of
the placental mass in sheep caused a reduction in fetal
weight. (Alexander, 1964.)
In the marmoset, there was not sufficient
data to correlate placental and fetal weight but like the
human, (McKeown and Record, 1952) there was less placenta
available to a triplet fetus than a twin, and triplet
fetuses weighed less than twins. The relative placental-
fetal growth pattern was also similar to the human and
rhesus as the ratio declined with advancing gestation and
a greater percentage of the placental birth growth was
achieved earlier in gestation than the fetal growth.
However, at birth, the placental-fetal ratio in the mar¬
moset (1:10) was lower than in the human (1:5) (Hendricks,
1964; Aherne, 1966) and rhesus (1:3) (van Wagenen and
Catchpole, 1965; Kerr, Kennan, Waisman and Allen, 1969;
Kerr, Allen, Scheffler and Couture, 1974) and it is likely
there are additional factors which may be a better
index of placental function (McKeown et al, 1976). These,
other factors may well be of greater relevance but are
more difficult to assess .and for the present, the weight
relationship remains the main means of interspecies com¬
parison.
(ii) Fetal growth velocity
The majority of mathematical formula
relating fetal weights to gestational age involve a linear
relationship between time (t) and a cube or higher root
(n) of the fetal weight (W). Growth in several species
follows nearly a cube-root relationship. Formula of' the
n y
nature W = <x(t-t0) or W3 = K(t-t0) are used for inter¬
species (Huggett and Widdas, 1951; Payne and Wheeler, 1967)
and intraspecies (Spencer, Coulombe and van Wagenen, 1966)
comparisons of fetal growth. The slope of the linear
relationship (t*0 was termed the specific growth velocity
(Huggett and Widdas, 1951), and characteristic values of <*•
12.S
were shown for particular species.
Comparison of the specific growth veloc¬
ity of different mammalian fetuses showed that there was
a clear-cut grouping of the primate, sub-primate and
Cetaceop species and that the marmoset fitted in with the
proposed primate grouping (see Figure 7-9). The contin¬
uous lines on this graph were suggested to represent the
limits of natural variation for land mammals. The present
data suggested that perhaps this limitation should be
slightly extended as calculation of the marmoset's specif¬
ic growth velocity-(0.039), although placing it within
the primate grouping, was the lowest value of c<. yet reported.
It should be noted that several of the values in this fig¬
ure were calculated from the weight at birth and estimation
of to and some errors may be caused by this estimation.
(iis) Fetal, birth and adult weight relation¬
ships
By birth, the marmoset vfs a percentage
of its adult size which would be expected for a species of
this size. The marmoset twin fetuses were a higher per¬
centage (20%) of the maternal body weight compared to other
primates (e.g. squirrel monkey: 16%, Goss, Popejoy, Fusiler
and Smith, 1968; rhesus monkey: 8%; man: 6%; reviewed:Leitch,
Hytten and Billewicz , 1959). This finding was to be
expected as the logarithms of maternal and newborn weights
have a straight line relation from bats to whales (Leitch
et al, 1959) and even among a subgrouping of the anthropoid
primates (Leutenegger, 1973). The marmoset wis well within
32b
Fig. 7-9: Plot of cube root of birth weight against ges¬
tation time less estimate of to• Continuous lines
through the origin indicate the range of values of
(chart from Huggett and Widda$> 1951^
Table 1. Formulae from published intrauterine weights and ages:
ll'l =0-102 (1-8) Mouse
W'l =0-17 (1 - 11) Hat
H'i =0-20 [I- 12-5) Rabbit
ll'l =0 00 (1 - 10) Guinea-pig
11*1 =0147 (1-37) Sheep
ll'l =0-145 (1-50) Cow
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the normal range and as a general rule, the smaller sized
species, have relatively larger newborns than larger
sized species.
At birth, organs were a similar percen¬
tage of their adult weight in the marmoset as in the
rhesus and human (rhesus: Kerr et al, 1969, 1974; Kerr and
Waisman, 1970; human: Schulz, Griordamo and Schulfe, 1962;
Gruenwald and Mint), 1960 and others). In all these species
the brain and adrenal were relatively large at birth.
The relatively large size of the adrenal in these other
species persisted only for a short time due to the involu¬
tion of the 'fetal zone' following birth (Schulz et al,
1962). Benirschke and Richart's (1964) observations on
the histology of the marmoset adrenal gland indicated a
comparable explanation fof the marmoset. Lanman (1957)
confirmed the high adrenal-body weight ratio at birth in
closely related tamarin species.
The actual percentage of the adult
brain growth achieved by birth varied between species.
The percentage for the marmoset (54%) was intermediate
between the rhesus (68%) and the human (30%). How this
overall interspecies comparison relates to the growth of
the different parts of the brain, which have different
functional significance, is only known from limited data
on the human (Tanner, 1978).
Some reservations must be kept in mind
regarding the organ weights. An organ may be difficult
to separate from surrounding fat and connective tissue.
Fluid or blood may be sequestered in the lungs. In the
present study, heart blood was removed for hormonal mea¬
surement. Small organ weights would be more susceptible
to weighing errors. Whereas fetal organ weights were
taken soon after hysterotomy, newborn and adult organ
weights were generally taken an unknown time after death.
Also, these animals generally died from unknown causes,
and may not be entirely normal.
(IV) Trunk, limb and head measurements
Similar to the human (Tanner, 1978) and
rhesus (van Wagenen and Catchpole, 1965), the peak in len¬
gth gain preceeded the peak in weight gain in the marmoset.
Also, by birth, the body dimensions were a larger percen¬
tage of their adult growth than the body and organ weights.
However, like all other species, the maximum growth rate
per unit of measurement was greatest at the earliest
stages studied for both the body dimensions and body
weights.
Possibly related to the relatively larger
percentage of brain growth achieved by birth, was the
relatively larger percentage of adult head size achieved
by birth". This was a common finding among primates
(Schultz, 1941, 1956). Head size may be an important
factor in the successful delivery of the young. The rel¬
atively large cranial dimensions of the squirrel monkey
(Leutenegger, 1970a,b) results in a difficult delivery
(Bowden, Winter and Ploog, 1967; Hopf, 1967). Leutenegger
(1973) suggested that the combination of the two factors of
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a relatively large fetal to maternal size and relatively
large head to body size in the marmoset resulted in new¬
born cranial dimensions that were quite large compared to
the maternal pelvic inlet dimensions and constituted a
strong reason for the production of multiple offspring in
callit)H'tV\ids. In other words, if singletons were regularly
produced, the negative allometric relationship generally
found for the above two factors would result in an over¬
sized fetus, which would be difficult to deliver.
(c) Temporal relationships of prenatal development
It was previously suggested that the marmoset
may have a lengthened embryonic period relative to other
species (Phillips, 1976). Further analysis of the gonadal
development data of Hampton and Taylor (1971) also indicated
a relatively later onset of fetal sexual differentiation.
(See Chapter 6). It was also suggested that there was not a
sustained rise in progesterone and oestradiol in the
peripheral plasma (Chapter 4) and that the placenta did
not assume a major role in hormone production (Chapter 5)
until later in gestation when compared to the human. The
data in this chapter will be utilised to show that prenatal
development is also slower during the first part of pregnancy
compared to other primate species.
Comparison of the percentage of birth growth
achieved at various stages of gestation showed that the
marmoset did not achieve 50% of its birth size until relat¬
ively late in gestation (Figure 7-5 and Table 7-6,9). An
interspecies comparison for the crown-rump length and
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body weight is shown in Figure 7-10. Halfway through
gestation, approximately day 70, the marmoset lags behind
the growth achieved by these other species and it is not
until more than three quarters of gestation is completed
observation on long bone growth in another fJew World
primate, the squirrel monkey, suggested that this species
may also achieve a lower percentage of its birth size
compared to the rhesus monkey when 50% of gestation is
completed (McKim, Hutchinson and Gavan, 1972).
Comparison among the primates in the initia¬
tion and duration of the embryonic period was presented
by Hendrickx, Sawyer, Lasley and Barnes (1975). A summa¬
tion of their data is given in Table 7-11. The embryonic
period was considered to begin with the formation of the
primitive streak and end with the initial ossification of
the humerus. This data shows that although the marmoset
has one of the shortest gestation lengths (only the galago
was shorter) the embryonic period began and ended later in
gestation, with respect both to the number of days of ges¬
tation and the percentage of gestation achieved. The
embryonic period was also of substantially longer duration.
The lengthening of the embryonic period was
probably a post-implantation phenomena as implantation was
estimated to occur around day 10 in the marmoset (Hearn and
Hodges per'l commun.), a similar time as in the human,
rhesus and baboon. The primitive streak stage was approx¬
imately 15 to 20 days later in the marmoset (Phillips, 1976;
that the percentage becomes comparable. A preliminary
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Fig. 7-10: The percentage of the birth crown-rump length
(CRL) and the birth body weight (BWT) achieved 25, 50 and
75% through gestation-. Man (.0) (Streeter, 1920) rhesus
(0) (van Wagenen and Catchpole, 1965), baboon (O)
(Hendrickx, 1971) and. marmoset (■&) (present study).
Percentage of pregnancy
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Table 7-11. The embryonic period (e.p. ) in relation
to the gestation length (G.L.) for several primate
species. Date for all species except the marmoset was
derived from Plendrickxet al, 1975; the marmoset data
was obtained from Phillips (1976) and the present study.
Snecies G.L. begiilining of e.p. end of e.p. Duration







Galago 130 23 15 50 38 27
Green 155 21 13 48 31 27
Crab-
eating 165 17 10 46 28 29
Bonnet 165 17 10 46 28 29
Rhesus 165 17 10 . 46 28 29
Baboon 180 17 9 46 16 29
Man 270 19 7 54 20 33
Marmoset 144 -v30 ~20 -v80-85 ^55 -v50
present study) but less than 10 days later in these other
species. Furthermore, comparison of the external char¬
acteristics of the marmoset embryo with the human,
rhesus and baboon embryo indicated that the 60 day marmoset
embryo resembled approximately the 29 to 31 day human
embryo (Streeter, 1951) the 24 to 26 day rhesus embryo
(Heuser and Streeter, 1941) and the 27 to 28 day baboon
embryo (Ilendrickx, 1971). This was approximately a 40
day interval from the primitive streak stage in the marmoset
compared to about a 10 day interval in these other species.
The 80-85 day marmoset embryo was similar to approximately
the 50 day human, the 45 day rhesus and the 46 day baboon
embryo and in this case, the interval between the latter
2 stages of embryonic development was approximately 20
days for all of the species.
Therefore the lengthened initiation and duration
of the embryonic development period was probably primarily
due to a lengthening of the earlier stages of development,
which occurred between days 10 and 60 in the marmoset.
A fairly similar conclusion was reached by Phillips (1976).
Although he more accurately compared the stages of embryonic
development by utilisation of the Streeter classification,
he did not generally know the accurate gestation age assoc¬
iated with the developmental horizon.
The reason for the slower development of the
marmoset embryo during the first part of gestation is
unknown. It may be associated with the generally slower
placental development which is found in New World monkeys
compared to Old World monkeys (Hill, 1932; Beck, 1976;
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Hampton, 1975;TBaker, per'1 commun.). A seasonal factor
is probably irrelevant as young are produced throughout
the year (Phillips, 1975).
A common finding is a delay in the prenatal
development (e.g. delayed implantation) in species which
ovulate shortly after birth and during lactation (reviewed
Aitken, 1979)0 Although the marmoset is often lactating
for the first 60-80 days of pregnancy (Lunn and McNeilly,
1981), there are significant differences between the
marmoset and these species. Prenatal development in the
marmoset is not halted, but merely slowed down and this
occurs whether the mother is suckling young or not.
Phillips (1976) suggested that the lengthened
embryonic period may be related to the unusual embryology
of the marmoset. There may be delayed development during
which time the twin chorionic cavities enlarge and fuse to
become the common exo-coelom, which then undergoes a
period of enlargement.
In summary, if comparable times in pregnancy
are compared for prenatal development between species,
the marmoset would lag behind other species for more than
the first half of pregnancy. This factor should be remem¬
bered in interspecies comparisons of peripheral and fetal
hormonal levels and of relative ovarian-placental function.
7.5 Chapter summary
1) Standards for prenatal growth were established
for known gestational ages. These could be easily used by
other investigators.
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2) The marmoset apparently has a lengthened
period of embryonic development compared to other prim¬
ate species. The extension was due to prolonged
development between 10 and 60 days of pregnancy, after
which prenatal development proceeded at a similar rate
to other species.
3) Overall, placental and fetal growth followed
a similar pattern to other species: a) the growth rate
was greatest at the earliest time period studied; b)
maximum linear growth preceeded maximum weight growth;
c) head, and brain growth was accelerated compared to the
rest of the organs and body; d) there was a linear rela¬
tionship between the cube root of the weight and gestat¬
ional age; e) the placental to fetal weight ratio declined
with advancing gestation^ ^Maximum placental growth pre¬
ceeded maximum fetal growth.
4) Comparison of the birth size with the adult
size showed that the marmoset had achieved a size at birth




The purpose of this study was to investigate the •
endocrinology of pregnancy in the marmoset monkey. The
initial work provided essential detailed basic inform¬
ation on normal hormonal levels and interrelationships
in the peripheral plasma during pregnancy and lactation
(Chap 4). Radioimmunassays were used which had been
adapted and fully validated for marmoset plasma,(Chap
3). The later studies investigated ovarian and
placental function (Chap 5), the fetal hormonal
environment (Chap 6) and fetal development (Chap 7) at
frequent intervals throughout gestation utilising samples
from accurately dated pregnancies. The data in the
various chapters was interrelated to provide an inte¬
grated picture during pregnancy.
This is the first such study for a New World
primate species. The data obtained allowed comparison
of this species with other Old World sub-human primate
species and the human (See Chap 4-7) and provided a
base for more applied studies in this species in the
future. The marmoset is a suitable laboratory primate
for studies in reproductive biology (Chap 1.5) and some
of the parallels and divergencies between the marmoset
and other species suggest .it has considerable inherent
scientific interest. The studies in this thesis were
designed to investigate some of these aspects (See Chap
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1.6)., This chapter will further discuss the findings in
this thesis in relation to these aspects, perhaps indicating
some further areas of research required in this species.
Unlike other primate species so far studied, lactation
does not interfere with the return to fertility in the marmo¬
set, Why is there this difference between the marmoset and
other primates? This study shows that, like other primate
species, there is a clear association during lactation
between high levels of prolactin and a maintained suckling
stimulus. Ovulation and pregnancy occur soon after birth in
both lactating and non-lactating animals and it appears there¬
fore, that the marmoset is not susceptible to the inhibitory
influences of suckling and/or prolactin on reproductive function
Both of these are implicated as causal agents for inhibiting -
/
reproductive function in women, but which of these two
components is the more important has yet to be resolved
(McNeilly, 1979), Since the return to fertility is delayed
in lactating women, the mechanisms controlling this inhibition
of reproductive function have been of considerable interest
for contraceptive research (Howie and McNeilly, 1979). The
differences between the marmoset and women in their return to
fertility following birth may limit the use of the marmoset
in this field. However, further investigations on the role
of prolactin and the factors controlling prolactin secretion^
in the marmoset, may provide useful comparisons with the
human; as this study suggested significant differences between
the species in the role of prolactin in inhibiting reproductive
function and in its relationship with oestradiol during
pregnancy.
The marmoset perhaps has no need of a lactation-
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induced delay in the return to fertility. -In contrast
to the human, chimpanzee and gorilla which have long
lactation induced birth intervals (Short, 1980)
marmoset gestation is relatively long for such a small
mammal, the young are well developed at birth, weaned
between 60-90 days, grow rapidly and are relatively
independent of the mother by the time the next young are
born, approximately 160 days later (Lunn & McNeilly,
1981 ). Data in the present study showed that a high
percentage of marmosets are lactating during the first
part of pregnancy and that marmoset gestation is rela¬
tively long because:of the lengthening of the early
stages of development. Although the causes of this
lengthening do not seem to be due to lactation per se
as it occurs in all pregnancies irrespective of the
lactational status of the animals, the effect of this
lengthening is that the heavy physical and nutritional
demands of later pregnancy and the steep increase in
progesterone and oestradiol values associated with
increasing placental function are delayed until lactat¬
ion is completed.
The lengthened period of early development is one
of the striking differences between the marmoset and the
human. The reasons for the delay in early pregnancy are
not known (See Chap 7.4). However, differences in the
timetable of prenatal development may not be an unusual
finding and as more species are studied, an increasing
range of interspecies differences may be found. From
data already available in other mammalian species, it
seems that there are 2 principal ways in which a delay in
prenatal development occurs'; first, delayed implant¬
ation, which is a well-known phenomena depending on
environmental or physiological conditions (reviewed:
Aitken, 1979) and second, a generally slower rate of
development, which was indicated for the galago (HendrickX,
et al, 1975) and possibly the squirrel monkey (Goss,
et al. 193&; McKim et al, 1972.)° The present study
confirmed, and in addition, defined the timing of the slow
period of development in the marmoset. The marmoset is
the first sub-human primate species in which the
differences in the timetable or prenatal development
were studied in conjunction with the hormonal events.
These studies showed that the events which are contained
within the first trimester of human pregnancy are spread
out for more than one-half of pregnancy in the marmoset.
This was seen in the hormonal profiles and ovarian-placental
function as well as the prenatal development.
This study provided the first detailed information
on the hormonal profiles of a wide range of hormones
during pregnancy and showed that there were several
similarities in the hormonal profiles and interrelation¬
ships to the human (See Chap 4.4). However, several
salient 'differences were also indicated, the most notable
of which include the very high oestradiol and oestrone
levels^ the reversal of the oestradiol to oestrone
ratio during the first 2/3rds of pregnancy, and the
significant decline in progesterone during the last weeks
of pregnancy. This thesis related the hormonal profiles
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to ovarian and placental function (See Chap 5 and below),
but other factors relevant in mediating the peripheral
plasma hormonal levels remain to be defined. These
factors include the production and metabolic clearance
rates, the amount of hormone conjugated, and the levels
of steroid binding proteins. This latter factor will
relate to how much of the measured hormone is actually
found in the unbound form, which is considered to be the
active form. Measurement of the unbound fraction of the
steroid hormones in the marmoset would perhaps provide
a better comparison with the human of the amounts of
hormones actually available to the target tissues.
Ovarian and placental function were studied in timed
pregnancies at frequent intervals throughout gestation,
These studies establish the timing of the periods of
ovarian and placental dominance and the timing of the
transitional period from ovarian to placental dominance.
The exact timing of the dispensability of the corpus luteum
still needs to be determined for the marmoset by
ovariectomies on timed pregnancies. The transitional
period may be of interest for establishing whether there
is a relationship between ovarian ana placental secretion,
and whether placental function is the same in normal
pregnancies and in those in which there is an earlier than
normal decline in ovarian function. In the marmoset,
ovarian - placental function may be easily compared
between normal animals and those which had been ovariecto-
mised during the transitional period, using the in vivo
3^
and in vitro techniques used in the present study.
These techniques may also be used to assess ovarian-
placental function in marmosets which become pregnant
following immunisation against hormones (e.g. hCG and
LHRH) (Hearn et al, 1975; Hodges and Hearn, 1978) which
may affect either ovarian and/or placental function
(See Chap 1,4), It may be of particular interest to
assess ovarian - placental function in these immunised
animals because when these animals returned to breeding,
they experienced a series of recurrent abortion during
the transitional period (Hearn, 1976),
The studies in this thesis on placental function also
showed that the steep increase in peripheral plasma
progesterone and oestradiol levels, initiated after day
90 of gestation, was related to the increasing placental
function at this time. In this respect, the marmoset
resembles the human more closely than does the macaque.
The factors involved in regulating the increase in
placental function, which occur in both the human and marmoset
are not yet known. Gome factors (See also Chap 1.4)'"that have
been investigated include the role of the fetus, in
particular for providing androgen percursors for placental
aromatisation to oestrogen (Beling, 1977; Levitz and
Young, 1977). In the marmoset, Ryan et al (1961) also
showed the necessity for androgen precursors for placental
oestrogen production but to what extent the fetus
supplies the necessary androgen precursors is not known.
There have also been some investigations on a fetal role
■"s£S3E» . <K- ■,
for placental progesterone production in the rhesus
(Hagemenas and Kittinge'r, 1973, 1975; Lanman et al, 1975)
but these studies have not generally been followed up.
A role for oestrogen in maintaining placental progesterone
secretion was suggested by Albrecht (1980), based on his
studies in the baboon, and an interrelationship between
placental CG, progesterone and LHRH was suggested by
Wilson and co-workers (1980a,b), based on in vitro
studies using human placental tissue.
This study showed that the marmoset has advantages
for investigating some aspects of the control of placental
steroidogensis„ First, the increase in placental function
is dramatic and is consistently associated with a precise
stage of gestation and therefore only a short period of
pregnancy need be studied. Second, the gestational
changes in placental "function were reflected in the
in vitro secretion of progesterone and L1I/CG in cultures
of placental tissue. Placental and fetal tissues of a
reasonable size for in vitro studies can be easily
obtained during this period of gestation from timed
pregnancies without interfering with an immediate return
to breeding in the animal or without precluding its use
for future hysterectomy procedures (Phillips, 1976; Hearn
and Chambers, unpublished observations). The main
disadvantage to the marmoset is that due to its small size,
studies involving manipulative fetal surgery may be
difficult.
This study found that the increasing placental
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secretion of hormones which occurs after 90 days of
pregnancy is also relected in the fetal compartment,
and there is a substantial elevation in fetal hormonal
levelso However, the changes in the fetal compartment
are not necessarily parallel to those in the maternal
compartment, the most obvious examples being the reversal
of the oestrone to oestradiol ratio in the umbilical
vein and fetal sera compared to the maternal plasma,
and the increases in androgen levels which occur in the
fetal compartment but not the maternal, The physiolog¬
ical significance of a reversal in the oestrogen ratio
is not known although it is also found in the human and
rhesus (See Chap 6.4).
The elevation in fetal testosterone levels occur both
in female and male fetuses as a result of the increased
placental secretion, and unlike the rhesus and human
(reviews include: Reyes et al, 1976; Winter et al, 1977;
Resko, 1977), there was not a distinct period of
elevated testosterone levels due to a significant gonadal
contribution in the male fetus com,-pared to the female.
Unless a short period of elevated testosterone levg^s ,
such as seen in the rat (Weisz and Ward, 1980), was
missed, female fetuses apparently experience a similar
androgen environment as males. The factors involved in
sexual differention in the marmoset are as yet not
completely understood (See also Chap 6.4„d)0 Perhaps a
special arrangement exist in the marmoset which allows
normal and independent development of male and female
BMH
fetuses despite their intimate, relationship afforded
by a common blood pool. Marmosets are unique among
primates because of their high incidence of twinning
and the presence of vascular anastomoses that occur
between twin fetuses (Wislocki, 1939; Gengozian, 1971).
Although this situation invariably results in haemopoeietic
chimerism there is no evidence of freemartinism
(Benirschke and Brownhill, 1962) or any masculinisation
of the female co-twin,, The freemartin question is
beyond the scope of this discussion. Partial
masculinisation of the female marmoset could be achieved
during the early post-natal period by testosterone
administration (Abbott, 1979), but whether females can
also be masculinised in utero by testosterone adminis¬
tration is not known. The studies in this thesis
showed that a critical period one might consider for
androgen administration would be between 75 and 100
days of pregnancy. This is approximately from the time
of the earliest sexual differentiation (Hampton and
Taylor, 1971; see also Chap 6.4) to the time prior to
the increase in circulating hormonal levels in the fetus.
It may be important that the female fetus is not exposed
to high androgen levels prior to this time. After 100
days, it may not matter that the female experiences high
androgen levels but consideration may then be given to
the effect of exogenous androgen on the progesterone
to testosterone ratio, as there was a significant sex
difference between male and female co-twins. Resko
(1977) suggested, based on studies in the rhesus, that
this hormonal ratio may.be important.
The studies on embryonic and fetal development in
this thesis were the first in this species to be rel¬
ated to accurately dated pregnancies. The timing of
the prenatal development patterns was accurately
assessed and was compared with other species (See
Chap 7.4). This study showed that although the
marmoset has a lengthened period of early develop¬
ment, the fetal growth patterns during the latter
half of gestation correspond to those that might be
expected from a primate species of comparable size.
Furthermore, the data provide, a set of accurately
timed growth standards for the fetal marmoset which
can be utilised by other investigators.
In summary, the studies in this thesis fully
describe the hormonal profiles and interrelation¬
ships in the peripheral and fetal plasma, the
ovarian and placental function and the fetal develop¬
ment throughout pregnancy for the marmoset monkey.
This is the first such study in a New World primate
species. The studies showed that there are several
similarities and differences to the human. One
difference is that high levels of prolactin associated
with suckling do . not inhibit the return to fertility,
whereas an important similarity is that the sustained
increase in progesterone and oestradiol is related to
increasing placental function. In the latter respect,
the marmoset more resembles the human than does the
much used rhesus monkey, and therefore, in this respect
the marmoset is a more useful primate model for studies
during pregnancy than the rhesus. The gestational
changes in ovarian and placental function were defined, and
serve as a base for future investigations on this
aspect of pregnancy, and some possible lines of
research are described in this chapter. Measurement
of fetal hormone levels showed that, unlike the human
and rhesus, there is no definitive sex difference
in hormone levels, and that the placenta is primarily
responsible for the elevation in fetal hormonal levels.
Finally, this study showed that a major difference
between the marmoset and human is that there is a
lengthened period of embryonic development in the
marmoset, and that a comparable lengthening is seen
in all aspects of pregnancy.
3^1
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